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Abstract 
New luminescent iridium(III) complexes containing N^C^N cyclometallated 
ligands: synthesis, photophysical properties and emission tuning 
Pierpaolo Brulatti 
 
The luminescence properties of cyclometallated iridium(III) complexes render them 
of interest, for example, as phosphorescent dopants in organic light-emitting 
devices (OLEDs), as photoactive units in solar energy conversion, and as 
biosensors.  The vast majority comprise three bidentate ligands, archetypal 
examples being Ir(ppy)3 and [Ir(ppy)2(bpy)]+ (ppy = 2-phenylpyridine; bpy = 2,2'-
bipyridine). 
 
The work described here explores the chemistry of iridium(III) complexes that 
contain a terdentate cyclometallating ligand.  Most of the complexes studied have 
the general formula Ir(N^C^N)(N^C)X, where N^C^N represents a terdentate 
ligand based on 1,3-di(2-pyridyl)benzene; N^C a bidentate ligand such as ppy; and 
X is a monodentate ligand such as chloride, cyanide, thiocyanate or an acetylide.  
The synthetic methodology developed involves reaction of the N^CH^N proligand 
with iridium(III) chloride to give a dimer of the form [Ir(N^C^N)Cl(-Cl)]2, which is 
cleaved upon treatment with a bidentate N^CH ligand.  The one remaining chloride 
ligand can then be exchanged for other monodentate ligands through silver-
catalysed metathesis. 
 
Most of these complexes are highly luminescent, with quantum yields in degassed 
dichloromethane at room temperature between 0.2 and 0.9.  The effect of 
substituents in both the aryl and pyridyl rings of the terdentate and bidentate 
ligands has been investigated, together with the influence of X.  The emission 
energy has been shown to vary over a very wide range, from the blue to red 
regions (max = 456 to 667 nm).  The trends have been partially rationalised using 
time-dependent density functional theory and cyclic voltammetry.  Some 
complexes have been incorporated into multi-layer OLEDs that display unusually 
high efficiency, particularly for the red-emitting devices. 
 
 ii 
Selected rhodium(III) analogues have been prepared, together with related 
iridium(III) complexes incorporating bidentate N^N (bpy) ligands.  A preliminary 
investigation into the utility of these complexes for the construction of multimetallic 
assemblies has been made, through the introduction of bridging ligands into 
position X. 
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CHAPTER  1 
 
INTRODUCTION 
 2
1. Introduction 
 
The increased interest in studying and synthesising novel coordination compounds 
containing transiton metals is due to the wide range of possible applications that 
have been found which exploit their properties.  “The metal-ligand interaction can 
lead to properties of dual nature, the metal-ligand synergy is weak enough to 
permit the presence of the intrinsic properties of metal and ligands simultaneously, 
but also strong enough to show new properties, characteristic of coordination 
compounds.”(1)  Particular attention is deserved to be given to the photochemical, 
photophysical and electrochemical properties of metal complexes containing 
conjugated ligands, which have attracted the attention of a large number of 
scientists over the past decades(2).  Of crucial importance in this field, being known 
since its early stages as Inorganic Photochemistry, is how metal complexes 
interact with visible and ultraviolet light, mainly but not exclusively in solutions and 
for a large number of cases at room temperature.(2)   
 
A great deal of attention has been focused on complexes of transition metals with 
polypyridyl ligands, one of the first examples of investigation being [Ru(bpy)3]2+(2), 
which was reported in 1959 by Paris and Brandt.  [Ru(bpy)3]2+ attracted interest 
primarily as an excited-state electron-transfer agent, before being largely studied 
as the main reference example of low-lying metal-to-ligand charge-transfer 
(MLCT).  The reason for the popularity of this complex among inorganic chemists 
lies in the fact that it is easily prepared and relatively stable towards 
photodecomposition.(3)  Moreover complexes containing polypyridyl and related 
cyclometallating ligands can display intense phosphorescence following 
excitation.(4)   
 
New application, in light-emitting devices, luminescent probes and sensors rapidly 
evolved which maintained the interest in developing the knowledge of such kind of 
materials and, most likely, will be maintained in the future.(5)  As anticipated, 
numerous efforts were made in investigating the properties and synthesising new 
complexes containing metal centres such as Ru(II), as well as Os(II) and Re(I).(6-9)  
Only more recently, interest has extended widely to other types of metals, such as 
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Rh(III), Ir(III), Pt(II) and Pd(II); nevertheless these too show very promising and in 
some cases superior photochemical and electrochemical properties.(10)  
 
1.1 Luminescence in metal complexes 
 
1.1.1. Absorption 
 
Absorption of light by a molecule in the visible or ultraviolet regions results in 
formation of excited electronic states of the molecule.  Each excited state has its 
own characteristic energy relative to the ground state.  Atoms in their absorption 
spectra show very sharp lines, each of which is related to a transition to a different 
electronic state.  In the case of polyatomic molecules, because of vibrational and 
rotational energy in every electronic state, we observe that absorption spectra 
manifest the transitions involved with a different appearance, as broad bands.(11)  
This can be explained considering that the Frank-Condon principle, in its classical 
form, states that since absorption is “instantaneous”, a molecule is formed in its 
excited state with the size and shape of its ground state, and therefore has 
vibrational excitation.(11)  Since the nuclei are much heavier compared to the 
electrons, the electronic transition is much faster than the possible response of the 
nuclei.(12, 13)  Therefore the size and shape of the molecule beeing different in each 
of the electronic states, according to the Frank-Condon principle, absorption is 
presented in the spectrum as broad bands(2, 14). (Figure 1.1) 
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Figure 1.1: Franck-Condon effect for absorption and emission (a) for excited state 
and ground state having different internuclear distances 
and (b) for excited state and ground state of the same geometry and size. 
 
 
 
In general terms absorption is defined by the Beer-Lambert law, which can be 
written as: 
 
Abs = log10 (I0/It ) = cl 
 
In the above equation, Abs is the absorbance, l is the light path length through the 
absorbant material, c is the concentration of the absorbant.  Io and It are 
respectively incident and transmitted light intensities.(11)  The molar exctinction 
coefficient is referred to as the molar absorptivity, a function of incident light.  In 
absorption, extinction coefficients are related to the nature of the transition.  If the 
transition is forbidden by the principles of quantum mechanics, the extinction 
coefficient results to be small.  On the other hand, if the transition is allowed, the 
extinction coefficient is larger.(11)  The integrated extinction coefficient for one band 
in the absorption spectrum is related to the probability of a transition from the 
lower ground state to the upper excited state.  The reciprocal of the transition 
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probability is the lifetime of the upper state before it spontaneously reverts to the 
ground state by emitting a photon. 
 
1.1.2. Charge transfer transitions 
 
Metal complexes are susceptible to absorbtion of light, which in some cases may 
lead to the transfer of an electron (or at least negative charge) from the ligand to 
the d orbitals or from the d orbitals to the ligands.  In these transitions, called 
cherge transfer, electrons move over a notable distance within the molecule.  
Since metal complexes have complicated electronic structures, the presence of 
both metal and ligand orbitals leads to a wide range of available excited states.  
Molecular orbitals (MOs) comprise of several atomic orbitals and can be described 
as being of predominantly metal or ligand character, depending upon which atomic 
orbitals have the most similar energy to the MO of interest.(15-17)  When radiation is 
absorbed, an electronic transition between two molecular orbitals occurs and the 
resulting excited state can be characterised approximately by the molecular 
orbitals involved.(18)  The assignment of the various bands which appear in the 
absorption spectra of transition metal complexes is often a very difficult task to 
solve because the absorption spectra reflect the complexity of the electronic 
structure of the molecule.(1)  Charge transfer (CT) involves displacement of the 
electronic charge from the ligands to the metal or vice versa and can be itself of a 
number of types (Figure 1.2).  In metal complexes the transitions that occur in 
absorption can often be classified to a first approximation as charge transfer, 
intraligand or metal centred.(19, 20)  For example, metal to ligand charge transfer 
(MLCT) is an appropriate description when an electron is promoted from a d orbital 
of the metal to a π* orbital of the ligand, or LMCT when the charge transfer can be 
regarded as an electronic transition from an orbital of the ligand to an orbital of the 
metal.  Similarly electronic transitions can take place by promotion of an electron 
between two orbitals both localized on the ligand such as π-π* transitions (LC, 
ligand-centred or intraligand transitions).  Also metal centred transitions (MC) may 
be observed in which the participating MOs are localised predominantly on the 
metal centre and involve electron promotion between two orbitals of the metal.(2, 14)  
The transitions localised on the central metal ion are of the d→d type, usually 
observed in fluid solutions and relatively weak.(21) 
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Figure 1.2: Schematic energy-level diagram for an octahedral 
transition metal complex. The various kinds of electronic transitions are also indicated. 
 
 
 
Also some less frequently encountered types of transitions exist, including those 
that involve transitions from a metal centred orbital to an orbital localised on the 
solvent (charge transfer to solvent, CTTS) and ligand-to-ligand charge transfer, 
LLCT where the transition is betwen two orbitals localised on different ligands 
coordinated to the same metal centre. 
 
1.1.3 Emission 
 
The energy acquired by a molecule during the formation of an excited state can be 
released following different ways.  The process of radiative decay involves the 
molecule dispersing its energy by emitting photons.  A more common way consists 
instead of non radiative decay, when the excess of energy is transferred to other 
molecules as vibrational, rotational or translational energy, either within the same 
molecule or to other molecules or solvent in the local enviroment.  Also thermal 
degradation can occur, in other words the energy can be trasfered to the 
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enviroment as heat.  Molecules in their excited states can also take part in a 
variety of chemical reactions.   
In order to observe emission by a molecule, excitation has to occur in the first 
place, in other words the excited state needs to be populated, and if the energy 
required comes from absorbed light, then the subsequent emission of a photon by 
a molecular system is referred as photoluminescence(22).  Upon absorption of a 
photon of light of suitable wavelength, an electron is promoted to a higher energy 
orbital, producing a singlet excited electronic state (Sn).  This process, termed 
excitation, is denoted by the orbital that the electron originated from, and the 
orbital to which it is promoted, e.g. π–π *.  In a singlet excited state (Sn); the 
orientation of the spin of the excited electron is anti-parallel to that of the ground 
state electron.  According to Kasha’s rule the excited molecule undergoes rapid 
relaxation via a non-radiative pathway to the lowest singlet excited state (S1), this 
process is much faster than the competing radiative process.(23) 
 
It is possible to identify two different types of emission.  In Figure 1.3 these two 
different types of emission, termed phosphorescence and fluorescence, are 
schematically shown with a Jablonski diagram for a d6 complex (e.g. Ir(III)).   
 
 
S1
S2
Sn
T1
T2
ISC
ISCIC
ground state
Energy
10-15 s
absorption
fluorescence phosphorescence
kISC
kISC'kIC
kf kp
 
 
Figure 1.3(24): processes involved in absorption and emission for d6 complex (Ir(III)). 
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1.1.4. Fluorescence 
 
Once the initial absorption promotes the molecule to its electronic excited state, 
the molecule can undergo internal conversion, which is a very fast non-radiative 
process that can occur for upper electronic excited states to revert spontaneously 
to lower excited states or to the ground state, the difference in energy being 
converted into vibrational energy and then to heat.  It is called fluorescence when 
radiative relaxation from a Sn excited state to the singlet ground state S0 occurs, in 
other words fluorescence is a process that does not involve a change in spin 
multiplicity (Figure 1.3).  Fluorescence happens at lower frequencies compared to 
the exciting radiation because the emissive transition takes place after the energy 
is partially dispersed to the environment as vibrational energy.  In fact many 
fluorescent materials absorb in the UV and blue region and emit in the visible 
region as green or orange light.   
 
1.1.5. Phosphorescence 
 
On the other hand, sometimes spontaneous crossing from the initially formed 
excited state to a second excited state of different spin occurs, a process named 
intersystem crossing (shown in figure 1.3).(25)  Intersystem crossing occurs when 
the energy curve of the singlet and triplet excited states cross each other, 
therefore conversion from ↑↓ to ↑↑ of the electronic spins is possible and the 
molecule enters an excited triplet state.  
 
The corresponding radiative transition back to the ground state, which is called 
phosphorescence, involves a change of spin quantum number.  Being spin-
forbidden, phosphorescence is normally characterized by a longer natural lifetime 
whilst non-radiative processes are much faster at room temperature.  Triplet-
singlet transitions become more favoured when spin-orbit coupling is relatively 
strong.(12), for example, in heavy metal complexes.  Here, the process is 
accelerated by the strong spin-orbit coupling of the metal atoms that promotes the 
triplet-to-singlet transition by introducing a mixed character of singlet and triplet 
states and provoking a breakdown of the selection rules(2).  In this situation, the 
spin quantum number thus becomes an inaccurate description of the system, and 
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promotion of the spin-forbidden triplet-to-singlet radiative pathway increases the 
rate constant of phosphorescence to the point that it becomes competitive with the 
spin-allowed processes.(26)  Since the triplet excited states are always lower in 
energy than singlet excited states according to Hund’s rules, phosphorescent 
emission is lower in energy than the corresponding fluorescent emission.   
 
The efficiency with which a compound emits light can be quantified in terms of the 
luminescence quantum yield, which is the number of photons that are emitted per 
photon absorbed by the system.   
 
A metal complex in an excited state can also lead to a wide range of 
photochemical reactions due to the change in the electronic distribution caused by 
absorption.  Thus the excited molecule is characterized by a different reactivity 
compared to that of the ground state situation, and a large number of processes 
caused by molecular excitation are known.  For instance, the most common 
photochemical reaction for a complex is represented by replacement of a ligand by 
the solvent (e. g. water).(2) 
 
1.2 Coordination complexes containing polypyridyl ligands 
 
1.2.1. Ruthenium(II) complexes with bidentate polypyridyl ligands 
 
[Ru(bpy)3]2+ (Figure 1.4) has certainly been one of the complexes containing 
polypyridyl ligands most extensively studied and most widely used in research 
laboratories.(27)  Thanks to its stability, photochemical and redox properties, this 
complex has attracted the attention of many researchers, first on this molecule 
itself and then on several of its derivatives.(28-30)  The great deal of interest in 
studying this class of complexes has stimulated the growth of several branches of 
pure and applied chemistry.(31-33)  In particular, the Ru(II) polypyridine complexes 
have played a key role in the development of, not only photochemistry and 
photophysics, but also electrochemistry, photoelectrochemistry, chemi- and 
electrochemi-luminescence, and electron and energy transfer.   
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Figure 1.4: structure of [Ru(bpy)3]2+. 
 
 
 
The synthesis of [Ru(bpy)3]2+ (Figure 1.4) was reported in 1959 by Paris and 
Brandt.  The emission of [Ru(bpy)3]2+ was firstly assigned as being fluorescence 
from a singlet 1MLCT, d→π*, excited state.(34)  Only in a second instance was its 
emission described as spin-forbidden phosphorescence from a triplet 3MLCT, 
d→π*, excited state.  In fact deactivation of the upper excited states via non-
radiative decay and the long luminescence lifetimes confirmed the latter 
assignment.(33, 35)  The 2,2'-bipyridine ligand plays a role in the emission of the 
complex by acting as π-acceptor during the MLCT transitions due to the significant 
π backbonding between the Ru(II) and π * orbitals of bpy.(36)   
 
The photochemical properties of polypyridyl Ru(II) complexes, but also the 
reversible oxidation of the metal and reduction of the ligand at accessible 
potentials, stability of the oxidation states and electronic stability in both the 
ground and excited state, allowed this class of complexes to offer the potential for 
a wide variety of applications as luminescent photosensitisers, photocatalysts and 
electron transfer reagents converting light to chemical energy.(27, 36-40)  Another 
important feature of this class of complexes is the possibility of inserting ancillary 
ligands with adequate modifications, in order to modulate their properties.  This 
aspect gives a fundamental importance to ligand design allowing a wide range of 
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different types of ligands to be part of the chemistry of the polypyridyl complexes 
of ruthenium. 
 
 
1.2.2. Ruthenium (II) complexes with terdentate polypyridyl ligands 
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Figure 1.5: structure of [Ru(tpy)2]2+ 
 
 
 
Particularly advantageous, from a structural viewpoint at least, was the 
introduction of terdentate polypyridyl ligands in the coordination sphere of 
ruthenium polypyridyl complexes.  Being achiral, complexes of the [Ru(tpy)2]2+ 
type present several synthetic and structural advantages over the chiral bpy-based 
systems.(41)  Although tpy-based systems display less favourable photophysical 
properties, functionalisation on the 4’ position of the terpyridine ligand opens up, 
together with their intrinsic achirality, the possibility of building linear arrays.(42-45)  
Even though intermolecular photochemical processes have been widely 
investigated and exploited, photoinduced processes in covalently-linked 
multicomponent systems are of great interest.(46, 47)  Formation of multicomponent 
systems is achieved by assembly of suitable monometallic “building blocks”.  
Complexes based on [Ru(bpy)3]2+ have been used, but are not geometrically ideal 
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due to their existence as a racemic mixture of Λ and  isomers.  Thus when two or 
more complexes of this kind are linked together, stereoisomers are formed which 
are difficult to separate and may exhibit subtly different photophysical 
properties.(48, 49)  The successful purification of geometrical isomers of 
monometallic ruthenium complexes, incorporating mono-functionalised bipyridine 
ligands, has achieved by selective precipitation from methylene chloride and 
preparative plate silica chromatography, as recently been reported by Fletcher et 
al. (50, 51)  The isolation of such isomerically pure building blocks gives the 
possibility to investigate stereoselective synthesis of multicomponent systems.(24)   
 
[Ru(tpy)2]2+  however is found to be not emissive at room temperature.(52)  This can 
be explained by the weak ligand field splitting caused by the terpyridine ligands, 
allowing a favourable deactivation via non-radiative decay of the 3MLCT to a 
higher-lying but a thermally accessible 3MC level.(53, 54)  Efforts were made to 
inhibit this non-radiative decay to the 3MC level by attempting to increase the gap 
between the 3MLCT and the 3MC excited states. (55) (Figure 1.6)  The strategies 
adopted to do so include the introduction of electron withdrawing groups in the 4’ 
position of the terdentate ligand, more extended tpy-type ligands and the 
introduction of stronger σ-donor ligands such as cyclometallated ligands.(56-59) 
 
 
E
 
 
Figure 1.6(27): Radiative versus non-radiative decay. 
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In order to avoid the non-radiative decay, successful notifications were made by 
Sauvage and collaborators in the 90s who found that [Ru(4,4'-dptpy)2]2+ and 
[Ru(tptpy)2]2+ (Figure 1.7) were both emissive, in contrast to [Ru(ttpy)2]2+, which is 
non emissive at room temperature.(60)   
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Figure 1.7(24): Structure of (a) [Ru(ttpy)2]2+, (b) [Ru(4,4'-dtpy)2]2+ and (c) [Ru(tptpy)2]2+. 
 
 
 
This experimental data showed how, when the number of phenyl groups attached 
to the ligand is higher, the ligand’s π-acceptor ability is enhanced and the ligand 
field splitting energy becomes wider.  The increase in energy of the MC excited 
state and decrease in the MLCT state work synergistically to increase ΔE, 
enhancing luminescence.(60, 61) 
 
1.2.3. Ruthenium(II) complexes containing cyclometallated ligands 
 
Cyclometallating ligands, coordinating the metal centre by an anionic carbon 
through C-M bonds, are stronger σ-donors compared to the pyridyl rings.  
Therefore the induced ligand field is stronger and the electron density around the 
metal centre is higher.  In this way the splitting of the ligand field energy becomes 
bigger leading to more intense luminescence, since the 3MC is now at higher 
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energies compared to the 3MLCT.(62)  Examples of Ru(II) complexes containing 
cyclometallated ligands are [Ru(bpy)2(ppy)]+ and [Ru(ttpy)(phbpy)]+ (see Figure 
1.8), synthesised by Constable et al.(63, 64)  These complexes show emission from 
3MLCT and red-shifted absorption compared to the bpy and tpy-based complexes 
due to the σ-donor effect of the anionic carbon coordinated to the metal centre.(65) 
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Figure 1.8(24): Structure of (a) [Ru(bpy)2(ppy)]+ and (b) [Ru(ttpy)(phbpy)]+ 
 
 
 
1.3. Iridium(III) complexes  
 
Over the past 8 years, there has been a rapid expansion of the literature regarding 
luminescent complexes of iridium(III).  In this work, we will particularly focus on the 
synthesis, properties and applications of iridium(III) complexes containing 
cyclometallated ligands as they are thought to be very promising for use in OLEDs 
(Organic Light Emitting Devices) and other applications that will be described 
further on.  The main features that make iridium(III) complexes so appealing to 
researchers include their good stability, high photoluminescent quantum yields, 
ease of spectral tuning through synthetic modifications, short triplet-state lifetimes 
and ability to participate in outer sphere electron transfer reactions.(66-68)  As 
ligands play an important role in changing the electron density localized on the 
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metal center and hence the energy of the excited states, we can distinguish 
between two different classes of complexes containing different classes of 
ligands.(69)  At one extreme one type of complex contains three or four anionic 
ligating atoms such as chloride and/or cyclometallating aryl ligands; the complexes 
in this case typically have low-lying MLCT excited states since the charge 
compensation to the anions allows oxidation on the metal center.  The class at the 
other extreme contains exclusively neutral ligands instead.  In this kind of complex, 
less charge density is localized on the metal and the lowest-lying excited states 
are approximated as ligand centered (LC) since metal oxidation is 
thermodynamically unfavourable.(66)  In early studies of luminescent iridium 
complexes, difficulties emerged for species such as [Ir(bpy)3]3+, [Ir(phen)3]3+ and 
other tricationic species due to the harsh conditions required for their synthesis 
and difficult purifications(66, 67).  On the other hand iridium(III) complexes containing 
cyclometallating ligands, such as fac-Ir(ppy)3, have found interest in OLED 
applications as their emission from triplet MLCT states is found to be very efficient 
and also this type of complex is robust and features synthetic versatility and 
reversible electrochemistry.  Between these two extremes are complexes 
containing only one or two anionic ligating atoms and five or four neutral ligands 
respectively, which may display excited states of intermediate (MLCT/LC) or quite 
different (e.g. LLCT) character.(70)  All these characteristics have allowed iridium 
based complexes to displace complexes based on other metals in various 
applications.(68,71-74)  
 
1.3.1. Iridium polypyridyl complexes 
 
1.3.1.1. Iridium(III) complexes with two bidentate (N,N) ligands, [IrL2Cl2]n+ 
 
During the first attempts to obtain [Ir(bpy)3]3+, De Simone et al. in 1969 reported 
the formation of [Ir(bpy)2Cl2]Cl instead as undesired product by fusing 
K3IrCl6*3H2O with bpy at 270°C.  Characterisation of the obtained complex by 
NMR revealed it to be the cis isomer.(66, 75)  Similar types of complexes were 
shortly after synthesised, for instance in 1969 Chiswell et al prepared cis-
[Ir(phen)2Cl2]Cl (phen = 1,10-phenanthroline) starting from K3IrCl6 as well.(76)  
Broomhead presented a different synthetic method to obtain the same 
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phenanthroline based complex in 1971.(77)  The synthesis was carried out following 
two steps, in the first [Ir(phen)Cl4]2[phenH]+ was prepared from (NH4)3IrCl6·2H2O 
and 1,10-phenanthroline by reflux in acidic water for 2 hours.  The second step 
consisted of heating the phenanthrolinium salt in refluxing glycerol for 1 hour to 
give cis-[Ir(phen)2Cl2]Cl as a yellow solid.  These early examples of iridium 
polypyridyl complexes reflected the synthetic difficulties and the harsh conditions 
needed when preparing even simple iridium(III) complexes.(66)  A new synthetic 
method to synthesise this class of iridium(III) complexes was introduced by Brewer 
et al. in 1990, when complexes containing different types of polypyridyl bidentate 
chelates [IrL2Cl2]+ (Figure 1.9) were obtained from IrCl3*3H2O upon addition of two 
equivalents of the chelate L in a mixture of EtOH and H2O.(78) 
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Fig. 1.9(78): Representation of [IrL2Cl2]+ complexes (L = bidentate chelate). 
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It was observed in electrochemical studies that in the [IrL2Cl2]+ complexes the first 
two reduction steps were ligand based, which was in contrast to what was 
observed in the Rh(III) based complexes, where the first step in reduction was 
metal centred.(66, 78)  The ligands bpm, dpb, dpq, and dpb (Figure 1.9) are all 
easier to reduce than bpy, and the first reduction potential for these [IrL2Cl2]+ 
complexes is clearly related to the extent of electronic delocalisation over the 
ligand.  After the uptake of two electrons by the ligand system, reduction is metal 
centred and involves displacement of the chlorine atoms from the coordination 
sphere of the metal generating a four coordinated Ir(I) complex.  A noteworthy 
feature of the above reduction pattern is that the reduced two-electron [IrL2Cl2]2 
species are stable.  The luminescence data at room temperature of this series of 
complexes reflect the emission expected from a MLCT excited state, in fact the 
following emission maxima were observed along the series of ligands respectively 
for bpy (510 nm), bpm (525 nm), dpp (562 nm) and dpq (634 nm).(78)  The increase 
of the reduction potential of the complexes follows a similar pattern according to 
the emission.(66) 
 
1.3.1.2. Iridium(III) complexes with three bidentate (N,N) ligands, [IrL3]n+ 
 
The first examples of [IrL3]n+ type of Ir(III) complxes were, [Ir(bpy)3]3+ which was 
firstly reported in 1958 by Martin et al and obtained from K3IrCl6 and bpy as an 
orange solid,(79) and Ir(phen)33+ ( Figure 1.10 ) in 1964 by Chiswell at al, but in this 
last case purity was not clearly achieved.(76)  The procedure later described by 
Demas et al in 1974 led to better results, the complexes were synthesised by 
converting K3IrCl6*3H2O into a halide-free sulfate upon treatment with K2S2O8 and 
KHSO4 in boiling water, evaporation to dryness, and fusion in air above 250 °C for 
30 min.  Upon cooling it was mixed with bpy and fused under CO2 at 230°C, 
leading to [Ir(bpy)3]3+.(80) 
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Fig. 1.10: Representation of Ir(bpy)3 and Ir(phen)3. 
 
 
 
Treatment of cis-[Ir(bpy)2Cl2]+ with trifluoromethanesulfonic acid in o-
dichlorobenzene led to cis-[Ir(bpy)2(OSO2CF3)2]+ in 95% yield, as reported by 
Meyer et al. in 1984.(81)  This trifluoromethanesulfonate complex proved to be an 
excellent precursor to [Ir(bpy)3]3+, the substitution proceeding in 80% yield by 
heating with bpy in ethylene glycol for 5 h. 
 
1.3.1.3. Iridium(III) complexes with one terdentate ligand (N,N,N) (IrLCl3 
species) 
 
The first work that reported formation of a complex of the class IrLCl3 (Figure 1.11) 
was that of Morgan and Burstall in 1937 by reaction of Na3IrCl6 in water with terpy 
to obtain formation of Ir(tpy)Cl3.(82)  Brewer et al in the 80s prepared the same 
complex by reacting IrCl3*13H2O and tpy in ethylene glycol.(83) 
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Figure 1.11: structure of Ir(terpy)Cl3. 
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1.3.1.4. Iridium(III) complexes with two terdentate ligands (N,N,N) ([IrL2]3+ 
species) 
 
Demas and co-workers presented a paper in 1990 reporting the synthesis of 
[Ir(tpy)2]3+.(84)  The synthesis was performed in a similar way to that used for the 
preparation of [Ir(bpy)3]3+.  Starting from K3IrCl6, the iridium sulfate formed after the 
first step was then reacted with tpy at reflux temperature in ethylene glycol. (Figure 
1.12) 
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Fig. 1.12(66) Representation of bis-terpyridine complexes. 
 
 
 
 
In the work of Sauvage et al a new synthetic pathway to prepare bis-terdentate 
iridium(III) complexes was carried out following two steps, the first being the 
formation under relatively mild conditions of IrLCl3 as an intermediate from 
IrCl3*2H2O and then its reaction with a second tpy-based terdentate ligand to give 
(IrLL’)3+ type of complexes (85) (Figure 1.13).  Iridium bis-terpyridine complexes 
showed luminescence at room temperature, with emission at 458 nm for the 
complex bearing the unsubstituted terpyridine and above 500 nm for the ones 
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containing aryl-substituted terpyridines.  The complexes showed a ligand centred 
emission with some extent of MLCT character in the aryl-substituted complexes 
and lifetimes of the excited states on the scale of microseconds.(85)   
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Figure 1.13(86): Examples of [(IrLL’)]3+ complexes synthesised by Sauvage et al. 
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Figure 1.14(86): Schematic structures of bis-terdentate complexes; the planes of the two terdentate 
units are roughly orthogonally each other. 
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The emission properties of this class of polypyridyl complexes can be varied 
depending on the substituents attached to the terdentate ligands.  Along the series 
of Figure 1.14, the lowest-lying excited level, as monitored from the emission 
features, moves to lower and lower energy, a result mainly ascribable to an 
increasingly large ligand and more extensive conjugation.  Interestingly, along this 
series the emission passes from a predominant 3LC character for [Ir(tpy)2]3+, to a 
mixed 3LC/3MLCT character in [Ir(ttpy)2]3+ and [Ir(tBtpy)2]+, and finally to a 
predominant 3MLCT character for [Ir(PBAtpy)2]3+.  For [Ir(BPtpy)2]3+ the emission is 
best assigned to a 3LC level, likely centered at the biphenyl moiety.(87)  The 
changes in the nature of the emission display usual features.  The emission profile 
of a 3MLCT emission shows broad luminescence bands, while spectra 
characteristic of 3LC emissions are generally narrower and well resolved; some 
representative cases are illustrated by the luminescence profiles of Figure 1.15.(87)  
Hypsochromic shift of the emission peak occurs on passing from room 
temperature to 77 K in frozen polar solvent (see Figure 1.15), and kr value seems 
to be much smaller for 3LC cases compared to those of 3MLCT character.(88, 89)  
For [Ir(terpy)(NMe2tpy)]3+, an intraligand charge transfer state (ILCT, presumably 
from NMe2 to tpy) is thought to be the lowest-lying excited state, resulting in very 
weak emission intensity for this complex.  (Figure 1.15 spectra).(87)  
 
 
 
 
Figure1.15(27) Luminescence profiles at room temperature (dashed line) and at 77 K (full line) for a 
3LC emitter, [Ir(tpy)2]3+, and a mixed 3LC/3MLCT emitter, [Ir(ttpy)2]3+ 
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A similar synthetic strategy was adopted by Williams et al to prepare complexes 
with pH sensitive groups on the ligands, showing how the luminescence of the 
complex changes from a predominantly LC character at higher pH to mainly MLCT 
at lower pH values, following protonation of the pyridine site (90) (Figure 1.16). 
 
 
 
 
 
Figure 1.16(66) : pH-dependence of the luminescence of a pyridine-appended bis-terpyridine 
complex. 
 
 
 
The [Ir(tpy)2]3+-type species have been devised for the building up of dyads and 
triads as models for photoenergy conversion schemes.(25, 71, 87)  In this respect, 
Ir(terpy)23+-type units offer also the possibility to create linear arrays with 
geometrically opposite photoactive and electroactive units, e.g. D and A, electron 
donor and acceptor units, respectively (thus allowing to prevent the well known 
problem of the geometrical isomers encountered for tris-bidentate 
arrangements(91)). This can be done by attaching suitable substituents at the 4’-
position of the coordinated terpy’s with the usually explored electrochemical 
potential range.(71)  
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1.3.2. Iridium complexes containing bidentate cyclometallating ligands 
 
Ir(III) 5d6 complexes show several similarities with analogous complexes of Fe(II), 
Ru(II), Os(II) and Re(I), that are respectively 3d6, 4d6, 5d6 and 5d6.  In an 
octahedral field, the d orbitals of the metal are split by a magnitude that is 
proportional to the strength of the ligand field.  Cyclometallating ligands are 
located amongst the “strong” ligands in the spectrochemical series.  In early 
studies of iridium(III) polypyridyl cyclometallating complexes, it was noticed that 
spontaneous cyclometallation could occur during the preparation of [Ir(bpy)3]3+ 
involving one of the bpy ligands(67), so that widespread use of ppy as a ligand was 
adopted, since a wide variety of complexes containing cyclometallating ligands 
could be deliberately synthesised.  In further studies on complexes containing ppy 
ligands, it was noticed that the carbon atoms of the cyclometallating ligands were 
in mutually cis positions, which means that each one of them was in turn in a 
position trans to a nitrogen atom (trans effect of the Ir-C bonds).(92-94)  Thus a 
complex such as Ir(ppy)3 can exist as two different isomers as shown in Figure 
1.17, namely facial (fac) or meridional (mer) configurations (Figure 1.17).  This 
effect was clearly seen in the stepwise reaction of Ir(acac)3 with ppy, where the 
ppy subsequently displaces the acac group until complete conversion to fac-
Ir(ppy)3.(95) 
 
 
 
 
 
Figure 1.17(87): mer and fac isomers in Ir(C^N)3 complexes 
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The two isomers show different structural properties considering that in the fac 
isomer Ir-C and Ir-N bonds are nearly of the same length, for the mer isomer 
instead the bond situated in a trans position to the Ir-C bond is longer than those 
trans to a Ir-N bond.  The two isomers can thus manifest different behaviour in 
terms of electrochemical and photophysical properties.(96)  Most of the work 
reported to date on synthesis and photophysics of cyclometallated complexes of 
d6 transition metals is relative to the facial isomers.(97-99)  Originally Nanoyama in 
1974 and succesively Watts and coworkers synthesised in 1984 di-chloro-bridged 
iridium dimers by refluxing IrCl3 with the ligand in a 2-ethoxyethanol-water mixture 
(Figure 1.18) as the intermediate from which a series of tris-cyclometallated 
complexes were prepared that showed luminescence at room temperature.  The 
redox processes on the iridium metal center were found to be tunable as a 
function of the type of the substituent attached to the cyclometallating ligands 
(electron-withdrawing or electron-donor agents having a different effect on the 
photophysical properties of the complexes).(66, 100-103) (Figure 1.18) 
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Figure 1.18(66): representation of examples of di-chloro bridged iridium(III) dimers 
 
 
 
In Tamayo and co-workers’ work, new synthetic routes for isolation of either the 
facial or meridional isomers of tris-cyclometallated Ir(III) complexes and 
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conversion between them are shown.  The meridional isomer is the kinetically 
favoured product while the facial isomer is the thermodynamic product obtained at 
higher temperatures.  In Tamayo’s work it is also described how the spectroscopic 
and photophysical properties of the two isomers have different features.  It is 
reported in the literature that meridional isomers display red-shifted emission and 
decreased quantum efficiencies compared to their facial relatives, a fact that can 
be explained by the efficient bond breaking that occurs for the meridional isomer in 
the excited state acting as an effective quenching pathway and giving 
isomerization to the facial isomer.(96)  The presence of three cyclometallating 
ligands on the metal centre induced a 3MLCT character of the emission at room 
temperature.  In 2000, in fact Thompson and coworkers published a paper 
reporting the first OLED based on Ir(ppy)3.(104)  Watts et al. also reported the 
synthesis and photophysical properties of complexes containing both 
cyclometallating and polypyridyl ligands (such as [Ir(ppy)2(bpy)]+, Figure 1.19). 
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Figure 1.19: structure of [Ir(ppy)2(bpy)]+ 
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[Ir(ppy)2(bpy)]+ displayed intermediate electrochemical and photophysical 
properties between the LC predominant character of [Ir(bpy)3]3+ and the MLCT 
character of [Ir(ppy)3].(105)   
 
1.3.3. Iridium complexes containing terdentate cyclometallating ligands 
 
Complexes containing terdentate ligands offer the possibility of creating linear 
arrays with photoactive and electroactive units avoiding the problems of 
geometrical isomers as seen in the case of units containing bidentate ligands.  The 
approach adopted is usually functionalization on the aromatic “ends” of the 
complex structure by attaching substituents and building up multicentred systems 
by reacting different metal fragments.  In particular, a good strategy to obtain 
linearly disposed multicentered complexes is by functionalization of the 4’ position 
of the coordinated terpy.(91, 106)  Moreover the introduction of terdentate ligands on 
the complex platform can help prevent molecular distortions during the formation 
of the excited states.(106) 
 
The research group of Campagna and Mamo synthesised in 1997 the first Ir(III) 
complex with terdentate cyclometallating ligands.  Preparation of complexes 
[Ir(LH)(L-)]2+ and [Ir(L-)2]+ was reported by refluxing IrCl3*3H2O in glycerol, where 
LH indicates 2,6-bis(7’-methyl-4’-phenyl-2’-quinolyl)pyridine(107) (coordinating as a 
N,N,N terdentate ligand) and L- its deprotonated form (which can coordinate the 
iridium as N,N,C cyclometallating ligand) (Figure 1.20).  Both complexes show low 
energy MLCT character in their emission due to the introduction of 
cyclometallating ligands in the coordination sphere of the metal centre.(107)  
However, the complex [Ir(LH)(L-)]2+ (heteroleptic monocyclometallated complex) 
showed lower luminescence intensity at room temperature compared to [Ir(L-)2]+ 
(homoleptic bis-cyclometalated complex).(107)  The investigation carried out by 
Williams and coworkers on mono-cyclometalated [Ir(NCN)(NNN)]2+ complexes 
(Figure 1.21) explained the low luminescence intensity in terms of the higher 
degree of ligand-to-ligand charge transfer character and low metal contribution of 
the excited state in heteroleptic monocyclometallated complexes.(108, 109)  On the 
other hand the higher luminescence observed in the homoleptic bis-
cyclometallated complexes can be explained by a higher MLCT degree caused by 
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the increase of the σ-donor effect with the introduction of a second 
cyclometallating ligand.(107, 108)   
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Figure 1.20(67): representation of Mamo and Campagna’s mono- and bis-cyclometallated 
complexes with terdentate ligands. 
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Figure 1.21: structure of a [Ir(NCN)(NNN)]2+ complex 
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Promotion of a higher degree of metal participation upon bis-cyclometallation is 
confirmed also in systems of the type [Ir(N^C^N)(N^N^C)]+.(109)  Moreover the fact 
that the cyclometallating carbons are part of a different terdentate ligand 
contributes to decrease the extent of the LLCT character.(107) 
 
The increased contribution of the metal centre in the excited states of the complex 
within the passage from mono- to bis-cyclometallated platforms suggests that the 
introduction of a third cyclometallating site in the coordination sphere may increase 
the MLCT character of the emission even further.(107)  The research group has 
been involved in the investigation of the synthesis and the photophysical 
properties of bis-terdentate coordinated complexes containing dipyridyl-xylene 
N^C^N ligand and a second terdentate ligand C^N^C or C^N^O-coordinating 
(Figure 1.22).  The C^N^C-coordinating class of bis-terdentate complexes were 
manifesting promising emission properties with quantum yields comparable to 
those of the analogous tris-bidentate complexes (e.g. Ir(ppy)3).  The emission was 
described as 3MLCT character, and, as confirmed by DFT calculations, the LUMO 
was mainly localised on the N^C^N ligand.(108, 109)  The C^N^O-coodinating 
systems, on the other hand, exhibited low luminescence quantum yields.  Despite 
the high luminescence, complexes bearing C^N^C ligands possess very low 
stability in solution, involved in photodissociation, leading to cleavage of one of the 
trans-disposed Ir-C cyclometallating bonds and probable fomation of the five 
coordinated species bearing a solvent molecule on the sixth coordination site.(107)   
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Figure 1.22(87): example of Ir(N^C^N)(C^N^C) complex 
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1.4. Nature of excited states in Iridium Cyclometallated 
Complexes and their modifications 
 
As noted previously, light absorption is associated with electronic transitions from 
a ground state to singlet levels of various electronic localization such as ligand 
centered (1LC), metal centered (1MC), metal-to-ligand charge transfer (1MLCT) 
and ligand-to-metal charge transfer (1LMCT),(110-113) whereas emission instead is 
nearly always associated with a process from the lowest lying triplet state (Figure 
1.23).(114)  Due to the separation of the energies of the d orbitals, Δ is large in 
iridium(III) complexes so that MC levels in such complexes do not participate in 
emission as they are hardly accessible in energy.  This implies that an electron 
promotion occurs from the HOMO (Highest Occupied Molecular Orbital), which is 
localized on the metal center for the MLCT transition, to π* orbital LUMO (Lowest 
Unoccupied Molecular Orbital) located on the ligand, mainly on the pyridine 
rings.(115)   
 
 
 
 
Figure 1.23(87): a) orbitals in octahedral field; b) orbital description of MC, MLCT and LC 
transitions. 
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Iridium complexes containing cyclometallating ligands show two main emissive 
transitions in the long-lived excited states, namely in approximation they are 
associated with metal-to-ligand charge transfer (MLCT) and ligand centered 
transitions (LC) respectively.  The formation, in Iridium(III) complexes, of a mixed 
emissive triplet excited state is enabled by the strong spin-orbit coupling 
associated with the metal centre which promotes intersystem crossing.  In fact a 
combination of measurements, such as excited state lifetime measurements, time 
resolved luminescence and computational investigation, showed how the excited 
state involved in the emission of cyclometallated iridium(III) complexes is thought 
to be a mixed MLCT-LC character.(68, 116)  This effect occurs when sufficient 
overlap is present between MLCT and LC states(116, 117).  Thus by changing the 
nature of the ligand and the substituents situated on them it is possible to tune the 
energy of the orbitals involved.(68)  Also in some cases, transitions between 
cyclometallating ligands and ancillary ligands are feasible.  On the other hand, 
when the contribution of the π* orbitals is mainly of the cyclometallating ligands, 
both frotier orbitals are associated with them and the ancillary ligand plays a more 
passive role in the excited states but, by influencing the metal orbitals via inductive 
communication through σ bonds, even a non-participating ligand can adjust the 
energy of the MLCT transition by changing the degree of mixing of states.(116)   
 
1.4.1. Emission tuning 
 
In summary, tuning the energy of the excited states can be aproached in different 
ways, such as coordination of different types of ligands to the metal center.  By 
selecting appropiate ligands, it is possible to tune the emission of the complexes, 
ranging over the visible spectrum from blue at high energies to red at low 
energies.(118-121)  The energy of the excited states can be also modified by 
changing the degree of conjugation on the ligands in order to diffuse or reduce the 
coordination sphere of the complex, or even changing the level of aromaticity 
present on the ligands themselves.  For example, recent investigations have 
shown that in iridium(III) complexes containing terdentate cyclometallating ligands, 
low-energy emission is achieved in cases of extended π systems.(122-124)  The 
introduction of anionic ligands in the complexes stabilizes the MLCT states and 
decreases the possibility of an intraligand charge transfer transition.  It is also 
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possible to tune the energy of the excited states of the complex by substituent 
effect, in order to change the electron density on the metal-ligand bonds and the 
energy of the orbitals involved.  In particular electron-withdrawing substituents on 
the ligands such as –F and -CF3, tend to stabilize the HOMO by lowering the 
electron density on the metal center or, on the other hand, electron-donating 
substituents such as –C(CH3) or –OCH3, lead to the opposite effect, and attached 
to the conjugated ligands they modulate the energy of the excited state.(68, 125)   
 
1.4.1.1. Yellow and red-shifted emission 
 
A wide range of colours obtained in electrogenerated chemiluminescence is 
reported for Ir(III) complexes as they move from green (Ir(ppy)3) to yellow 
(Ir(thpy)3) in neutral heteroleptic complexes of the structure (C^N)2Ir(LX), where 
the cyclometallating ligands are of various nature (Figure 1.24) and LX represents 
a monoanionic ligand such as acetyl acetone, picolinic acid or N-methyl 
salicylimmine (Figure 1.24).(126, 127)  It has been observed by Thompson, Forrest 
and co-workers that variation of colour depends on the different types of 
cyclometallating ligand coordinated to the metal (Figure 1.25) ranging from 512 nm 
to 612 nm for bis-cyclometallated complexes bearing a bidentate anionic ancillary 
ligand, with quantum yields within the interval 0.1 and 0.4.  In particular, as the 
size of the cyclometallating ligands increases (more delocalization of the electron 
density), the energy of the ligand-centred LUMO lowers, allowing the emission to 
change from green (Ir(ppy)3) to yellow (e.g. Ir(thpy)2(acac)) and then to red (e.g. 
Ir(αbsn)2(acac)), for the complexes that emit above 600 nm.(87, 126, 127) 
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Figure 1.24(126): neutral heteroleptic complexes of the structure (C^N)2Ir(LX) 
 
 
 
 
Figure 1.25(87): different C^N ligands used in neutral heteroleptic complexes of the structure 
(C^N)2Ir(LX) 
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Emission shift from green to red is shown with complexes of the structure fac-
Ir(C^N)3, in neutral homoleptic complexes, by varing the nature of the 
cyclometallating ligand coordinated to the iridium centre (figure 1.26).(86)  This 
class of complexes shows emission properties similar to those of (C^N)2Ir(LX) with 
quantum yields ranging from 0.08 to 0.4 and  red-shifted emission until reaching 
644 nm for the most red emitting complex of the series Ir(tiq)3.(86) 
 
 
 
 
 
Figure 1.26(87): examples of C^N ligands used in fac-Ir(C^N)3 to have colour change from green  to 
red 
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1.4.1.2. Blue-shifted emission 
 
The excited states of Ir(III) complexes can be tuned to shift the emission to the 
opposite direction, to the blue and near UV, by adopting different strategies.  In 
fact electron-withdrawing groups as substituents on the cyclometallating ring, such 
as fluorine, stabilize the HOMO level with little effect on the LUMO, provoking thus 
an increase in the HOMO-LUMO energy gap and finally leading to emission at 
higher energies.(96, 128, 129)  In Figure 1.27 are reported examples of 
cyclometallating ligands used by Thompson and co-workers, (96) in which phenyl-
pyrazole and tolyl -pyridine based ligands shift the emission to the blue with 
respect to the phenyl-pyridine based complexes.  This effect is induced by the 
electro-withdrawing fluorine substituents on the phenyl rings and also by changing 
of the nature of the N^C fragment with the introduction of a pyrazole ring in the 
place of a pyridyl ring, which destabilises the LUMO.  The emission for the 
complexes ranges from 492 nm for the fac-Ir(ppy)3 to 450 nm for the fac-Ir(dfppy)3, 
until 390 nm for fac-Ir(dfppz)3.(96) 
 
 
 
 
 
Figure 1.27(96): Cyclometallating ligands used to prepare blue emitting Ir(C^N)3 type of complexes.  
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On the other hand it has been found that ancillary bidentate ligands of the type LL 
or LX can also cause a blue shift in emission.(116, 129)  Thompson and co-workers 
prepared a series of complexes of the type Ir(N^C)2(LL) and Ir(N^C)2(LX) that 
show bluer emission if compared to analogous complexes containing acac as 
ancillary ligand (Figure 1.28).  Tuning the emission by ancillary effect can lead to 
significant shifts towards the blue region (e.g. from 512 nm for Ir(tpy)2(acac) to 458 
nm for the complex [(tpy)2Ir(dppe)](CF3SO3)).(116) 
 
 
 
 
 
 
Figure 1.28(116): LL ancillary ligand used from Thompson et al. for blue emitting complexes 
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Monodentate ancillary ligands such as cyanide and isocyanide can cause a blue 
shift in emission compared to that of fac-Ir(ppy)3.  This phenomenon can be 
rationalised by the fact that the cyanide and isocyanide are characterized by 
strong electron-withdrawing properties.  In blue emitting complexes the degree of 
mixing of MLCT and LC character is decreased in the excited state.  This happens 
because the iridium d orbitals, which participate the HOMO, are located at lower 
energies and only a little change is introduced in the energy of the LUMO.(107)   
Another strategy to blue-shift the emission of iridium(III) complexes consists in 
destabilising the LUMO energy level rather than stabilising the energy of the 
HOMO, in order to increase the HOMO-LUMO energy gap.(130-135)  Photochemical 
studies on complexes containing different heterocycles manifested significant 
shifts towards blue emission (e.g. Ir(dFppy)(ppz)2 390 nm and Ir(dFppy)2(ppz) 380 
nm, see Figure 1.29).(22)  However luminescence quantum yields for this type of 
complxes was reported to be 2 orders of magnitude lower than for the pyridyl 
analogues (e.g. Ir(pmb)3, Φ=0.04), probably due to the fact that the emission level 
lies at very high energies, thus a small 3MLCT-3MC energy gap characterises 
these complexes.(87, 129) 
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Figure 1.29(87): examples of bidentate ligands for blue emitting complexes containing different 
heterocycles from pyridyl rings. 
 
 
 
1.5. Applications of luminescent metal complexes 
 
Luminescent metal complexes are attractive for diverse applications.  The 
effectiveness of a complex in a specific role is determined by its excited-state 
properties and can be manipulated through synthetic modifications.(68)  Early works 
in this field were predominantly focused on ruthenium(II) tris-diimine complexes, 
but a limitation of the material was the limited possibility of colour tunig caused by 
a non emissive thermally accessible metal centred state.(1)  Iridium(III) complexes 
were found to be more suitable for many applications.  In fact, Ir(III) complexes 
have a broad colour tuning possibility, due to an increased ligand-field stabilisation 
energy, therefore the 3MC state is less accessible than in the case of Ru(II) 
complexes.(73, 74)  But also, the reversible electrochemistry, synthetic versatility, 
 39
and robust nature of iridium (III) complexes render them appealing materials for a 
multitude of applications. 
 
Consequently, the design of novel complexes for OLED applications has become 
a major synthetic goal in materials research.(127, 137)  The usefulness and 
applicability of new luminescent materials can be assessed according to their 
stability, external quantum yield, excited-state lifetime, and emission energy.  It is 
highly desirable to tailor transition-metal complexes that will emit across the visible 
spectrum and to produce molecules in which light emission predominates over 
nonradiative decay.  These properties can be evaluated using both photo- and 
electroluminescent methods.(138)   
 
1.5.1. OLED applications 
 
Organic electroluminescence (EL) is the electrically driven emission of light from 
noncrystalline organic materials, which was first observed and extensively studied 
in the 1960s.(139)  In 1987 Kodak introduced a double layer organic light-emitting 
device (OLED), which combined modern thin film deposition techniques with 
suitable materials and structure to give moderately low bias voltages and attractive 
luminance efficiency.(140)  Shortly afterwards, in 1990 the Cambridge group of 
Friend announced a conducting polymer-based LED(141, 142).  Since then, the 
interest in research in this new field has been increased, and progress has been 
made in improving color gamut, luminance efficiency and reliability of the devices.  
The growing interest is largely motivated by the promise of the use of this 
technology in flat panel displays.  The efficiency of an OLED is determined by 
charge balance, radiative decay of excitons, and light extraction.  Enormous 
progress has been made recently in developing phosphorescent emitters via 
triplet–singlet energy transfer, and high-efficiency OLEDs with a wide range of 
different colours have been prepared and reported.(142)  Current research activity is 
directed towards surface modifications that can increase light extraction efficiency, 
while the problem of light-trapping remains unsolved in terms of its application to 
displays.  The most critical performance characteristic for OLEDs is the device 
operational lifetime.  Continuous operation of OLEDs generally leads to a steady 
loss of efficiency and a gradual rise in bias voltages. Although OLEDs have 
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achieved long operational stability, the material issues underlying the EL 
degradation are not fully understood.(142) 
 
An OLED has an organic EL medium consisting of extremely thin layers (<0.2 mm 
in combined thickness) sandwiched between two electrodes.  In a basic two-layer 
OLED structure, one organic layer has the function of transporting holes and the 
other organic layer is specific for transporting electrons.  The interface between 
the two layers provides recombination of the injected hole–electron pair resulting 
in electroluminescence.(13)  When an electrical potential difference is applied 
between the anode and the cathode such that the anode is at a more positive 
electrical potential with respect to the cathode, injection of holes occurs from the 
anode into the hole-transport layer (HTL), while electrons are injected from the 
cathode into the electron-transport layer (ETL).(142)  The injected holes and 
electrons both migrate towards the oppositely charged electrode, and upon 
recombination, energy is released as light.  The heterojunction should be designed 
to facilitate hole-injection from the HTL into the ETL and to block electron injection 
in the opposite direction in order to enhance the probability of exciton formation 
and recombination near the interface region.(142)  
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Figure 1.30: schematic recombination process in the Energy level diagram of a two-layer OLED.  
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As shown in Figure 1.30, the highest occupied molecular orbital (HOMO) of the 
HTL is slightly above that of the ETL, so that holes can enter into the ETL, while 
the lowest unoccupied molecular orbital (LUMO) of the ETL is significantly below 
that of the HTL, in order that electrons are trapped in the ETL.  The simple 
structure of a two layer OLED can be modified to a three-layer structure, in which 
an additional luminescent layer is introduced between the HTL and ETL to function 
primarily as the site for hole–electron recombination and thus 
electroluminescence.(142)  A great advantage of the three layer OLEDs is that the 
functions of the individual organic layers are distinct and can therefore be 
optimized independently.  Thus, the luminescent layer can be chosen to emit a 
desired color as well as a high luminance efficiency.  Moreover ETL and HTL can 
be optimized primarily for the carrier-transport property.  The extremely thin 
organic EL medium offers reduced resistance, permitting higher current densities 
for a given level of electrical bias voltage.  Since light emission is directly related to 
current density through the organic EL medium, the thin layers coupled with 
increased charge injection and transport efficiencies have allowed acceptable light 
emission to be achieved at low voltages.(142) 
The composition of OLEDs consists of an organic matrix in which the luminescent 
chromophore is embedded, then the matrix (for example 4,4’-N-N’-
dicarbazolylbiphenyl, CBP) is sandwiched between multiple layers of charge 
transport materials such as 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline, BCP 
and 4,4’-bis-[N-(naphthalyl-N-phenylamino)biphenyl, α-NPD (electron and hole 
transport materials respectively) and capped with a low work-function cathode 
(LiF/Al) and a transparent anode (indium-tin oxide.(Figure 1.31)(68) 
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Figure 1.31(68):a) A multilayer device ensemble involving an organic material (e.g., CBP) doped 
with a neutral or anionic iridium(III) chromophore. This matrix is sandwiched between hole- (e.g., 
-NPD) and electron-injecting (e.g., Alq3, q=8-hydroxyquinoline) layers as well as a hole blocking 
layer (e.g., BCP) and capped with a low work-function cathode (e.g., LiF/Al) and a transparent 
anode (e.g., ITO). b) Single-layer device geometry in which a cationic iridium(III) chromophore is 
spin-coated on an ITO substrate and capped with a gold electrode. c) Electroluminescence from 
[Ir(ppy)2(dtbbpy)](PF6) in a single-layer, air-stable device (560 nm). 
 
 
 
Transition metal-based organic light emitting diodes (OLEDs) are considered to be 
promising candidates for flat panel displays, due to their color versatility, low 
operational voltages and phosphorescence efficiency.(143, 144)  Many efforts in this 
field have been made during the recent years to replace liquid crystal displays 
(LCDs).(143)  Industrial interest was already attracted by SMOLEDs (Small 
Molecule OLEDs) and polymer-based OLEDs with some cases already available 
on the market.(142, 145, 146)  The ongoing design of new material leads to higher 
efficiencies, enhanced brightness and improved lifetimes of optoelectronic 
devices.(142)  Tang and Van Slyke in 1987 assembled the first OLED based on 
metal complexes by using an Alq3 (q=8-hydroxyquinoline) which emits green light 
from a singlet excited state chromophore.(140)  Since then altering the device 
characteristic through modifications on the chromophores has aroused large 
attention among scientists, specially by using heavy metal complexes such as 
those containing Ir(III), Ru(II), Os(II) and Pt(II).(141, 142, 147)  Thanks to the strong 
spin-orbit coupling, singlet-triplet mixed states are generated in metal complexes 
and the spin-forbidden nature of the relaxation of the triplet state is removed so 
that high efficency electrophosphorescence is achieved in OLEDs containing 
heavy metal complexes (in figure 1.32 some examples are shown).(142)   
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Figure 1.32(142, 148): triplet emitting materials and related intermediates 
 
 
 
The electrically generated excitons, produced when holes and electrons, after 
being injected, migrate through the thin film to the interface between the two layers 
recombine, can be either singlets or triplets.(149)  Theoretical predictions and 
experimental measurements suggest a singlet-to-triplet ratio for the excitons of 1 
to 3.  The strong spin-orbit coupling due to the presence of heavy-metal 
complexes enhances therefore the efficiency of the emission.(147)  In fact triplet 
emitters can have theoretical limit of emission efficiency of 100% against the about 
25% of the singlet emitters such as organic molecules.(68)  Thanks to their 
electroluminescence properties, iridium(III) complexes have been found to be 
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promising for use in OLEDs, as they are not subject to displacement effects under 
electrical fields(141) and neutral iridium(III) complexes have attracted a lot of 
attention in this field during the last decade. The interest shown towards Ir(III) 
metal complexes is also driven by the possibility of changing the emission energy 
in order to make possible a wide variety of colours, ranging from green for Ir(ppy)3 
to yellow, red and blue according to the ligand.(86, 133, 150, 151)  In their work, 
Thompson and Forrest reported how, by changing the nature of the excited states, 
they observed emission from different regions of the visible spectrum.(150, 152)  
Holmes and Friend in a similar way tuned the electrochemiluminescence into 
green-blue emission by synthetic modifications and improved operational lifetimes 
of the devices by introducing less labile ancillary ligands on the complexes.(153)  
Anionic iridium complexes of the form [Ir(ppy)2X2], where X can be CN- or NCO-, 
are found to show similar properties that can be exploited in OLED fabrication 
thanks to their improved stability(68).  Cationic iridium(III) complexes have recently 
emerged since they show ability to electrochemiluminesce from a single-layer of 
neat complex sandwiched between two air-stable electrodes.(68)   
 
1.5.2. Oxygen sensing 
 
Ir(III) cyclometallated complexes show high luminescence in degassed solution, 
with quantum yields of the order of 0.5 and even higher and lifetimes in the range 
of µs.(154, 155)  In the presence of oxygen (aerated solutions) quantum yields and 
lifetimes can be quenched by a factor of even 60 times compared to the values in 
degassed solutions.(147)  Thanks to their tunable excited state properties and 
relatively high stability in presence of singlet oxygen,(156) iridium(III) luminophores 
have found potential application as oxygen probes in various medicinal, chemical 
and environmental sensors.(157-159)  This is due to the fact that an efficient energy 
transfer occurs to the triplet ground state of molecular oxygen that results in 
luminescence quenching of the complex and the formation of singlet state oxygen 
O2(‘Δg).(68, 160)  Oxygen concentration is then quantified according to the changes 
in the luminescence intensity and in the lifetime of the complex.(161)  The biggest 
limitation to the successful application of solid state iridium(III) based sensors is 
due to the possibility of self-quenching between neighboring molecules.(68)  
Ongoing studies are focussing on trying to avoid such a limitation, which can be 
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done by separating the luminescent dyes by embedding them in oxygen 
permeable polymeric matrices with the intention of preventing dye aggregation, but 
the low loading concentration limits the sensitivity of the sensor.(68, 160) 
 
1.5.3. Solar energy harnessing and photocatalytic water splitting 
 
Of major interest for scientists is the possibility to convert solar irradiation into an 
usable form of energy.(68)  Iridium(III) complexes can be used as photosensitisers 
in harnessing solar energy through a photocatalytic cycle to split water into oxygen 
and hydrogen that can provide a valid source of fuel.(68)  In fact in such processes 
a transition metal is required as photosynthesiser in conjunction with an electron 
relay to collect and store radiant energy and then convert protons to hydrogen 
molecules.(68, 162-164)  The process involved is composed of two half reactions; in 
one the water is oxidised into molecular oxygen and in the other reduced into 
molecular hydrogen.(68)  The possibility of producing hydrogen attracts a big deal 
of attention into this process since hydrogen can represent a potential source of 
fuel.  Due to the ease with which cyclometallated iridium(III) complexes may be 
involved in typical photoreduction schemes, they can serve as photosensitisers in 
combination with an electron relay used to collect and store radiant energy in order 
to transform protons into molecular hydrogen.(161, 162)  In particular heteroleptic 
iridium(III) complexes are thought to be promising candidates for this type of 
application and recently have displayed significant improvements in terms of 
hydrogen production compared to the previously used [Ru(dmphen)3]2+ 
(dmphen=4,7-dimethyl-1,10-phenanthroline).(165) (Figure 1.33)  The improvement 
in hydrogen production has been attributed to the fact that Ir(III) complexes are 
stronger reducing agents compared to ruthenium complexes, allowing an easier 
passage of electrons to the electron relay.(68) 
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Figure 1.33(165): heteroleptic Ir(III) complex synthesised by Bernhard et al. The complex showed 
improvements in hydrogen production compared to the standard [Ru(dmphen)3]2+ previously used. 
 
1.5.4. Bioanalytical applications 
 
Iridium(III) complexes can be good candidates for bioanalytical applications as 
well.(68)  Intense emission and long-lived excited states are the properties that 
render them excellent materials for sensitive and time resolved detection.(166)  The 
ability of suitably functionalised iridium complexes to bind biological substrates 
allows biological labelling applications.(68)  The complexes can bind substrates in 
two different way, the complex can be bound covalently with, for example, 
aldehyde-amine cross linking or for example noncovalently by DNA 
intercalation.(167, 168)  The complexes bound to the substrates exhibit different 
luminescence properties from their substrate-free forms, changing the features of 
their properties according to the different enviroment they are bound to.  Therefore 
labels based on luminescent complexes can be used for monitoring bioconjugation 
reactions and the binding affinity to different substrates.(169) 
 
1.5.5. Light-emitting Electrochemical Cells (LECs) 
 
Light-emitting Electrochemical Cells (LECs) can potentially offer an alternative 
type of light emitting device to OLEDs.(170-174)  Unlike conventional OLEDs in fact, 
LECs display some advantageous properties, in particular light emission with low 
threshold voltages.  Moreover, the onset voltage has been found to be almost 
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independent of the film thicknesses.  LECs exhibited signignificantly improved 
electroluminescence efficiencies compared with analogous OLEDs and proved to 
be fairly insensitive to the electrode work-function.  Higher quantum efficiencies of 
the LECs have been attributed to a balanced electron and hole injection as well as 
the favourable location of the emissive layer in the centre of the organic medium.  
LECs are composed of an active polymer layer which contains both electronic and 
ionic conductors sandwiched between two electrodes.(172)  A semiconducting 
polymer and a polyelectrolyte form an intimate blend with a phase-separated 
bicontinuous network morphology in which both ionic and electronic charge-
carriers are mobile. (Figure 1.34a.)  Upon a sufficiently high voltage being applied 
to the electrodes, near the cathode the polymer is reduced and at the anode is 
oxidised.  In order to mantain charge neutrality, the positive-type (p-type) and 
negative-type (n-type) doped layers formed are stabilised by counter ions available 
in the ion conducting phase.(Figure 1.34b.)  Under the influence of the applied 
field, these regions extend towards the centre of the layer, forming an 
electrochemically induced p-n junction, where the p-type carriers (holes) and n-
type carriers (electrons) meet and recombine leading to emission of a photon.(174)  
(Figue 1.34c.)   
 
 
 
 
 
Figure 1.34(174): schematic diagram showing the mechanism of charge recombination in LECs 
leading to emission of light. 
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De Cola and co-workers introduced devices containing metal complexes as 
charged species, in particular a combination of dinuclear [Ru(bpy)3]2+ complexes 
blended in PPV was used.(175)  Even though most of the reported examples of 
LECs contain Ru(II) based complexes, and only few cases of Ir(III) complexes 
have been investigated, positively charged Ir(III) coplexes show promising 
characteristics to be exploited in this type of application.  Liu, Pend and co-workers 
reported the application of cationic iridium(III) complexes in LECs in 2007.(176) 
(Figure 1.35) 
 
 
 
  
 
Figure 1.35(176): cationic complexes used by Liu, Pend and co-workers in LECs 
 
 
 
1.6. Rhodium complexes 
 
Luminescent ruthenium(II) complexes have played a major role in inorganic 
photochemistry and less attention has been given to iridium(III) complexes, but 
even leser has probably been given to rhodium(III) complexes.(177)  A possible 
explanation may be the fact that tri-cationic species present more synthetic and 
work-up difficulties if compared to dicationic Ru(II) based species.(178)  
Nevertheless Rh(III) complexes can find application in DNA and RNA biological 
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sensors and also in photomolecular devices.(179)  In 1979 Demas et al synthesised 
[Rh(bpy)3]3+ with an analogous synthetic strategy to [Ir(bpy)3]3+.(180)  The emission 
displayed by the bpy based Rh(III) was lower in intensity compared to the 
analogous Ir(III) and Ru(II) complxes and with shorter lifetimes.  The emission of 
[Rh(bpy)3]3+ was described as being of a 3LC character.(181) (Figure 1.36a)) 
 
 
 
N
NN
N
N N
3+
Rh
N
NN
N
N N
3+
Rh
a) b)
 
 
Figure 1.36: structure of [Rh(bpy)3]3+ and [Rh(tpy)2]3+ 
 
 
 
The complex, [Rh(tpy)2]3+ (Figure 1.36b)) containing two terpyridine terdentate 
ligands having a lower ligand field strength than three bipyridine only shows 
emission at 77 K from a MC excited state.(182)  Rhodium complexes containing 
cyclometallating ligands were also synthesised.  In fact fac- and mer-[Rh(ppy)3] 
were prepared adopting synthetic procedures similar to those reported for 
[Ir(ppy)3].  However the emission was much weaker than that of the iridium 
analogue, being relatively weak for fac-[Rh(ppy)3] (Figure 1.37a)) in degassed 
solution at room temperarature.(183)  The most commonly studied cyclometallated 
rhodium complexes are the bis-cyclometallated tris-bidentate complexes of the 
class [Rh(ppy)2(bpy)]+ (Figure 1.37b)) synthesised similarly to their iridium 
anologues (via di-chloro bridge dimer as an intermediate).(184)  [Rh(ppy)2(bpy)]+ 
showed structured long-lived emission at low temperature from a predominantly 
ppy-based π– π*, LC excited state with a small amount of mixing with the MLCT 
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state associated with the ppy ligands.(24)  This differs significantly from the iridium 
analogue, from which emission of MLCT character was observed.(185)   
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Figure 1.37(24): Structure of (a) fac-[Rh(ppy)3] and (b) [Rh(ppy)2(bpy)]+. 
 
 
 
The photophysical properties of [Rh(NC)2(NN)]+ complexes can be modulated by 
varying or functionalising the NC and/or NN-coordinating ligands.  The introduction 
of 2-thienylpyridine as N^C fragment leads to an increase of the emission intensity 
and lifetime at room temperature, which is thought to be due to the lower energy of 
emission and thus to reduce thermal deactivation of the emissive state by the 
higher-lying MC states.(186, 187)   
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CHAPTER  2 
 
Synthesis of mononuclear 
Iridium(III) and Rhodium(III) 
complexes 
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2. Synthesis of mononuclear iridium and rhodium complexes 
 
2.1 Background and objectives of the work 
 
The research of the group has focused on assessing the influence of 
cyclometallation on the excited states of iridium(III) complexes.  As mentioned in 
Chapter 1, the increased participation of the metal centre in the excited states of 
the complexes increases with the number of cyclometallation sites in the 
coordination spere.  This is displayed by comparing the photophysical properties 
of complexes with a different degree of cyclometallation.  Systems containing 
exclusively polypyridyl ligands with no cyclometallation sites have generally a 
ligand-centred emission.  In those with one and two cyclometallating units, the 
participation of the metal centre in excited states increases progressively until 
being assigned as mainly MLCT in complexes with three cyclometallating ligands 
(Figure 2.1).(106)   
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Figure 2.1: the role of the metal centre in the excited states is related to the number of 
cyclometallating sites in the coordination spehere, here bis-terpyridine, mono-, bis and tris-
cyclometallated complexes are shown. 
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Within our research group, systems of the classes Ir(N^C^N)(C^N^C), 
Ir(N^C^N)(C^N^O) and Ir(N^C^N)(N^N^N) were previously studied, in which two 
terdentate ligands fullfilled the coordination sphere of the iridium(III) centre.  In 
particular, tris-cyclometallated complexes containing terdentate ligands displayed 
photophysical properties similar to those of tris-bidentate analogues, such as 
Ir(ppy)3, which is one of the most used green emitters for OLEDs applications.  
Despite the photophysical properties manifested by Ir(N^C^N)(C^N^C) complexes, 
very low stability in solution required the design of a new iridium(III) platform.  To 
date, previous work within the research group on iridium (N^C^N)-coordinated 
complexes included the synthesis and photophysical properties of one complex of 
the form Ir(N^C^N)(N^C)Cl, containing two cyclometallating ligands, the second 
being phenyl-pyridine.  This charge-neutral complex showed high luminescence 
quantum yield in solution and blue-shifted emission compared to that of 
Ir(N^C^N)(C^N^C) complexes.   
 
In this work, particular attention is given to bis-cyclometallated complexes with the 
same general structure, but containing different types of N^C^N ligands, each of 
which is investigated in the presence of dFppy (2-(4,6-difluoro-phenyl)-pyridine) 
and ppy (2-phenyl-pyridine) as N^C bidentate ligands in the metal coordination 
sphere.  The same ligand units were also introduced onto rhodium(III) metal 
centre.  The synthesis of new iridium(III) bis-cyclometallated complexes is 
promising for OLED applications as charge-neutral complexes are generally 
preferred over charged compounds.(188)  Also, introduction of bipyridine as 
bidentate ligand was investigated (complexes of the general structure 
[Ir(N^C^N)(bpy)Cl]+), in order to compare the effect of a neutral ligand on the 
complex properties and its introduction offers an interesting point of comparison 
with the bis-cyclometallated analogues.  Moreover, recent studies have pinpointed 
positively charged iridium(III) complexes as appealing candidates for LECs 
applications and the complexes [Ir(N^C^N)(bpy)]+, being relatively highly 
luminescent, may match the properties required for such applications.   
 
A new class of trans-bis-cyclometallated Ir(III) complexes have also been 
investigated, namely complexes of the form [Ir(N^C^N)2]+ and 
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[Ir(N^C^N)(N^C^N)’]+, their synthesis is discussed in this work, although the range 
of complexes of this type that have been possible to isolate in pure form has 
proved to be limited. 
 
In general, the achiral structures introduced with the use of terdentate ligands in 
the iridium(III) coordination sphere offer advantages; in fact this new class of Ir(III) 
complexes can represent a possible candidate in creating multicentered systems 
in which the problem of geometrical isomerism is overcome.(87)   
 
The generic pathway adopted to synthesize bis-cyclometallated complexes 
proceeds through two steps, each of which involves the coordination of a 
cyclometallating ligand to the metal center (Figure 2.2).  The first synthetic step 
involves the coordination of an N^C^N ligand to the iridium(III) ion.  The 
coordination of the terdentate ligand leads to the formation of a di-chloro-bridged 
iridium dimer which is then cleaved to yield a bis-cyclometallated complex by the 
addition of a second cyclometallating ligand (N^C^N or N^C).  
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Figure 2.2: general scheme for the synthesis of bis-cyclometallated iridium complexes, where X = -
CH3, -CF3, -F, Y = -CH3, -F 
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In the formation of the di-chloro bridged iridium dimers, an important role is played 
by the substituents present in the 3 and 5 positions of the cyclometallating ring of 
the terdentate ligand.  Their presence avoids the formation of different types of 
coordination modes of the cyclometallating ligand to the iridium centre, as shown 
in figure 2.3.  In fact, since the C-C bonds connecting pyridyl and phenyl rings of 
the terdentate ligands are free to rotate, two different ways of coordination are 
possible in the absence of these substituents, since cyclometallating sites are also 
available at positions 3 and 5 of the cyclometallating ring.  Coordination from the 
ligand can occur as a terdentate N^C^N when cyclometallation occurs on position 
1 of the phenyl ring (Figure 2.3b)), but also, the same unsubstituted N^C^N ligand 
can aproach the iridium centre as a bidentate N^C ligand when cyclometallation 
occurs on positions 3 or 5, with the remaining pyridyl ring not coordinating to the 
metal center (figure 2.3a)). 
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Figure 2.3: a) two different modes of coordination are possible with unsubstituted N^C^N units, in 
the absence of substituents in 3 and 5 positions of the phenyl ring; b) in the presence of only 
substituents the mode of coordination possible is as a terdentate ligand 
 
 
 
 57
The possibility of two cordination modes leads to a mixture of products, wich are 
difficult to separate, given the generally low solubility of iridium di-chloro bridged 
dimers.  Two different aproaches can be adopted in order to avoid this problem.  
Design of ligands bearing substituents on the positions 3 and 5 of the phenyl ring 
of the N^C^N frame (e.g. the methyl groups as in Figure 2.3) prevents the 
formation of the undesired products with the N^C coordination mode of Figure 2.3 
a).  An alternative strategy to avoid the same problem, previously adopted by our 
research group, is also represented by synthesising ligands with a C3 symmetry 
(Figure 2.4).(24)   
 
 
 
N
NN
 
 
Figure 2.4: example of terdentate ligand in which all three potentially cyclometallating sites are 
equivalent, forming N^C^N coordination. 
 
 
 
Complexes Ir(N^C^N)(N^C)Cl can undergo displacement of the Cl, leading to the 
introduction of a different ancillary ligand at the sixth site of the coordination 
sphere of the iridium centre.  For instance, in this work is described introduction of 
CN, SCN and a variety of substituted and unsubstituted aryl acetylides, all of 
which are monodentate monoanionic ancillary ligands. 
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For each complex synthesized, characterization by mass spectrometry and NMR 
spectroscopy gave important information about the structural identity and purity of 
the target complexes.  Particular attention was also given to new strategies in 
tuning the emission energy of the complexes.  Substituents on both the N^C^N 
and the N^C ligand are proved to play a role in tailoring the energies of the frontier 
orbitals that determine the colour of the emission.  The electron-withdrawing or 
electron-donating nature of the substituents plays a determinant role in shifting the 
emission over a wide range of colours, towards either the blue or the red region.  
The support of theoretical studies, such as DFT calculations, is fundamental in 
order to design ligands capable of varying the energy of the orbitals involved in the 
emission process, with the aim of affecting the HOMO-LUMO energy gap of the 
complexes.   
 
2.2. Synthesis of Ligands 
 
In this section the synthesis of two main types of ligands is discussed, depending 
on the mode with which they can coordinate the metal centre: ligands which are 
able to coordinate the metal centre as N^C^N monocyclometallating terdentate 
ligands and C^N monocyclometallating bidentate ligands. 
 
2.2.1. Synthesis of terdentate N^C^N ligands 
 
Coordination of polypyridyl ligands, such as 2,2′:6′,2′′-terpyridine (tpy), to metal 
centres leads to formation of highly stable complexes whose formation is enforced 
by σ-donating nitrogen and π-accepting heterocycles.(109, 189-191)  In addition, the 
use of terdentate fragments coordinating metal centres offers structural 
advantages (see Chapter 1).  In this chapter, the synthesis of derivatives of 1,3-
di(2-pyridyl)benzene (bpybH) as terdentate cyclometallating N^C^N ligands is 
described.  This class of ligands is isoelectronic with tpy, but N^C^N ligands are 
anionic, due to the C-H unit that replaces the central N atom of the neutral ligand 
tpy.(109)  The activation of the C-H unit is thus fundamental to give cyclometallation 
towards the metal centre (Figure 2.5).   
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Figure 2.5(109): 1,3-di(2-pyridyl)benzene coordinating a metal centre upon activation of the C-H 
unit. 
 
 
 
The first examples of N^C^N-coordinating bpyb were reported by Sauvage and 
Collin in the 1990s, using ruthenium and osmium.(109)  The preparation of the 
N^C^N moieties was achieved by reaction of 1,3-dicyanobenzene with acetylene, 
under 10 atm pressure and at 130°C, the reaction being catalysed by 
Co(Cp)(COD) (where Cp=cyclopentadiene and COD=1,5-cyclooctadiene).(192, 193)  
(Figure 2.6)  This synthetic pathway, even though leading to a high yield of the 
desired terdentate ligand, includes the use of acetylene, which is potentially 
explosive under pressure.(109) 
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Figure 2.6(109): cobalt-catalysed synthesis of 1,3-bis(2-pyridyl)benzene from 1,3-dicyanobenzene 
and acetylene. 
 
 
 
More recently, palladium catalysed cross-coupling reactions have been widely 
used for the synthesis of polyaromatic ligands.(24)  In particular, cross-coupling 
involving a 1,3-dihalogen aryl ring and 2-substituted pyridyl substrates represents 
a general scheme for the synthesis of terdentate N^C^N ligands (Figure 2.7).  
Stille cross-coupling conditions can produce the desired N^C^N systems, when -
SnR3 is the substituent attached onto the pyridyl ring.(194)  Alternatively, py-ZnCl 
precursors were also used by Negishi for the synthesis of similar frames.(195)  
Suzuki cross-coupling(196) has also been reported as an advantageous procedure 
in the synthesis of dpybH type of ligands, borate substituted moieties being less 
toxic if compared to the analogous stannyl derivatives.  However, owning to the 
instability of the pyridine-2-boronic acid, Suzuki cross-coupling is significantly 
troublesome in the synthesis of N^C^N ligands and Stille and Negishi’s methods 
result thus to be more of an appealing choice.(109)   
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Figure 2.7(109) : summary of the synthetic pathways leading to fomation of bpybH ligands, Stille’s 
method (E = -SnR3 precursor), Negishi’s method (E = -ZnR precursor) and Suzuki’s method (E = -
B(OR)2). 
 
 
 
2.2.1.1. Synthesis of N^C^N ligands via Stille cross-coupling 
 
Even though Stille’s method involves the use of rather undesirable toxic 
compounds, whilst good results are reported in the literatue for the synthesis of 5-
methyl-1,3-di(2-pyridyl)benzene (dpymbH) by Negishi’s coupling(197), during 
previous work within our research group poor yields were obtained by adopting 
Negishi’s procedure.(197)  Therefore Stille cross coupling is described in this 
Chapter as the main synthetic route towards preparation of N^C^N cordinating 
units, due to the availability of 2-tri-n-butyl-stannylpyridine.  In 1999, Cardenas and 
co-workers reported the first example for the synthesis of dpybH via Stille’s cross-
coupling (Figure 2.7).(194)  The reaction mechanism of the Stille’s cross-coupling is 
summarised in Figure 2.8 and it involves in a first step the reduction of the 
palladium catalyst (compound 1 in Figure 2.8) to the active Pd(0) species 2.  This 
is followed by oxidative addition of the organohalide (3) to give a cis intermediate 
which isomerizes to the trans intermediate (4).  Then transmetallation with the 
stannane takes place (5) to form the intermediate shown (7), which is finally 
converted into the desired product (8), and regenerating the active Pd(0) species 
2, by reductive elimination.(198)   
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Figure 2.8(198): general mechanism of Stille cross-coupling involving activation of the catalyst to 
Pd(0), followed by oxidative addition and reductive elimination to give the desired cross-coupled 
species. 
 
 
 
In this work the synthesis of terdentate N^C^N ligands bearing substituents on the 
positions 3 and 5 of the phenyl ring has been carried out, owing to the previously 
discussed synthetic advantages which they offer during the preparation of the 
intermediate iridium di-chlorobridged dimers.  Synthesis of 1,3-di-(2-pyridyl)-4,6-
dimethyl-benzene (HL1) (Figure 2.9) was carried out in two steps:  Dibromination 
of m-xylene was achieved upon reaction with excess bromine in the presence of a 
catalytic amount of iodine, giving 2,4-di-bromo-m-xylene with a yield of 22%.(199)  
(Figure 2.9a))  Stille’s cross-coupling reaction(194, 200) then carried out by reacting 
this product with 2-tri-n-butyl-stannyl-pyridine in the presence of 
bis(triphenylphosphine)palladium(II) chloride as catalyst and lithium chloride, all 
under an inert atmosphere in toluene as a solvent at reflux for 3 days.  (Figure 
2.9b))  Purification of the final product was achieved by silica gel chromatography, 
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which separated the desired N^C^N system (yield=26%) from the starting material 
and the mono pyridyl-substituted benzene.  Formation of the bis pyridyl-substituted 
benzene is confirmed by 1H-NMR and mass spectrometry.(197)   
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Figure 2.9: synthesis of HL1, a) bromination of m-xylene; b) Stille’s cross-coupling 
 
 
 
The synthesis via Stille’s conditions of other 4,6-substituted N^C^N ligands is also 
reported, following preparation of the dihalogen precursors.  Similarly to HL1, the 
ligand HL2 (Figure 2.10), was prepared by a two step synthetic pathway.  
Bromination of 2,4-difluorobromobenzene gave 1,5-dibromo-2,4-difluorobenzene 
(yield=77%).  (Figure 2.10a)) which was followed by Stille’s cross-coupling to give 
the target N^C^N ligand with a yield of the order of 50-60% (Figure 2.10b)).   
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Figure 2.10: synthesis of HL2 by a) bromination of 2,4-difluoro-bromobenzene and b) Stille’s 
reaction to give the target product. 
 
 
 
Synthesis of HL3 was achieved by a three-step pathway.  3,5-Bis-trifluoro-methyl-
aniline was dibrominated(201) (yield=77%)  (Figure 2.11a)), then the amino group 
was removed from the 1,5-dibromo-2,4-bis-trifluoromethyl-aniline by treatment with 
sulfuric acid and sodium nitrite to yield 2,6-dibromo-3,5-bis-trifluoro-methyl-
benzene(201) (yield=37%), (Figure 2.11b)) Finally, this compound was cross-
coupled with 2-tri-n-butyl-stannyl-pyridine to obtain the N^C^N target ligand HL3 
(yield=25%) purified by silica gel chromatography (Figure 2.11c)).  
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Figure 2.11: synthesis of HL3, a) bromination of 3,5-bis-trifluoromethyl-aniline; b) removal of –NH2 
and c) Stille’s cross-coupling 
 
 
 
As will be discussed in Chapter 3, it was also of interest to us to prepare N^C^N 
ligands incorporating substituents in the pyridyl rings, in addition to the phenyl 
rings.  For this purpose, the appropriately substituted pyridines carrying a tributyltin 
group at the 2-position were required.  They should be accessible by reaction of 
the 2-lithio derivatives with Bu3SnCl. 
Conventionally, halogen-lithium exchange is used.  However, in this work, we 
made use of a reactant diverted ortho lithiation procedure, which avoids the need 
for the 2-halogen pyridine.(202) 
For example, treatment of 4-(trifluoromethyl) pyridine with butyl lithium in dry THF 
in the presence of dimethylaminoethanol led directly to 2-lithio-4-(trifluoromethyl) 
pyridine which, upon treatment with Bu3SnCl, gave the corresponding stannane 
 66
(Figure 2.12).  Subsequent reaction with 1,3-dibromo-4,6-bis(trifluoromethyl) 
benzene gave ligand HL4 (Figure 2.13). 
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Figure 2.12: preparation of 2-tri-n-butylstannyl-4-(trifluoromethyl)-pyridine via ortho-diverted 
lithiation, where DMAE = dimethylamino ethanol 
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Figure 2.13: synthesis of HL4 via Stille’s cross-coupling. 
 
 
 
2.2.1.2. Synthesis of N^C^N ligands via Miyaura cross-coupling 
 
As shown in Figure 2.14, 1,3-benzenediboronic acid can be cross-coupled with 2-
bromopyridine and to give bpyH derivatives.(109)   
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Figure 2.14: synthetic path leading to formation of bpybH ligands via Suzuki’s method, where E = -
B(OH)2 and hal’ = halogen 
 
 
 
The mechanism of this type of reaction is illustrated in Figure 2.15.     
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Figure 2.15(203): generic mechanism of Suzuki-Miyaura cross-coupling of an aryl halide with 
boronic ester or acid. 
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This methodology can be exploited in order to synthesise bpybH systems bearing 
a larger variety of substituents on the position 4 of pyridyl rings avoiding the use of 
stannyl derivatives.  In this section, the synthesis of such bpyb bearing –OMe and 
-NMe2 in the pyridine rings is discussed.  The synthesis of HL5 (see Figure 2.18) 
involved prior preparation of the 4-methoxy substituted bromopyridine and of the 
aryl diboronate ester fragment, followed by Suzuki-Miyaura cross-coupling 
reaction.(204, 205)  The synthesis of 2-bromo-4-methoxy pyridine was carried out in 
the four steps summarised in Figure 2.14, starting from 2-bromopyridine. 
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Figure 2.16: synthetic pathway to 2-bromo-4-methoxypyridine 
 
 
 
The aryl fragment 1,3-di-(pinacolatoboron)-4,6-difluoro-benzene was prepared 
from 1,3-di-bromo-4,6-di-fluoro–benzene, by a Pd catalysed Miyaura reaction with 
bis(pinacolato)diboron.  In line with the conditions originally defined by Miyaura for 
simple aryl halides, Pd(dppf)Cl2 was used as a catalyst, in the presence of KOAc 
(Figure 2.17).(206)  The diboronic ester was obtained in 80% yield following a 
simple work-up procedure.  This is the first reported example of the utility of the 
Miyaura reaction in preparing 1,3 aryl diboronate esters incorporating flanking 
substituents.  It should be noted that the classical procedure for boronic acid 
formation, involving lithiation and subsequent treatment with B(oipr)3, is likely to be 
incompatible with the substitution pattern, owning to the subsceptibility of the C-F 
bonds to nucleophilic attack. 
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Figure 2.17: synthesis of the di-boronic ester 1,3-di-(pinacolatoboron)-4,6-di-fluoro-benzene 
 
 
 
The di-boronic ester precursor is then reacted with the 2-bromo-4-methoxypyridine 
under inert atmosphere in Suzuki-Miyaura cross-coupling conditions, using 
dimethoxyethane as solvent and in presence of Na2CO3.H2O with Pd(PPh3)4 as a 
catalyst.  HL5 was thus obtained as a product (Figure 2.18).(207)     
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Figure 2.18: synthesis of HL5 
 
 
 
Similarly, via Suzuki-Miyaura cross-coupling under analogous conditions, 1,3-di-
(4-pinacolatoboron)-4,6-di-fluoro-benzene can also be reacted with 2-bromo-4-
dimethylaminopyridine in order to synthesise 1,3-bis(4-dimethylamino)pyridine-4,6-
difluoro-benzene (HL6).(207)  Prior formation of 2-bromo-4-(dimethylamino)pyridine 
was achieved starting from 2-bromopyridine via diverted ortho lithiation followed by 
treatment with CBr4 (Figure 2.19).(207)  
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Figure 2.19: preparation of 2-bromo-4-dimethylaminopyridine and subsequent synthesis of HL6 via 
Miyaura cross-coupling. 
 
 
 
2.2.2. Synthesis of bidentate N^C ligands 
 
As for the terdentate ligands, the bidentate phenylpyridines can be accessed by 
cross-coupling methods such as the Suzuki or Stille reactions of the appropiately 
substituted precursors.  The synthesis of 2-(2,4-difluorophenyl)pyridine (dFppyH) 
involves a Suzuki cross coupling reaction of 2-bromopyridine with 2,4-
difluorophenyl boronic acid (Figure 2.20).(208)  The same method was employed to 
prepare 2-(2,4-difluorophenyl)-4-methoxypyridine (Figure 2.21). 
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Figure 2.20: Suzuki coupling for the synthesis of N^C bidentate ligand 2-(2,4-
difluorophenyl)pyridine (dFppyH) 
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The synthesis of 2-(2,4-difluorophenyl)-4-methoxypyridine (dFpOMepyH) was 
carried out adopting Suzuki croos-coupling procedure, giving better results (yield = 
80%), Stille reaction for the synthesis of the same molecule, due the the poor 
stability of 2-(tri-butylstannyl)-4-methoxypyridine. 
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Figure 2.21: scheme for the synthesis of 2-(2,4-difluorophenyl)-4-methoxypyridine 
 
 
 
In contrast, 2-(2,4-difluorophenyl)-4-methylpyridine (dFpMepyH) was prepared by 
a Stille coupling, as shown in Figure 2.22.  The Stille reaction for the synthesis of 
this molecule has a yield of 74%, the good result here obtained is due to the 
tolerable stability of the 2-(tri-butylstannyl)-4-methylpyridine, if compared to the 
methoxy-substituted analogue. 
 
 
 
N SnBu3 F F
Br Pd(PPh3)Cl2
toluene N
F
F
+
 
 
Figure 2.22: scheme for the synthesis of 1,3-di-fluoro-phenyl-4-methoxypyrydine. 
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The previous examples of Suzuki cross-coupling involved exclusively bromo 
substituted substrates.  However, also chlorine substituted substrates are active in 
respect to this type of cross-coupling reactions when ortho to heterocyclic nitrogen 
atoms, allowing the possibility to obtain a wider variety of cyclometallating ligands.  
Such an example is the synthesis of 2-(1-benzo[b]thiophene) iso-1-quinoline 
(btiqH) (Figure 2.23). 
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Figure 2.23: scheme for the synthesis of 2-(1-benzo[b]thiophene) iso-1-quinoline. 
 
 
 
2.3. Synthesis of iridium complexes 
 
2.3.1. Synthesis of intermediate iridium di-chlorobridged dimers 
 
The synthesis of the target complexes involves the formation of an intermediate 
iridium dimer before coordination of the second cyclometallating ligand.  The dimer 
formed is di-chloro bridged and its synthesis is relatively straightforward.  Starting 
from IrCl3*3H2O in a mixture of 2-ethoxyethanol and water (3:1 v/v), the terdentate 
ligand is added and the solution refluxed for one day(209).  Figure 2.24 shows the 
general synthetic route for the iridium(III) di-chlorobridged dimers, where X and Y 
represent different substituents attached on the N^C^N ligand.  In this work, the 
different dimers were prepared following the same synthetic pathway: when Y = -
H, all three dimers with X = -CH3, -F and -CF3 as substituents on the phenyl ring of 
the N^C^N frame were synthesised.  When Y = -CF3, X = -CF3, and when X = -F, 
Y = OMe.  After the reflux period the dimers are obtained as a precipitate from the 
reaction mixture.  In most of the cases represented in Figure 2.24, the dimer 
formed is characterized by a very low solubility, precipitating from the solution.  
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However, those in which X = CF3 do not form a precipite following the reaction 
period and are easily soluble in dichloromethane and chloroform (Figure 2.24).   
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Figure 2.24: iridium(III) di-chloro bridged dimer containing N^C^N ligand with substituents X on the 
3,5 positions of the phenyl ring ligand and Y on the pyridyl rings of the N^C^N. 
 
 
 
Due to the very low solubility of the dimers where the substituent X is –CH3 or –F, 
the NMR characterization is performed in deuterated DMSO, which probably 
cleaves the dimer by replacing the chlorine bridging atoms in the sample to give 
the soluble mononuclear [Ir(N^C^N)Cl2(DMSO)]+ cation.  The dimer containing –F 
groups on the N^C^N ligand presents a very low solubility and either does not 
undergo cleavage in DMSO, or the resulting complex is insoluble in DMSO.  
Therefore its NMR characterisation could not be carried out and the solid was 
used directly for the following reactions.   
 
2.3.2. Synthesis of Ir(N^C^N)(N^C)Cl complexes 
 
Upon reaction of di-chlorobridged dimers containing N^C^N ligands with a second 
N^C mono-cyclometallating bidentate ligand, formation of complexes of the class 
Ir(N^C^N)(N^C)Cl takes place, leading to neutral bis-cyclometallated complexes.  
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During previous work within the research group the synthesis of Ir(L1)(ppy)Cl 
(Figure 2.25) was reported by refluxing [Ir(L1)Cl(µ-Cl)]2 with an excess of ppyH in 
the presence of AgOTf, in ethylene glycol at 196°C for 1 hour.(106)   
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Figure 2.25(210): structrue of Ir(L1)(ppy)Cl previously synthesised within the research group 
 
 
 
In this work, we sought to synthesise Ir(L1)(dFppy)Cl (1)  (Figure 2.26) in a similar 
manner, but using dFppyH in place of ppyH.  However, the reaction gave a low 
yield compared to that from the synthesis of Ir(L1)(ppy)Cl.  NMR spectroscopy 
also showed that the target complex was not obtained as a pure product since the 
unreacted dFppyH was not separated properly from the desired complex, so 
another methodology was adopted.  The solvent was changed to toluene and the 
reaction mixture heated at 110°C overnight.  The yield was found to be improved 
up to around 60% and purification of the target complex was achieved by silica gel 
chromatography.  Initially, impurity due to chlorine loss from Ir(L1)(dFppy)Cl (1)  
was observed during the characterisation of the complex.  Therefore during the 
work-up the reaction mixture was dissolved in dichloromethane and washed with a 
1M aqueous solution of HCl, as a source of Cl- ions, improving the yield up to 
94%.  The HCl wash also seems to remove excess ppyH as its hydrochloride salt. 
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Figure 2.26: scheme for the synthesis of Ir(L1)(dFppy)Cl (1)  and the atom numbering system for 
assignement of NMR 
 
 
 
Formation of the complex was confirmed by electrospray mass spectrometry 
which showed signals for the [Ir(L1)(dFppy)]+ parent ion, where no ancillary ligand 
occupied the sixth coordination site, and for [Ir(L1)(dFppy)(CH3CN)]+ due to the 
displacement of the Cl- ion by acetonitrile present in the eluent of the 
spectrometer.  Confirmation of formation of the complex containing the chlorine as 
ancillary ligand is given by elemental analysis.  1H-NMR Spectroscopy (in 
deuterated acetonitrile and chloroform) also shows the formation of the target 
complex.  In both solvents, also, the purity of the complex synthesised is 
confirmed by the pattern of the signals relative to the ligands coordinated, which is 
similar to that of the previously synthesised Ir(L1)(ppy)Cl.  The spectrum displays 
doublets for the proton in position 6 of the N^C ligand and for the proton in position 
6 of the N^C^N whose corresponding integrals are in a 1:2 ratio.  Particularly 
indicative are the resonances at highest and lowest fields, respectively assigned to 
the protons in position 6 (typically between 9.50 ppm and 10.20 ppm) and 6’ 
(typically between 5.20 ppm and 6.00 ppm) of the N^C ligand.  In fact, the 
presence of isolated signals in these regions confirms the purity of the complex 
obtained (Figure 2.27).   
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Figure 2.27: 1H-NMR spectrum in CDCl3 of Ir(L1)(dFppy)Cl (1)  
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2-D techniques such as COSY and NOESY also give information about the 
structure of the complex showing cross peaks between the proton in position 6-
N^C and the protons 6-N^C^N and 5-N^C^N.  Formation of a sole isomer is 
deduced namely the C-trans-N isomer (Figure 2.28) in which the cyclometallating 
carbons are not mutually trans to one another.  There was no evidence for the 
formation of the C-trans-C isomer.  Both isomers are meridional and no formation 
of facial isomer is considered to be possible due to the presence of the terdentate 
N^C^N ligand which is too rigid and resticted to coordinate as a facial ligand.  The 
formation of the isomer with cyclometallating carbons not mutually trans to each 
other is thought to be the thermodynamically favoured product, in fact because of 
the high trans influence of the cyclometalated carbons the other isomer, where two 
carbon atoms are in trans position to each other, would be disfavoured (see Figure 
2.28).   
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Figure 2.28: scheme of the two different isomers possible in principle for Ir(N^C^N)(N^C)Cl 
complexes 
 
 
 
Formation of the C-trans-N isomer is confirmed conclusively by the X-ray 
crystallography on crystals of the complex obtained from dichloromethane/ethyl 
ether (10/90), which will be discussed in Section 2.3.2.1. 
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The complexes Ir(L3)(dFppy)Cl (3) and Ir(L2)(dFppy)Cl (2) are prepared in a 
similar manner (Figure 2.29), with comparable conclusions being drawn from mass 
spectrometry and 1H-NMR spectroscopy.  In this case, coupling of the protons of 
the cyclometallating ring of the N^C ligand leads to a more complicated pattern of 
resonances in the high-field region.  19F-NMR offers a further probe (Figure 2.30).  
It reveals two mutually coupled signals for the F atoms of the bidentate ligand and 
one for the CF3, consistent with the formation of a single complex with C2 
symmetry in the terdentate ligand only. 
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Figure 2.29: synthesis of Ir(L3)(dFppy)Cl (3) (X = -CF3) and Ir(L2)(dFppy)Cl (2) (X = -F) 
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Figure 2.30: 19F-NMR specrum of Ir(L3)(dFppy)Cl (3) in CDCl3. 
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Figure 2.31: scheme for the synthesis of Ir(L3)(ppy)Cl (5) and Ir(L2)(ppy)Cl (4) 
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Ir(L3)(ppy)Cl (5) (Figure 2.31) was prepared using the same methodology adopted 
in the previous cases, giving a yield of 17%.  In order to improve this value another 
strategy was then adopted, using ppyH as the solvent as well as the reactant.  The 
di-chloro bridged iridium dimers containing respectively the L2 and L3 N^C^N 
ligand were added to 0.25 ml of 2-phenylpyridine and refluxed for one day (Figure 
2.31).  This second method gave a yield of 91% of the target product.  X-ray 
crystallography confirmed the exclusive formation of the thermodynamically 
favoured C-trans-N isomer (see Section 2.3.2.1.). 
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Table 2.1: 1H-NMR and mass spectrometry characterisation of Ir(N^C^N)(N^C)Cl complexes 
 
Complex Yield Resonance of 
H6-N^C 
(CDCl3)/ppm 
Resonance of 
H6’-N^C 
(CDCl3)/ppm 
Resonance of 
H6-N^C 
(CD3CN)/ppm 
Resonance of 
H6’-N^C 
(CD3CN)/ppm 
Mass Spectrometry (ES+) m/z 
Ir(L1)(dFppy)Cl (1) 94% 10.15  5.51  9.44  5.43  642 [M–Cl]+, 682 [M–Cl+CH3CN]+ 
Ir(L3)(dFppy)Cl (3) 35% 10.17  5.21  10.02  5.20  791 [M–Cl+CH3CN]+ 
Ir(L2)(dFppy)Cl (2) 39% 9.52  5.44  - - 691 [M–Cl+CH3CN]+ 
Ir(L1)(ppy)Cl 59% 10.12  6.00  - - 606 ([M – Cl]+), 638 ([M –Cl+MeOH]+) 
Ir(L3)(ppy)Cl (5) 91% 10.12  6.07  - - 755 [M-CH3CN] 
Ir(L2)(ppy)Cl (4) 88% 10.12  6.07  - - 655 [M–Cl+CH3CN]+ 
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In Table 2.1 a summary of the 1H-NMR and mass spectrometry characterisation of 
this class of complexes is presented.  The NMR samples in deuterated acetonitrile 
of the complexes Ir(L1)(dFppy)Cl (1) and Ir(L3)(dFppy)Cl (3) displayed a signal 
pattern typical of the presence of a sole complex.  These two complexes are 
relatively stable in acetonitrile.  Whereas the complex Ir(L2)(dFppy)Cl (2) and the 
three complexes bearing ppy as a bidentate ligand showed, in their NMR spectra 
in CD3CN, the presence of two species; one for the chlorine coordinated complex 
and the other for the complex formed upon loss of Cl in acetonitrile solution, 
presumably being [Ir(N^C^N)(N^C)(CH3CN)]+.  NMR samples prepared in 
deuterated chloroform, on the contrary, showed, for all the six complexes, higher 
stability, and the presence of the solvent-coordinated species is not observed.  
However, if the complexes are in solution for relatively long times and exposed to 
daylight, loss of the ancillary chlorine is observed. 
 
Comparing the NMR data in CDCl3 of the complexes containing dFppy (see Table 
2.1), the pattern of the signals appears similar for the three complexes, although 
some differences in the resonance of the most de-shielded and the most shielded 
signals are displayed.  In fact, the resonance for H6’-NCN of the L3 coordinated 
complex appears at lower fields (5.21 ppm) compared to that of the complexes 
conataining L1 and L2, which are located at respectively at 5.51 ppm and 5.44 
ppm.  Whereas the proton H6-NCN of the L2 coordinated complex displays a 
resonance of 9.52 ppm, which is located at lower fields in relation to those at 10.15 
ppm and 10.17 ppm for the species bearing respectively L1 and L3.  Considering 
the series of the complexes containing ppy as bidentate ligand, on the other hand, 
the resonances of the protons H6’-NCN and H6-NCN are located at similar values 
for the three complexes. 
 
2.3.2.1. X-ray crystallography 
 
The molecular structures of the complexes Ir(L1)(dFppy)Cl (1) and Ir(L3)(ppy)Cl 
(5) in the crystals are shown respectively in Figures 2.32 and 2.33, and selected 
bond lengths and angles are collated in Tables 2.2 and 2.3.  Bond lengths and 
angles involving the metal are essentially identical in the two cases, when the 
standard deviations are taken into account.  Thus we shall consider the values for 
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only one complex, Ir(L1)(dFppy)Cl (1).  As expected, due to the geometric 
constraints associated with binding of a terdentate ligand that forms 5-membered 
chelating rings, the iridium centre exhibits a distorted octahedral geometry, with an 
NNCN–Ir–NNCN angle of 161.2(2)˚.  The M–L bond lengths to the terdentate and 
bidentate ligands reveal significant differences.  Thus, the Ir–CNCN bond is shorter 
than the Ir–CNC (1.940(6) and 2.005(6)Å respectively), presumably reflecting the 
constraints imposed on the former by binding of the two flanking pyridyl rings.  The 
Ir–NNCN bonds {average 2.042Å} are likewise shorter then the Ir–NNC {2.156(5)Å}.  
The main factor in play here is almost certainly the fact that in the latter two cases, 
the N atoms are trans to cyclometallated carbon atoms, which have a very strong 
trans influence, whereas the N atoms of the NCN ligand are necessarily trans to 
one another.   
 
 
 
 
 
Figure 2.32: X-ray crystallography structure of the complex of Ir(L1)(dFppy)Cl (1), co-crystallised 
with CH2Cl2, T = 120 K. 
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Figure 2.33: X-ray crystallography structure of the complex Ir(L3)(ppy)Cl (5), T = 120 K. 
 
Ir–N(1) 2.156(5)   N(13)-Ir-N(30)  161.2(2) 
Ir–C(12) 2.005(6)   N(13)-Ir-C(24)  80.7(2) 
Ir–N(13) 2.036(5)   N(30)-Ir-C(24)  80.5(2) 
Ir–N(30) 2.048(5)   N(1)-Ir-C(24)   174.6(2) 
Ir–C(24) 1.940(6)   C(12)-Ir-Cl   172.0(2) 
Ir–Cl  2.461(2)   N(1)-Ir-C(12)   78.9(2) 
      N(1)-Ir-Cl   93.2(2) 
      C(24)-Ir-Cl   92.0(2) 
C(24)-Ir-C(12)  95.9(3) 
 
Table 2.2:  Selected bond lengths (Å) and angles (˚) for [Ir(L1)(dFppy)Cl (1)]. 
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Ir–N(1) 2.156(3)   N(13)-Ir-N(30)  161.9(1) 
Ir–C(12) 2.018(4)   N(13)-Ir-C(24)  80.7(1) 
Ir–N(13) 2.049(3)   N(30)-Ir-C(24)  81.1(1) 
Ir–N(30) 2.047(3)   N(1)-Ir-C(24)   176.4(1) 
Ir–C(24) 1.930(4)   C(12)-Ir-Cl   172.2(1) 
Ir–Cl  2.467(1)   N(1)-Ir-C(12)   79.4(1) 
C(3)-Ir-C(12) 97.0(1)   N(1)-Ir-Cl   93.4(1) 
      C(24)-Ir-Cl   90.2(1) 
 
Table 2.3  Selected bond lengths (Å) and angles (˚) for [Ir(L3)(ppy)Cl] (5). 
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Figure 2.35: atom labelling used for the representation of the crystal structures 
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2.3.2.2. Synthesis of complexes Ir(N^C^N)(N^C)Cl with substituents on the 
pyridyl rings of the ligands 
 
The synthesis of a new class of iridium(III) complexes of the same structure 
Ir(N^C^N)(N^C)Cl, but bearing additional substituents (-CH3, -OMe or –NMe2) on 
the pyridyl rings of both the terdentate and the bidentate ligands is here reported.  
An analogous synthetic pathway to that discussed in section 2.3.2. is carried out 
by reaction of the respective di-chloro bridged dimers with the bidentate moiety, in 
the presence of AgOTf and using toluene as the solvent.  The synthetic scheme 
for complexes carrying methoxy or dimethylamino substitutents on the 4 position  
of the N^C^N pyridyl is illustrated in Figure 2.36 and 2.37 respectively and the 
synthesis summarised in Table 2.4.  Formation of target complexes and purity was 
confirmed by mass spectrometry and by 1H-NMR and 19F-NMR spectroscopy in 
deuterated chloroform.   
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Figure 2.36: scheme for the synthesis of OMe substituted Ir(L5)(N^C)Cl, where X = -H, -CH3  
or –OMe. 
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Figure 2.37: scheme for the synthesis of Ir(L6)(dFppy)Cl 
 
 
 
Complex Yield Resonance of H6-
N^C (CDCl3)/ppm 
Resonance of 
H6’-N^C 
(CDCl3)/ppm 
Mass 
Spectrometry 
(ES+) m/z 
Ir(L5)(dFppy)Cl (6) 65% 10.11 5.56 751 [M-CH3CN]+ 
Ir(L5)(dFppic)Cl (7) 65% 9.96 5.58 759 [M-H]+,  
724 [M-Cl]+ 
Ir(L5)(dfpOMepy)Cl (8) 26% 9.89 5.55  740 [M-Cl]+,  
775 [M+H]+ 
Ir(L6)(dFppy)Cl(207) 81% 10.14 5.64 771 [M-Cl]+ 
 
Table 2.4: 1H-NMR (CDCl3) and mass spectrometry characterisation of Ir(N^C^N)(N^C)Cl 
complexes carrying substituents on the N^C^N pyridyl ring. 
 
 
 
Similarly to the synthesis of the previously discussed Ir(N^C^N)(N^C)Cl 
complexes, reaction of [Ir(L4)Cl(µ-Cl)]2 with ppyH leads to formation of the 
complex Ir(L4)(ppy)Cl (9) (Figure 2.38).  Whereas [Ir(L3)Cl(µ-Cl)]2 with btiqH leads 
to formation of Ir(L3)(btiq)Cl (11) (Figure 2.38).  Characterisation of these 
complexes by 1H-NMR spectroscopy in CDCl3 and mass spectometry leads to 
analogous conclusions regarding purity and structure to those relative to the other 
Ir(N^C^N)(N^C)Cl systems (Table 2.5).   
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Figure 2.38: scheme for the synthesis of Ir(L4)(ppy)Cl (9) and Ir(L3)(btiq)Cl (11). 
 
 
 
 
Table 2.5: 1H-NMR (CDCl3) and mass spectrometry characterisation of Ir(N^C^N)(N^C)Cl 
complexes carrying substituents on the N^C^N pyridyl ring, for Ir(L4)(btiq)Cl (10) the resonance at 
lowest fields is that of H6’’-NC. 
 
 
 
 
 
Complex Yield Resonance of 
H6-N^C 
(CDCl3)/ppm 
Resonance of 
H6’-N^C 
(CDCl3)/ppm 
Mass Spectrometry 
(ES+) m/z 
Ir(L4)(ppy)Cl (9) 40% 10.01  5.58  891 [M-CH3CN]+ 
Ir(L3)(btiq)Cl (11) 86% 10.12  5.99 * 855 [M]+ 
 89
2.3.2.3. Synthesis of Ir(N^C^N)(ppyz)Cl  
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Figure 2.39(122): structure of Ir(L1)(ppyz)Cl 
 
 
 
A complex of the structure Ir(N^C^N)(N^C)Cl in which N^C is 1-phenylpyrazole, 
was previously synthesised by Whittle within our research group (Figure 2.39).(122)  
The reaction was carried out in refluxing ethylene glycol at 196°C and the product 
was obtained with a yield of 54%.  In this work, Ir(L2)(ppyz)Cl (12) was prepared in 
a similar manner, upon treatment of [Ir(L2)Cl(µ-Cl)]2 with ppyzH in toluene at 
110°C, in the presence of AgOTf (Figure 2.40). 
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Figure 2.40: scheme for the synthesis of Ir(L2)(ppyz)Cl (12). 
 
 
 
2.3.3. Synthesis of [Ir(N^C^N)(N^N)Cl]+ complexes 
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Figure 2.41(24): structure of [Ir(L1)(bpy)Cl]+ 
 
 
If di-chloro iridium(III) dimers are reacted with a neutral bidentate ligand, formation 
of positively charged mono-cyclometallated complexes is achieved, of the class 
[Ir(N^C^N)(N^N)Cl]+.  Previously within the research group the synthesis of 
[Ir(L1)(bpy)Cl]+ (Figure 2.41) was achieved in 84% yield upon treatment of 
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[Ir(L1)Cl(µ-Cl)]2 with bipyridine (bpy) in ethylene glycol at reflux.(24)  [Ir(L3)(bpy)Cl]+ 
(13) and [Ir(L2)(bpy)Cl]+ (14) (Figure 2.42) were prepared by a method identical to 
that used for [Ir(L1)(bpy)Cl]+. 
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Figure 2.42: synthesis of [Ir(L3)(bpy)Cl]+ (13) and [Ir(L2)(bpy)Cl]+ (14). 
 
 
The positively charged complexes bearing bpy as bidentate ligand showed lower 
solubility in deuterated chloroform than the neutral bis-cyclometallated complexes.  
Their NMR characterisation is thus carried out in deuterated acetonitrile (Table 
2.6).  In fact, due to their positively charged nature, the Ir-Cl bond is stronger than 
that of the bis-cyclometallated analogues, so no loss of the chloride ligand is 
observed in acetonitrile.  The proton H6-NN resonates at 9.88 ppm for 
[Ir(L3)(bpy)Cl]+ (13), a value which, compared to that of H6-NC of Ir(L3)(dFppy)Cl 
(3) in CD3CN at 10.02 ppm, is located at lower fields. 
 
 
Complex Yield Resonance of H6-
N^N (CDCl3)/ppm 
Mass Spectrometry 
(ES+) m/z 
[Ir(L3)(bpy)Cl]+ (13) 76% 9.88  751 [M]+ 
[Ir(L2)(bpy)Cl]+ (14) 62% 9.79  651 [M]+ 
 
Table 2.6: 1H-NMR (CD3CN) and mass spectrometry characterisation of Ir(N^C^N)(N^N)Cl 
complexes 
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2.3.4. Synthesis of [Ir(N^C^N)(N^C^N)′]+ complexes 
 
During previous work of the research group, different types of bis-cyclometallated 
irirdium(III) complexes containing exclusively terdentate ligands were synthesised, 
those in particular being of the structure Ir(N^C^N)(C^N^N), Ir(N^C^N)(C^N^C) or 
Ir(N^C^N)(O^N^C) (Figure 2.43).(106)     
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Figure 2.43(106): examples of Ir(N^C^N)(C^N^N), Ir(N^C^N)(C^N^C) and Ir(N^C^N)(O^N^C) 
previously synthesised by the research group 
 
 
 
The reason for using asymmetric terdentate cyclometallating ligands was based 
on avoiding the disposition, in bis-cyclometallated complexes, of cyclometallating 
sites in mutually trans position to each other.  Due to the strong σ-donor effect of 
the cyclometallating phenyl rings, coordination leading to formation of trans bis-
cyclometallated systems is in fact disfavoured.  The coordination of two terdentate 
monocyclometallating ligands might however be facilitated, by using ligands 
whose structure forces the second cyclometallating site to be located in trans 
position with respect to the first one, and also by modulating the strength of the σ-
donor effect through changing the substituents on the N^C^N ligands.  This has 
been confirmed in the present work by the first reported formation of complexes of 
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the structure  [Ir(N^C^N)(N^C^N)’]+.  This class of complexes is new and was 
realised for two combinations of terdentate ligands.  [Ir(L2)(L1)]+ (15) and [Ir(L2)2]+ 
(16) (Figure 2.44) were synthesized, starting respectively from [Ir(L1)Cl(µ-Cl)]2 or 
[Ir(L2)Cl(µ-Cl)]2, upon treatment with respectively L1 or L2 in toluene with addition 
of AgOTf in the reaction mixture and reflux for one day.  The yields were 
respectively 84% and 27%.  The formation of both complexes was confirmed by 
mass spectrometry and 1H-NMR Spectroscopy.   
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Figure 2.44: [Ir(N^C^N)(N^C^N)’]+ complexes synthesized 
 
Attemps to synthesise [Ir(L3)2]+, [Ir(L3)(L1)]+, [Ir(L1)2]+ and [Ir(L3)(L2)]+ were also 
made, but the yield and purity of compounds obtained were very low, a fact that 
can probably be attributed to the high trans effect of the cyclometallating carbons.  
In fact the structure of the desired bis-cyclometallated complex with both N^C^N 
ligands bound terdentately in an octahedral configuration requires that two carbon 
atoms be in trans position to each other.  For this reason, another mode of 
coordination of the second ligand as an N^C bidentate instead of the N^C^N mode 
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may be favourable as shown in Figure 2.45.  This is confirmed by mass 
spectrometry, which displays peaks that can be related to the parent ion 
[Ir(N^C^N)(N^C^N)Cl]+ and by 1H-NMR showing a pattern of signals attributable to 
such complexes, in which the C2 symmetry of one of the N^C^N ligands is broken. 
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Figure 2.45: in the attempted preparation of [Ir(N^C^N)(N^C^N)']+ the second ligand may 
coordinate as a bidentate N^C ligand. 
 
 
 
In the cases of the two complexes successfully obtained, probably the electron 
withdrawing effect of the fluorine atoms on the cyclometallating ligands reduces 
the electron density at the metal centre, hence diminuishing the trans effect and 
making more feasible the coordination of the second N^C^N ligand. 
 
2.3.5. Complexes with pyridylbenzimidazole as bidentate ligand, 
Ir(N^C^N)(pbi)Cl and [Ir(N^C^N)(Me-pbi)Cl]+  
 
Previous work was reported on systems incorporating 2,6-bis(indolyl)pyridine 
(dinpyH2).  It was found that coordination to the metal centre can occur in two 
different modes, (24)  (Figure 2.46) which are thought to be dependent upon the 
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reaction conditions.  Treatment of [Ir(L1)Cl(µ-Cl)]2 with dinpyH2 in the presence of 
AgSO3CF3 in acetic acid leads to deprotonation of the imidazolic proton and 
subsequent coordination of dinpy as a dianionic N-^N^N- ligand, whereas the 
corresponding reaction carried out in the presence of K2CO3 in ethylene glycol 
leads to coordination of dinpy as a biscyclometallating C^N^C-coordinating ligand 
(Figure 2.46) 
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Figure 2.46(24): scheme for the synthesis of [Ir(dpydmb)(dinpy-NNN)] and [Ir(dpydmb)(dinpy-CNC)] 
 
 
 
For the Ir(N^C^N)(N^C)Cl complexes discussed so far in this chapter, the  donor 
character of the cyclometallating site of the N^C^N ligand is believed to strongly 
influence the subsequent coordination of the bidentate ligand, similarly to the 
observed preference of tris(phenylpyridine) complexes to form facial rather than 
meridional isomers.  As observed in the synthesis of the Ir(N^C^N)(N^C)Cl 
complexes, formation of the isomer where the (N^C^N) cyclometallating site and 
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the pyridyl N atom of the N^C ligand were in mutually trans position was favoured 
(Figure 2.47).   
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Figure 2.47: isomer favoured in Ir(N^C^N)(N^C)Cl complexes 
 
 
 
The coordination of 2-(2-pyridyl)benzimidazole (pbiH) to [Ir(ppy)2]+ fragments 
was studied by our research group leading to in Ir(ppy)2(pbi) and [Ir(ppy)2(pbiH)]+ 
complexes (Figure 2.48).  Reaction of [Ir(ppy)2(µ-Cl)]2 with pbiH in DMF in the 
presence of K2CO3 as a base led to formation of Ir(ppy)2(pbi) (Figure 2.48a)) in 
which pbi is an anionic bidentate ligand.  In contrast, reaction under milder 
conditions (DCM/MeOH at reflux) in the absence of a base gave [Ir(ppy)2(pbiH)]+, 
in which pbiH is a neutral bidentate ligand (Figure 2.48b)). 
 
 
N
N Ir N
N
N
N
N Ir N
N
NH
+
a) b)  
 
 97
Figure 2.48: a) Ir(NC)2(pbi) synthesised in DMF in the presence of K2CO3; b) [Ir(NC)2(pbiH)]+ 
synthesised in DCM/MeOH. 
 
Aside from the ambidentate nature of pbi/pbiH, it is an asymmetric ligand, and so 
its coordination to an Ir (N^C^N) fragment can lead to formation of two different 
isomers.  One is that in which the coordinating N atom of the imidazolic ring is 
positioned in trans position to the cyclometallating carbon of the N^C^N ligand, 
which will be referred to as C-trans-N(imid) isomer.  The other isomer, where the N 
atom of the pyridyl ring is in trans position to the cyclometallating site, is named C-
trans-N(pyr) isomer. (figure 2.49). 
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Figure 2.49: two different modes of coordination of pbi to iridium(N^C^N) dimers 
 
 
 
In summary, coordination of pbi as a bidentate ligand in N^C^N coordinated 
iridium complexes offers several points of interest since four possible coordination 
modes to the iridium centre are possible (figure 2.50). 
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Figure 2.50: four possible modes of coordination of pbi to the metal centre: a) the pbi coordinates 
as an anionic ligand forming a C-trans-N(imid) complex; b) pbiH as a neutral ligand giving C-trans-
N(imid); c) pbi as a anionic ligand giving C-trans-N(pyr); d) pbiH as a neutral ligand giving C-trans-
N(pyr).  
 
 
 
In an attempt to obtain Ir(L1)(pbi)Cl (17) as a target complex, [Ir(L1)Cl(µ-Cl)]2 was 
reacted wih pbi in DMF and in the presence of K2CO3.  Formation of the target 
complex was not observed.  However, the corresponding reaction in toluene in the 
presence of AgOTf led (Figure 2.51), after chromatography, to a yellow solid in 
28%, for which the mass spectrum showed the signal of the parent ion 
[(Ir(L1)(pbi)Cl)+H]+.  
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Figure 2.51: synthesis of Ir(L1)(pbi)Cl (17), Ir(L2)(pbi)Cl (18) and Ir(L3)(pbi)Cl (19). 
 
 
 
Information provided from Mass Spectrometry and 1H-NMR confirms that 
coordination of pbi to the iridium metal centre occured successfully, but it does not 
provide definitive proof of which of the four coordination modes illustrated in Figure 
2.50 has occured.  Definitive identification is fortunately provided by X-ray 
diffraction of crystals of the complex (Figure 2.52), which showed the absence of a 
counter ion, indicating a neutral complex, and that the deprotonated imidazolic 
nitrogen is trans to the carbon of the N^C^N ligand i.e. coordination mode (a). 
 
 
Figure 2.52: crystal structure of Ir(L1)(pbi)Cl (17). 
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In order to investigate the properties of the cationic analogues, in which binding 
occurs through the =N- atom, we chose to block deprotonation at the –NH- atom 
by methylation.  Me-pbi was prepared by addition of NaH to pbiH in dry THF, 
followed by treatment with a solution of MeI in THF at room temperature over night 
(Figure 2.53). 
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Figure 2.53: synthesis of Me-pbi 
 
 
[Ir(L1)Cl(µ-Cl)]2 was reacted with Me-pbi in toluene in the presence of AgOTf, 
leading to the cationic complex [Ir(L1)(Me-pbi)Cl]+ (20) (Figure 2.54).  The product 
was obtained by precipitation following addition of a saturated aqueous solution of 
KPF6 and purification was achieved by chromatography giving a yellow solid with 
53% yield. 
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Figure 2.54: synthesis of [Ir(L1)(Me-pbi)Cl]+ (20) and [Ir(L3)(Me-pbi)Cl]+ (21). 
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Ir(L1)(pbi)Cl (17), Ir(L2)(pbi)Cl (18), Ir(L3)(pbi)Cl (19), [Ir(L1)(Me-pbi)Cl]+ (20) and 
[Ir(L3)(Me-pbi)Cl]+ (21) are obtained as sole isomers according to the 1H-NMR 
spectra (data summarised in Table 2.7).  A significant difference is observed 
between the resonance (8.73 ppm) of the most deshielded proton assigned to 
position 6 of the bidentate ligand in Ir(L1)(pbi)Cl (17) and the resonance of the 
proton in position 6 of Ir(L2)(pbi)Cl (18) (9.88 ppm).  It is possible that this 
difference is related to the formation of the C-trans-N(imid) or the C-trans-N(pyr) 
isomer.  The 1H-1H-NOESY of Ir(L1)(pbi)Cl (17) and [Ir(L1)(Me-pbi)Cl]+ (20) shows 
the presence of cross peaks between the proton in position 6 of the pyridyl ring of 
the bidentate ligand and the protons in position 5 (observed only for Ir(L1)(pbi)Cl 
(17)) and 6 on the pyridyl ring on the terdentate ligand, suggesting formation of the 
C-trans-N(imid) isomer, whereas Ir(L2)(pbi)Cl (18) shows a weak cross peak 
between proton 6 of the pbi and proton 3 of the pyridyl ring of the N^C^N, 
suggesting possible formation of the isomer C-trans-N(pyr) for this complex.  In the 
1H-1H-NOESY of the complex Ir(L3)(pbi)Cl (19) and [Ir(L1)(Me-pbi)Cl]+ (20), cross 
peaks between the proton in position 6 and the protons in position 5’’ and 6’’ are 
not observed suggesting a possible formation of the C-trans-N(pyr).  The crystal 
structure of Ir(L1)(pbi)Cl (17) (Figure 2.52) indicates the formation of the C-trans-
N(imid) isomer.  Upon these observations it is possible to deduce that formation of 
different isomers can be influenced by the substituent groups on the phenyl of the 
N^C^N ligand.  However, this evidence must be treated with caution as these 
assumptions are based on intuitive considerations of the fact that in the C-trans-
N(imid) isomer, the H6-pbi is closer in space to the proton 6 and 5 of the N^C^N, 
whereas in the C-trans-N(pyr) isomer, H6-pbi is closer in space to H3-NCN.  A 
further evidence is that the crystals obtained might not represent the isomer 
present in the corresponding solution of the sample, owning to a different 
propencity, if formation of both was obtained, of the two isomers to form crystals. 
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Complex Yield Resonance of H6-
N^N (CDCl3)/ppm 
1H-1H-NOESY cross 
peaks 
Ir(L1)(pbi)Cl (17) 28% 8.73  H6-pbi with  
H6 and H5-NCN 
Ir(L2)(pbi)Cl (18) 42% 9.88  H6-pbi with 
H3-NCN 
Ir(L3)(pbi)Cl (19) 37% 9.79  - 
[Ir(L1)(Me-pbi)Cl]+ (20) 53% 10.06  H6-pbi with  
H6-NCN 
[Ir(L3)(Me-pbi)Cl]+ (21) 53% 10.01  - 
 
Table 2.7: 1H-NMR (CDCl3), 1H-1H-NOESY and mass spectrometry characterisation of 
Ir(N^C^N)(pbi)Cl and [Ir(N^C^N)(pbi)Cl]+ complexes. 
 
 
 
2.3.6. Metathesis reaction of monodentate ligand 
 
The bond Ir-Cl in the Ir(N^C^N)(N^C)Cl systems, as previously discussed, is 
relatively weak and, for some complexes, loss of chlorine upon exposure of light or 
only dissolving the complex in an appropriate solvent (i.e. acetonitrile) occurs.  
This phenomenon can be exploited in order to coordinate a different type of 
monoanionic ancillary in the place of chlorine.  Synthesis of iridium complexes 
bearing a variety of monodentate ancillaries, starting from the corresponding 
halide species, is reported in various works in the literature, amongst those Haga 
et al. in 2006 reported the incorporation of a series of monoanionic ligands by 
displacing Cl in Ir(Mebib)(N^C)Cl systems (Mebib = bis(N-
methylbenzimidazolyl)benzene.(154)  In particular the monoanionic ligands used 
were –Br, -I, -CN, CH3CN and –pha (Figure 2.55). 
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Figure 2.55: monoanionic ancillaries ligands used by Haga and co-workers for displacing the Cl in 
the sith position of the coordination sphere of Ir(Me-bib)(ppy)Cl and Ir(Me-bib)(Me-ppy)Cl 
 
 
 
In this work, the synthesis of complexes in which the chlorine atom on the sixth 
coordination site of complexes of the structure Ir(N^C^N)(N^C)Cl is displaced by –
CN, -SCN and different acetylides is described. 
 
The complex Ir(L1)(dFppy)CN (22) (Figure 2.56) was synthesised, starting from 
Ir(L1)(dFppy)Cl (1)  dissolved in methanol treated with AgOTf, which facilitates the 
removal of the Cl from the coordination sphere of the complex.  The solution was 
refluxed for 4 hours to allow complete loss of Cl, then a solution of NaCN in 2 ml of 
water was added.  The reaction led to the formation of mono-CN bridged dinuclear 
complex (Figure 2.56) as the main product.  The reaction was then attempted by 
dissolving Ir(L1)(dFppy)Cl (1) in acetone and adding AgOTf, followed by addition 
of an excess of KCN in methanol.  After allowing to react at room temperature, the 
excess of KCN was removed by extraction from DCM into water.  The product was 
a yellow solid obtained with a yield of 68% (Figure 2.57). 
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Figure 2.56: mono-bridged CN complex 
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Figure 2.57: synthesis of Ir(L1)(dFppy)CN (22). 
 
 
 
The formation of the target product was confirmed by mass spectometry, showing 
the parent ions [Ir(L1)(dFppy)]+ and [Ir(L1)(dFppy)CN]+.  The 1H-NMR of 
Ir(L1)(dFppy)CN (22) and Ir(L1)(dFppy)Cl (1) display an identical pattern of 
signals.  Same reaction method was then adopted to synthesise the complexes 
Ir(L2)(dFppy)CN (23), Ir(L2)(ppy)CN (24), Ir(L3)(dFppy)CN (25), Ir(L1)(ppy)CN 
(26) and Ir(L5)(dFppy)CN. 
 
 
 105
 
Ir
N
N
Cl
N
F
F
1.AgOTf
2.NH4NCS
Ir
N
N
SCN
N
F
F
(27)
 
 
Figure 2.58: synthesis scheme of Ir(L1)(dFppy)NCS (27). 
 
 
 
The complex Ir(L1)(dFppy)SCN (27) (Figure 2.58) was synthesised by stirring 
Ir(L1)(dFppy)Cl (1) for 1 hour in acetone in the presence of AgOTf, followed by 
addition of an excess of NH4SCN in methanol.  The product was a yellow solid 
obtained with a yield of 95%.  The formation of the target product was confirmed 
by mass spectometry, by the presence of the species [Ir(L1)(dFppy)]+ and 
[Ir(L1)(dFppy)SCN]+.  Proton NMR displayed the presence of a sole product.  
Following same method also was achieved preparation of Ir(L1)(ppy)SCN (28) and 
Ir(L2)(ppy)SCN (29).  
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Figure 2.59: synthesis scheme of Ir(L1)(dFppy)(A1) (30). 
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The synthesis of Ir(L1)(dFppy)(A1) (30) (A1 = 1,3-trifluoromethyl-phenylacetylide) 
(Figure 2.59) was carried out by strirring for 4 hours dtfmba in a solution of KOH in 
methanol, followed by addition of Ir(L1)(dFppy)Cl (1) dissolved in methanol and 
then stirring the combined solutions overnight in presence of CuI as catalyst.  The 
product formed as a yellow precipitate from the reaction mixture and was easily 
purified by washing the precipitate with methanol in order to wash out the 
remaining unreacted materials; a yield of 52% was obtained.  The target product 
was identified by mass spectrometry and by 1H-NMR due the presence of the 
signals assigned to the protons of the phenyl ring of the ancillary ligand.  (Figure 
2.60)  Mass spectrometry showed precence of the ions [Ir(L1)(dFppy)Cl (1)]+ and 
[Ir(L1)(dFppy)(A1)]+.   
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Figure 2.60: 1H-NMR spectrum of Ir(L1)(dFppy)(A1) (30). 
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Complex Yield Resonance of 
H6-N^C 
(CDCl3)/ppm 
Resonance of 
H6’-N^C 
(CDCl3)/ppm 
Mass Spectrometry 
(ES+) m/z 
Ir(L1)(dFppy)Cl (1) 40% 10.15  5.15  642 [M–Cl]+,  
682 [M–Cl+CH3CN]+ 
Ir(L1)(dFppy)CN (22) 68% 9.99  5.41  668 [M+H]+,  
642 [M-(CN)]+ 
Ir(L1)(dFppy)SCN (27) 95% 9.59  5.41  700 [M+H]+,  
642 [M-(SCN)]+ 
Ir(L1)(dFppy)(A1) (30) 50% 10.18  5.44  879 [M]+,  
642 [M-(dtfmbA)]+ 
 
Table 2.8: 1H-NMR (CDCl3) and mass spectrometry characterisation of the complexes with 
different ancillary ligands 
 
 
 
In Table 2.8, the 1H-NMR data of the complexes containing different ancillary 
ligands is summarised.  Although the pattern relative to the signals assigned to the 
N^C^N and N^C ligand is similar for all complexes, the resonance of the proton 
H6-NC is significantly influenced by the type of ancillary ligand incorporated in the 
coordination sphere of the complex.  For example, considering the series of 
complexes containing L1 as terdentate ligand, the H6-NC signal is shifted to lower 
fields by the introduction of SCN and CN as ancillary ligand (respectively 9.59 ppm 
and 9.99 ppm) with respect to that of the halide complex (10.15 ppm).  In the 
acetylide containing species the shift is observed in the other direction, with a H6-
NC resonating at 10.18 ppm.  This trend is consistent with the data observed 
relative to the complexes bearing different cyclometalling ligands.  The resonance 
of the H6-NC is thus strongly influenced by the type of ancillary ligand coordinated 
to the iridium centre. 
The same procedure was performed in order to coordinate different acetylides in 
place of chlorine in Ir(L1)(dFppy)Cl (1).  In particular A2 (1-phenylacetylide), A3 
(1-(4-methoxy)phenylacetylide), A5 (1-(4-benzonitrile)acetylide and A4 (1-(4-
dimethylamino)phenylacetylide) were used (Figure 2.59).  However, even though 
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the eperiments performed are thought to have led to the target products, the very 
low solubility of the precipitates from the reaction mixtures made them difficult to 
characterise.  Definitive evidence of purity and formation of the complexes was not 
achieved.  To this aspect, Ir(L3)(ppy)Cl (5) represents a more suitable precursor 
for the synthesis of complexes containing acetylides as monodentate ancillary 
ligands, owing to the higher solubility of the complexes conferred by the –CF3 
groups on the N^C^N ligand.  A range of acetylide derivatives were prepared from 
this precursor, using the same methodology, as indicated in Figure 2.61. 
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Figure 2.61: scheme for the synthesis of Ir(L3)(ppy)(acetylide) based complexes. 
 
 
 
Formation of the complexes was confirmed by mass spectrometry by detection of 
the ions for [Ir(L3)(ppy)(acetylide)]+ and proton NMR showing formation of a sole 
complex.  Complexes containing the monoanionic ancillary btfmb and CNph 
manifested relatively high stability in solution, in which they also showed red 
 110
emission at room temperature.  On the other hand the complexes containing OMe, 
NMe2 and unsubstituted arylacetylides showed degradation upon storage under 
light and in solution.  This is probably due to the fact that  the electron-withdrawing 
–CF3 and -CN substituents on the phenyl ring of the acetylide lower the electron 
density around the metal centre.  So that the trans effect associated with the 
acetylide being trans to the cyclometallating carbon is less of a problem in terms of 
stability.  In contrast, the electron donating effect of -NMe2 and –OMe (and 
apparently even just ph itself) groups provokes the opposite effect, inflating the 
electronic density at the metal centre.   
 
2.4. Rhodium complexes 
 
2.4.1. Synthesis of rhodium di-chloro-bridged dimers 
 
As for the iridium analogues, synthesis of the target Rh(III) complexes has to occur 
via formation of the intermediate di-chloro-bridged dimers (Figure 2.62), obtained 
by reacting RhCl3 with the N^C^N ligands (L1), (L2) and (L3) in a mixture of 
ethoxy-ethanol/water at reflux temperature. The dimers were formed as 
precipitates and washed with water, ethanol and ether.(68)  Similar observations 
were made about their characterisation and solubility to those for the iridium based 
dimers.  Again, the –CF3 substituted Rh dimer can be characterised in CD3CN, 
due to its higher solubility, with respect to that of the –CH3 and the –F containing 
counterparts, characterised in their mononuclear form in deuterated DMSO. 
 
 
 
 111
X X
NN
Rh
Cl
ClCl
Rh
XX
N N
Cl
+ 2RhCl3
X X
NN
2
 
 
Figure 2.62: synthetic scheme for the di-chloro-brdged rhodium dimers, where X= -CH3, -F, CF3 
 
 
 
2.4.2. Synthesis of Rh(N^C^N)(N^C)Cl complexes 
 
Synthesis of Rh(N^C^N)(N^C)Cl  is not new to the research interest of our group, 
as Whittle reported previously the synthesis of Ir(L1)(ppy)Cl.  (Figure 2.63)  
Following reaction of [Rh(L1)Cl(µ-Cl)]2 at 110°C in excess of ppyH and in the 
presence of AgOTf, formation of a side product, Rh(ppy)3, alongside the desired 
complex, indicated some scrambling of ligands and suggested a weaker 
interaction between the Rh centre, a second row metal, and the N^C^N ligand unit, 
compared to that of complxes of iridium, a third row metal.  Synthesis of the same 
complex in ethylene glycol at 196°C, revealed formation of the target Rh complex, 
which displayed loss of Cl over time by mass spectrometry.(24) 
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Figure 2.63(24): synthesis of Rh(L1)(ppy)Cl 
 
 
 
A similar synthetic method to that previously adopted by our research group for the 
synthesis of new Rh(N^C^N)(N^C)Cl was used in the present work, reacting 
dichloro bridged rhodium dimers with dFppyH in ethylene-glycol in the presence of 
AgOTf.  The product was then washed several times in a 1M aqueous solution of 
HCl in order to remove any non-reacted dFppyH.  Rh(L1)(dFppy)Cl (38) (Figure 
2.64) was obtained as a pale brown solid with a yield of 41%.  The formation of the 
complex as a sole product was confirmed by 1H-NMR which showed a similar set 
of signals to those of Ir(L1)(dFppy)Cl (1).  A similar procedure was adopted for the 
synthesis of Rh(L2)(dFppy)Cl (39) and Rh(L3)(dFppy)Cl (40) (Figure 2.64).  
Although formation of the target complexes is not unequivocally confirmed by 
mass spectrometry for Rh(L2)(dFppy)Cl (39) and Rh(L3)(dFppy)Cl (40), due to the 
presence of a sole peak related to the species of the form [Rh(N^C^N)(N^C)]+, the 
formation of the chlorine containing species during the synthesis is suggested by 
the presence of this peak.  Higher lability of the Rh-Cl compared to the Ir-Cl bond 
would be expected.  Moreover, neutrality of the synthesised complexes is 
displayed by the relatively high solubility of all three desired complexes and by the 
pattern showed by the 1H-NMR signals, typical of neutral complexes. 
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Figure 2.64: synthesis of Rh(N^C^N)(N^C)Cl, where X = -CH3, -F or –CF3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.9: 1H-NMR and mass spectrometry characterisation of Rh(N^C^N)(N^C)Cl complexes 
 
 
 
Comparing the NMR data of the Rh(N^C^N)(N^C)Cl complexes with their iridium 
analogues, as summarised in Table 2.9, the pattern of the signals relative to the 
cyclometallating ligands similar between rhodium and iridium complexes.  Also the 
resonances relative to the proton H6-NC and H3-NC of the complexes of rhodium 
Complex 
Yield Resonance 
of H6-N^C 
(CDCl3)/ppm 
Resonance 
of H6’-N^C 
(CDCl3)/ppm 
Mass Spectrometry 
(ES+) m/z 
Ir(L1)(dFppy)Cl (1) 94% 10.15  5.51  642 [M–Cl]+,  
682 [M–Cl+CH3CN]+ 
Ir(L3)(dFppy)Cl (3) 35% 10.17  5.21  791 [M–Cl+CH3CN]+ 
Ir(L2)(dFppy)Cl (2) 39% 9.52  5.44  691 [M–Cl+CH3CN]+ 
Rh(L1)(dFppy)Cl (38) 41% 10.18  5.72  552 [M-Cl]+,  
586 [M] 
Rh(L3)(dFppy)Cl (40) 56% 10.12  5.32  660 [M–Cl]+] 
Rh(L2)(dFppy)Cl (39) 16% 10.11  5.69  560 [M-Cl]+ 
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containing the L1 and L3 are located at similar fields compared to those of the 
iridium analogues.  The complex Ir(L2)(dFppy)Cl (2), on the other hand, displays a 
resonance relative to the proton H6-NC at 10.11 ppm, which is at higher fields 
compared to that of Ir(L2)(dFppy)Cl (2) (9.52 ppm). 
 
2.5 Concluding remarks 
 
In this chapter the synthesis of a series of N^C^N and N^C ligands via Stille cross-
coupling and Miyaura cross-coupling is discussed.  In particular synthetic ways to 
introduce substituents on the central phenyl ring (-CH3, -F and –CF3) and on the 
pyridyl rings (-OMe, -NMe2, -CF3) of the N^C^N ligands have been reported.  
Coordination of N^C^N ligands to an Ir(III) centre gave dimeric complexes of the 
structure [Ir(N^C^N)Cl(µ-Cl)]2.   
 
Reaction of [Ir(N^C^N)Cl(µ-Cl)]2 with ppy and dFppy led to formation of neutral bis-
cyclometallated complexes Ir(N^C^N)(N^C)Cl.  The coordination of the second 
cyclometallating ligand selectively gave a sole isomer (C-trans-N) (see Section 
2.3.2.). Formation of this isomer, due to the strong σ donor effect of the 
cyclometallating site of the N^C^N ligand, was suggested by spectroscopic data 
and X-ray crystallography (see Section 2.3.2.).  A series of new Ir(N^C^N)(N^C)Cl 
complexes were thus synthesised in relatively mild conditions at 110° C, in the 
presence of AgOTf and using toluene as a solvent, whereas in previous works the 
synthesis of Ir(N^C^N)(N^C)Cl complexes was carried out at 196° C using 
ethylene glycol as a solvent.(66, 106)  The Ir-Cl bond of the sixth coordination site 
displayed different stability depending on the type of substituents on the 
cyclometallating ring of the N^C^N ligand.  In particular -CF3 and –CH3 substituted 
complexes are stable in both acetonitrile and chloroform whereas the -F 
substituted complexes could be characterised only in chloroform since the chloride 
ligand dissociated in acetonitrile.   
 
Also other classes of iridium complexes have been presented in this work starting 
from the same iridium di-chloro bridged dimers used for the synthesis of 
Ir(N^C^N)(N^C)Cl complexes. 
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Reaction of [Ir(N^C^N)Cl(µ-Cl)]2 with bpy led to formation of positively charged 
mono-cyclometallated iridium complexes, [Ir(N^C^N)(N^N)Cl]+, whereas reaction 
of [Ir(N^C^N)Cl(µ-Cl)]2 with a second N^C^N terdentate ligand led to formation, but 
only in some cases (see Section 2.3.4.), of positively charged bis-cyclometallated 
complexes [Ir(N^C^N)(N^C^N)’]+.  In the [Ir(N^C^N)(N^C^N)’]+ complexes 
synthesised the two cyclometallating sites occupy a mutually trans position, due to 
the only coordination mode available with which the two cyclometallating sites can 
coordinate the metal centre as terdentate ligands. 
 
Also the synthesis of new Ir(N^C^N)(pbi)Cl complexes has been carried out but 
unfortunately spectroscopic data and X-ray crystallography did not allow the 
identification of which isomer is selectively formed upon coordination of pbi as 
bidentate ligand (see Section 2.3.5.).  However formation of Ir(N^C^N)(pbi)Cl 
complexes has beed confirmed by NMR spectroscopy and mass spectrometry.  
Further investigation might provide additional information on the structural 
properties of these systems. 
 
Replacement of the Cl on Ir(N^C^N)(N^C)Cl has been carried out successfully in 
order to introduce –CN, -SCN and -≡-R as monodentate ancillary ligands, giving a 
series of complexes bearing one terdentate, one bidentate and one monodentate 
ligand and with three Ir-C bonds Ir(N^C^N)(N^C)(ancillary).  These complexes 
containing three cyclometallating sites displayed relatively high stability in solution 
in contrast with previously investigated tris-cyclometallating complexes 
incorporating only terdentate ligands (e.g. Ir(N^C^N)(C^N^C), Ir(N^C^N)(C^N^O)), 
which low stability limited their performances in their application.(108, 109, 198) 
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3. Photophysics, electrochemistry, DFT and OLEDs  
 
3.1. Ir(N^C^N)(N^C)Cl complexes 
 
3.1.1. Theoretical studies based on DFT calculations  
 
Prediction of the energy-minimised, gas-phase structures of the complexes and 
identification of the frontier orbitals has been carried out by density functional 
theory (DFT) calculations using B3LYP.  The approach adopted is well-established 
for third-row transition metal complexes, using the LANL2DZ basis set for Ir(III), 
with the inner core electrons replaced by a relativistic core potential, and 6-31G for 
the ligands.(210)  The frontier orbitals (HOMO–1 to LUMO+1) for Ir(L1)(ppy)Cl are 
represented in Figure 3.1, together with the percentage of the total electron 
density on the three ligands and the metal.  Similarly in Figure 3.2 are represented 
those of the complexes Ir(L3)(ppy)Cl (5) and Ir(L2)(ppy)Cl (4). 
 
 
 
Complex HOMO-1 HOMO LUMO LUMO+1 
Ir(L1)(ppy)Cl  
  
 
E(eV) -0.18339 -0.18302 -0.05341 -0.04759 
Ir 0.25 0.32 0.02 0.04 
N^C^N 0.2 0.36 0.88 0.16 
Cl 0.32 0.23 0 0 
N^C 0.23 0.07 0.11 0.81 
 
Figure 3.1: summary of DFT calculations for Ir(L1)(ppy)Cl, where E(eV) is the energy of the 
frontier orbital expressed in eV, and Ir, N^C^N, Cl, N^C represent the contribution of the respective 
parts of the molecule to the orbitals involved. 
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Complex HOMO-1 HOMO LUMO LUMO+1 
Ir(L2)(ppy)Cl 
(4) 
 
 
  
E(eV) -0.19745 -0.19365 -0.0636 -0.05753 
Ir 0.45 0.45 0.02 0.07 
N^C^N 0.21 0.08 0.93 0.88 
Cl 0.27 0.27 0 0.04 
N^C 0.07 0.2 0.05 0.01 
Ir(L3)(ppy)Cl 
(5) 
 
  
 
E(eV) -0.20608 -0.20178 -0.09287 -0.06567 
Ir 0.42 0.43 0.03 0.06 
N^C^N 0.19 0.2 0.96 0.89 
Cl 0.31 0.33 0 0.04 
N^C 0.07 0.07 0.01 0.01 
 
Figure 3.2: similarly to Figure 3.1, summary of DFT calculations for Ir(L3-NCN)(ppy)Cl and Ir(L2-
NCN)(ppy)Cl 
 
 
 
For the complex Ir(L1)(ppy)Cl (Figure 3.1), observing the contribution of the 
ligands, it is noticeble that the HOMO is delocalised across the metal, the ancillary 
ligand, and the cyclometallating ring of the N^C^N ligand.  The calculations show 
also how the cyclometallating ring of the bidentate ligand makes only a minor 
contribution.  Considering the HOMO-1 orbital, although the metal and halide have 
a similar contribution, in this case, it is the participation of the bidentate rather than 
the terdentate ligand that is more important.  For the complexes Ir(L2)(ppy)Cl (4) 
and Ir(L3)(ppy)Cl (5) (Figure 3.2), the situation is similar to the methyl substituted 
complex, but an inversion in the order of the orbitals is observed; in fact, the 
HOMO is formed by the metal, ancillary ligand and the aryl ring of N^C, whilst 
HOMO–1 involves metal, halide and aryl ring of N^C^N.  This inversion can be 
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explained by the fact that the energy of the orbitals with N^C^N contribution are 
influenced by the inductively electron-withdrawing nature of the fluorine and 
trifluoromethyl substituents, resulting in a lowering of the energy of N^C^N-based 
orbitals.  The three complexes discussed above containing ppy as N^C will be 
here identified as series 1.  Analogous considerations can be postulated for the 
three corresponding complexes with dFppy as bidentate N^C ligand 
Ir(L1)(dFppy)Cl (1), Ir(L3)(dFppy)Cl (3) and Ir(L2)(dFppy)Cl (2) (series 2), DFT 
calculations of which are shown in Figure 3.5, a summary at the end of this 
chapter.  The LUMOs of all six complexes have a very similar electron distribution 
to one another, being delocalised across the N^C^N ligands, but not significantly 
involving the other ligands or the metal ion.  Identical considerations can be drawn 
for the LUMOs levels of the dFppy complexes. 
 
3.1.2. Electrochemistry 
 
 
 
Complex Eox / V vs SCE Ered / V vs SCE 
Ir(L1)(ppy)Cl 1.18 (E1/2) –2.12 (Ep) 
Ir(L1)(dFppy)Cl (1) 1.16 (E1/2) –2.14 (Ep) 
Ir(L2)(ppy)Cl (4) 0.99 (E1/2) < -2.20 (Ep) 
Ir(L2)(dFppy)Cl (2) 0.98 (E1/2) –1.90 (Ep) 
Ir(L3)(ppy)Cl (5) 1.02 (E1/2) –1.97 (E1/2) 
Ir(L3)(dFppy)Cl (3) 1.11 (E1/2) –1.65 (Ep) 
 
Table 3.1: cyclic volatammetry in solution of dichloromethane (10–3 M) with Bu4NBF4 as 
supporting electrolyte at room temperature, data for the complexes bearing ppy and dFppy as N^C 
ligand. 
 
 
 
Electrochemical study of the complexes, by cyclic voltammetry, in 
dichloromethane solution (10–3 M) with Bu4NBF4 as supporting electrolyte at 
room temperature, was carried out using the ferrocene/ferrocenium couple as a 
reference (E1/2 = 0.42 V vs SCE).  All of the complexes display a reversible or 
pseudoreversible oxidation process between 0.9 and 1.2 V versus SCE (Figure 
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3.3), values that are comparable to those of bis-cyclometallated complexes with a 
monoanionic, bidentate ancillary ligand (e.g. for Ir(Meppy)2(acac), Eox = 0.92 
V).(116)  For the well studied tris-cyclometallated complexes, such as fac-Ir(ppy)3 
(Eox = 0.77 V), oxidation occurs at lower potentials than those observed for the 
complexes of series 1 and 2.(95)  Taking into consideration previous studies, the 
oxidation is thought to involve the metal and cyclometallating parts of the 
molecule, due to the high degree of covalency of the Ir–C bonds, which is also 
supported by the DFT calculations described above.  Moreover, as illustrated in 
Figure 3.3 (also see data in Table 3.1), the substituents positioned on the N^C^N 
ligand cause a significant shifting effect on the oxidation potential of the 
complexes, resulting in oxidation of the –CF3 substituted complex at lower 
potentials in comparison with the oxidation of the –F substituted complex. 
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Figure 3.3: cyclic voltammetry of Ir(L3)(ppy)Cl (5) (red line) and Ir(L2)(ppy)Cl (4) (blue line), 
showing how the –CF3 substituted complex is easier to oxidise than the –F substituted complex. 
 
 
 
Amongst the set of six complexes, the reduction ranges from –1.65 V for 
Ir(L3)(dFppy)Cl (3) to –2.14 V for Ir(L1)(dFppy)Cl (1), and to potentials lower than 
–2.20 V for Ir(L2)(ppy)Cl (4).  In this last case, the reduction could not be recorded 
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by the electrochemical analysis in dichloromethane, probably occuring at more 
negative potentials than that permitted by the solvent window.  Nevertheless, due 
to the strongly electron-withdrawing influence of the trifluoromethyl group, 
reduction is clearly seen to be more accessible for the complexes containing these 
substituents.  The reduction potentials observed are comparable to those of 
charge-neutral, bis- and tris-cyclometallated complexes (e.g. –2.17 V and –2.19 V 
for Ir(Meppy)2(acac) and fac-Ir(ppy)3 respectively).(95, 116)   
 
3.1.2. Ground state absorption 
 
UV-visible spectral bands and relative exctinction coefficients of the six complexes 
in CH2Cl2 at room temperature are listed in Table 3.3.  For all the complexes, 
intense bands in the region between 230 and 300 nm are observed, related to π-
π* transitions of the aromatic ligands (Figure 3.4).  Also, slightly weaker but still 
intense bands around 400 nm, with no counterpart in the free ligands, can be 
identified.  Moreover less intense bands at lower energies are identified around or 
above 450 nm.  Comparing the band at lower energies of the complexes within 
series 1 or series 2, the bands relative to the L2 complexes are blue shifted with 
respect to those of the L1, whilst the bands of the L3 complexes are shifted 
towards the red.  Upon fluorination of the N^C ligand, in the dFppy coordinated 
complexes, a blue-shift is observed in series 2 compared to the corresponding 
complexes of series 1, although the N^C^N ligand clearly has a larger influence on 
the energies of corresponding bands (see Table 3.3). 
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Figure 3.4: normalised absorption spectra to the most intense low-enegy band at room 
temperatue in dichloromethane of the complexes Ir(L1)(ppy)Cl (green line), Ir(L3)(ppy)Cl (5) (red 
line) and Ir(L2)(ppy)Cl (4) (blue line). 
 
 
 
Quantitative comparison of experimental and theoretical data should be treated 
with caution, as the calculations apply to the gas-phase at 0 K, and do not take 
into account the spin-orbit coupling (SOC), whilst bands arising from transitions 
within the singlet and triplet manifolds may overlap.  Nevertheless, in order to 
assist in the assignment of bands in this region, time-dependent DFT (TD-DFT) 
calculations have been carried out in order to provide useful information about the 
likely electronic origins of the observed bands, the results of which are 
summarised in Table 3.2 for the two lowest-energy triplet states and five lowest-
energy singlet excited states.  Looking at Ir(L1)(ppy)Cl, for example, the TD-DFT 
suggests that the lowest-energy band, which has a relatively low intensity (494 
nm, ε = 1300 M–1cm–1), is probably due to the formally forbidden S0T1 and 
S0T2 transitions (calculated values 487 and 483 nm).  These considerations are 
confirmed from further evidence observed from emission spectroscopy (see 
Section 3.1.4.).  These transitions are found to be of HOMO–1LUMO and 
HOMOLUMO character respectively, and thus can be regarded as 
dIr/πNCπ*NCN charge-transfer (mixed MLCT/LLCT) and dIr/πNCNπ*NCN (mixed 
MLCT/IL) transitions respectively.  Similar assignments are quite typical for 
iridium(III) complexes containing cyclometallating ligands, due to the high degree 
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of covalency in the C–Ir bond, leading to a mixed d/π character to the HOMO-1 
and HOMO.  Since the metal appears to have a high degree of partiipation, with a 
significant SOC, relaxation of the spin selection rule is observed.  Meanwhile, the 
lowest-energy, spin-allowed singlet bands involve mostly the two highest-energy 
filled orbitals and the two lowest-energy unfilled orbitals, and they also have a high 
degree of MLNCNCT character.  Analogous assignment can be postulated for all 
the other complexes (see Table 3.2 and the frontier orbitals illustrated in Figure 3.1 
and 3.2) and the calculated HOMO-LUMO energy gaps agree with the trend 
observed in absorption energies amongst the complexes (Table 3.2).  Upon 
introduction of electron-withdrawing trifluoromethyl groups into the N^C^N ligand, 
a decrease of the energy of all orbitals is caused but the effect is larger for the 
LUMO, being localised on the N^C^N ligand, than for the HOMO (see Figure 3.5).  
This provokes a shift of the transitions to lower energies, thus the absorption 
bands are red-shifted.  Even though fluorine atoms are also expected to lower the 
energy of orbitals, due to their electron-withdrawing effect, a mesomeric electron-
donating effect is revealed, which will tend to counteract the inductively 
withdrawing effect at positions ortho and para (but not meta) to the F atom.  Since 
the metal is disposed meta to the F atoms, whereas the pyridyl rings of the N^C^N 
ligand are ortho to F, it is possible to predict that the HOMO will be lowered in 
energy more than the LUMO, leading to a blue-shift, as observed.  These 
considerations agree with the work previously carried out by De Cola and co-
workers on systems containing bidentate phenylpyridine-based ligand bearing –F 
and –CF3 groups.(211)  A corresponding effect is also manifested in the slightly 
higher energy of the spectra of the dfppy complexes compared to their ppy 
analogues, leading to the blue-shifted emission upon coordination of dFppy, as 
previously reported in the work of Tamayo et al., in which tris-cyclometallated 
iridium complexes, containing three dFppy ligands, displayed blue-shifted MLCT 
absorption bands compared to those of the complexes containing unsubstituted 
ppy ligands.(96, 212, 213) 
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Table 3.2: TD-DFT B3LYP excitation energies for the two lowest-lying triplet states and five lowest-lying singlet states, in units of eV (with corresponding 
wavelength in parenthesis), and their oscillator strengths. The predominant nature of the excitation is also indicated (H = HOMO; L = LUMO). 
 Ir(L1)(ppy)Cl  Ir(L1)(dFppy)Cl (1) Ir(L2)(ppy)Cl (4) Ir(L2)(dFppy)Cl (2) Ir(L3)(ppy)Cl (5) Ir(L3)(dFppy)Cl (3) 
T1 2.541 (487) 
H–1L 
H–6L 
H–5L+1 
2.598 (477) 
H–1L 
HL+2 
HL+5 
2.604 (476) 
HL 
H–5L 
H–6L 
2.679 (463) 
HL 
H–1L+1 
H–2L 
H–6L 
2.109 (588) 
H–1L 
2.172 (571) 
H–1L 
T2 2.566 (483) 
HL 
2.627 (472) 
HL 
2.693 (460) 
HL+1 
H–1L 
H–5L+1 
2.766 (448) 
H–1L 
HL+1 
H–1L+2 
2.145 (578) 
HL 
2.261 (548) 
HL 
S1 2.805 (442), f = 
0.015 
HL 
2.885 (430), f = 0.027 
HL 
H–1L+2 
2.862 (433), f = 
0.0003 
HL+1 
H–1L 
2.957 (419), f = 0.004 
HL+1 
H–1L 
2.322 (534), f = 0.018 
HL 
2.438 (509), f = 0.017 
HL 
S2 2.859 (433), f = 
0.026 
H–1L 
2.959 (419), f = 0.020 
H–1L 
HL+3 
2.873 (432), f = 0.019 
HL 
H–1L+1 
2.985 (415) 
f = 0.017 
HL 
H–1L+1 
2.416 (513), f = 0.040 
H–1L 
2.479 (500), f = 0.042 
H–1L 
S3 2.935 (422), f = 
0.015 
HL+1 
HL 
HL+2 
2.979 (416), f = 0.0002 
HL+1 
HL 
3.010 (412), f = 0.100 
H–1L 
3.083 (402) 
f = 0.087 
H–1L 
2.930 (423), f = 0.028 
HL+1 
3.018 (411), f = 0.006 
H–2L 
H–7L 
H–5L 
H–4L 
HL 
S4 2.954 (420), f = 
0.011 
H–1L+1 
H–2L+2 
H–1L+2 
3.024 (410), f = 0.012 
H–1L+1 
H–1L+2 
3.034 (409), f = 0.015 
HL+2 
H–1L+1 
3.112 (398) 
f = 0.014 
HL+2 
H–1L+3 
2.942 (421), f = 0.005 
H–2L 
3.026 (410), f = 0.021 
HL+1 
H–2L+1 
H–3L+1 
S5 2.996 (414), f = 
0.096 
H–1L+2 
HL 
3.069 (404), f = 0.093 
H–1L+2 
H+1L-1 
3.119 (397), f = 0.005 
H–1L+1 
HL+3 
3.165 (392), f = 0.009 
H–1L+2 
3.075 (403), f = 0.019 
HL+2 
3.130 (396), f = 0.012 
H–1L+1 
HL+2 
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Figure 3.5: similarly to Figure 3.1, summary of DFT calculations for Ir(L1)(dFppy)Cl (1), 
Ir(L3)(dFppy)Cl (3) and Ir(L2)(dFppy)Cl (2). 
 
 
 
 HOMO-1 HOMO LUMO LUMO+1 
Ir(L1)(dFppy)Cl 
(1) 
 
E(eV) -0.19391 
 
-0.19137 
 
-0.05953 
 
-0.05467 
 
Ir 0.39 0.48 0.02 0.05 
N^C^N 0 0.08 0.77 0.18 
Cl 0.24 0.18 0 0 
N^C 0.37 0.25 0.22 0.77 
Ir(L2)(dFppy)Cl 
(2) 
  
E(eV) -0.20604 -0.20434 -0.06963 -0.06388 
Ir 0.27 0.19 0 0.02 
N^C^N 0.26 0.17 0.98 0.93 
Cl 0.35 0.42 0 0.02 
N^C 0.08 0.2 0.07 0.03 
Ir(L3)(dFppy)Cl 
(3) 
  
E(eV) -0.21398 -0.21216 -0.09852 -0.07184 
Ir 0.44 0.43 0.03 0.07 
N^C^N 0.19 0.08 0.96 0.88 
Cl 0.31 0.33 0 0.03 
N^C 0.07 0.16 0.01 0.01 
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Table 3.3: absorption bands of the series of complexes containing ppy (series 1) and dfppy (series 
2) as N^C ligands 
 
 
 
3.1.4. Emission from complexes in solution 
 
The same six complexes manifest intense photoluminescence in degassed 
dichloromethane solution at ambient temperature.  Data is compiled in Table 3.4 
Complex 
(series 1) 
Absorption λmax / nm 
(ε / mol-1 dm3 cm-1) 
Complex 
(series 2) 
Absorption λmax / nm 
(ε / mol-1 dm3 cm-1) 
Ir(L1)(ppy)Cl 264 (35 900), 288 
(34 900), 369 (7 
400), 397 (10 
100), 418 (11 
300), 457 (3 300), 
494 (1 300) 
Ir(L1)(dFppy)Cl (1) 286 (50 600), 363 (11 
600), 390 (13 400), 
412 (10 600), 451 (4 
500), 488 (1 800) 
Ir(L3)(ppy)Cl (5) 259 (45 600), 272 
(45 300), 373 (8 
900), 429 (11 
100), 461 (8 000), 
506 (3 100), 541 
(2 400) 
Ir(L3)(dFppy)Cl (3) 254 (43 800), 266 (42 
900), 364 (7 900), 418 
(9 900), 451 (6 900), 
492 (3 000), 523 (2 
200) 
Ir(L2)(ppy)Cl (4) 260 (44 800), 280 
(40 300), 358 (9 
100), 381 (11 
300), 402 (14 
000), 438 (3 600), 
473 (1 540) 
Ir(L2)(dFppy)Cl (2) 278 (21 100), 351 (4 
800), 375 (5 800), 393 
(6 800), 433 (1 400), 
467 (800) 
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and the emission spectra at 298 K are shown in Figure 3.6, showing a broad range 
of emission colours, from blue to orange/red (λmax from 476 to 593 nm).  The order 
of emission energies is identical to that observed for the lowest-energy absorption 
bands.  Also the complexes coordinated by dFppy are consistently blue-shifted by 
around 500 cm–1 compared to the corresponding ppy complexes.  For the 
complexes bearing methyl and fluorine groups on the N^C^N unit, in particular, the 
difference in energy between the 0-0 vibrational component in emission and the 
lowest-energy absorption band is very small, of the order of 400 cm–1, suggesting 
that the lowest-energy absorption band and the emission involve the same excited 
triplet state for these four complexes. 
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Figure 3.6: normalised emission spectra in degassed dichloromethane solution at room 
temperature of the complexes of series 1 (dotted lines) and series 2 (full lines), where –CF3 
substituted complexes are represented in red, -CH3 substituted in green and –F substituted in blue. 
 
 
 
The quantum yields of emission in degassed solution are high, ranging between 
0.2 – 0.7.  The green-emitting complexes of the L1 ligand present the highest 
luminescence quantum yields, with values 0.71 and 0.66 for the ppy containing 
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species and for the dFppy containing species respectively, characterised by 
luminescence lifetimes of around 1.5 µs.  Slightly smaller quantum yields have 
been measured for the orange/red-emitting complexes of L3 (0.46 and 0.57 for the 
ppy coordinated complex and dFppy coordinated complex respectively), although 
their lifetimes are longer (3.3 and 4.0 µs respectively).  On the other hand, the 
quantum yields and lifetimes are significantly reduced for the blue-emitting 
complexes of L2 (0.20 in both cases). 
 
The rate constants for radiative (kr) and non-radiative (Σknr) decay can be 
estimated from the quantum yields and lifetimes: kr = Φlum/ and Σknr = (1/ ) – kr.  
The values thus obtained are summarised in Table 3.4.  They indicate that the 
reduced quantum yields and shorter lifetimes of the blue-emitting L2 based 
complexes are due to a greater non-radiative decay, Σknr compared to L1 based 
systems.  Blue-emitting transition metal complexes are subject to enhanced non-
radiative decay pathways compared to those that emit in the green region, as 
encountered in numerous other studies with various metal ions including 
iridium(III) and platinum(II).(214, 215)  This can be attributed to a decreased gap 
between the energy of the emissive excited state and higher-lying, deactivating d-
d states, such that it becomes comparable to kT at ambient temperature(216), or to 
increased coupling with vibrational modes of the complex.(217)  In the case of the 
complexes discussed here, the photoinduced cleavage of the Ir–Cl bond 
mentioned in the previous Chapter is thought to be the limiting factor.  This 
process presumably proceeds via population of the d-d state and it is most 
significant for the two blue-emitting complexes, where the energy gap between the 
emissive state and the d-d state is necessary at its smallest.  Despite this effect, 
however, the efficiencies remain quite competitive with some of the best blue 
phosphors reported to date.  Upon cooling to 77 K, the lifetimes of the L2 
complexes become longer; and at this temperature the thermally-activated 
deactivating pathways are eliminated.  The luminescence lifetimes of the red-
emitting L3 complexes are longer, compared to the other complexes.  For these 
complexes, kr is significantly decreased, whereas Σknr is slightly reduced.  These 
observations suggest that the nature of the emissive state of the red emitting 
complexes is rather different from the others, and at 77 K, the luminescence 
lifetime increases by an order of magnitude to > 40 µs.  This increase cannot 
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simply be due to reduced non-radiative decay, as the room temperature quantum 
yields were already around 0.5.  The nature of the emissive state must be different 
under these conditions; the long lifetimes point to an excited state with a relatively 
poor SOC and thus perhaps with relatively little metal character. 
 
 
 
 130
 
 
Table 3.4: Luminescence data in solution in dichloromethane at 298±3 K and in EPA = diethyl ether / isopentane / ethanol (2:2:1 v/v) at 77 K for the 
complexes of series 1 and series 2, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and Φlum values; estimated 
uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions. 
Complex λmax / nm  degassed 
(aerated) /ns 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 λmax / nm (77 
K) 
 / µs (77 K) 
Ir(L1)(ppy)Cl 503, 537 1400 (110) 0.71 51 20 38 489, 529, 564, 
613 
3.7 
Ir(L3)(ppy)Cl (5) 590 3300 (1100) 0.46 14 16 28 576, 621 41 
Ir(L2)(ppy)C 487, 516 390 (120) 0.20 51 210 26 471, 508, 537, 
548, 593 
2.5 
Ir(L1)(dFppy)Cl (1) 495, 529 1500 (160) 0.66 44 23 25 481, 519, 553, 
604 
2.6 
Ir(L3)(dFppy)Cl (3) 572 4000 (1700) 0.57 14 11 1.5 563, 607, 
668(sh) 
46 
Ir(L2)(dFppy)Cl (2) 476, 508 410 (120) 0.20 49 190 27 464, 499, 528, 
538, 578 
2.0 
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3.1.5. Ir(N^C^N)(N^C)Cl complexes of series 1 and 2 in OLEDs, and 
photochemistry in polymer matrices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7(219): composition of the devices doped with Ir(N^C^N)(N^C)Cl complexes 
 
 
 
All complexes of series 1 and series 2 were investigated in electroluminescent 
devices, in collaboration with Dr. M. Cocchi and Dr. V. Fattori, of the ISOF institute 
in CNR, Bologna.  The complexes were used as phosphorescent dopants in 
OLEDs.  A schematic summary of the composition of the devices prepared for the 
investigation of Ir(N^C^N)(N^C)Cl dopants is illustrated in Figure 3.7.  The 
preparation of the multilayer devices was carried out over glass substrates pre-
coated with ITO (anode made of indium/tin oxide), by first spin-coating of a mixture 
of TPD/PC from dichloromethane solution.  The following layer was composed of 
TCTA (see Figure 3.7) and was deposited by thermal evaporation under high 
vacuum.  In succession, in the order as illustrated in Figure 3.7 from the left to the 
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right, the emitting layer (doped with the Ir(III) complex, 5% in TCTA) and the 
electron-transporting layer (TAZ) were deposited by combined sublimation under 
high vacuum.  Finally, the cathode, consisting of LiF and Al, was similarly 
deposited over the previous layers.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: EL spectra and CIE diagram for the complexes of series 2, with photographs of the 
devices prepared emitting at different colours. 
 
 
 
Figure 3.8 shows the EL (electroluminescence) spectra and the CIE coordinates 
diagram for the complexes of series 2, revealing a similar trend for the emitted 
colours to that observed in solution photochemistry, with maxima respectively at 
476 nm, 496 nm and 593 nm for the –F, -CF3 and –CH3 substituted complexes of 
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series 2 (similar conclusions can be drawn for EL and CIE of the complexes of 
series 1, see Figure 3.9).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: EL spectra and CIE diagram for the complexes of series 1. 
 
 
a)                                                                            b) 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: a) device efficiency (EL QE) vs potential (j); b) Luminance vs applied voltage for the 
complexes of series 2 
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Figure 3.10b) shows the dependence of the luminance versus the voltage applied, 
which increases up to 1000 cd/m2 until high voltage roll-off for the complexes 
Ir(L1)(dFppy)Cl (1) and Ir(L2)(dfppy)Cl (2), whereas for Ir(L3)(dFppy)Cl (3) 
saturation occurs at around 10000 cd/m2.  Figure 3.10a) shows the efficiency of 
the devices at different current densities.  The efficiency is almost constant over a 
relatively wide range of current densities (between 10-5 and 10-2 A/cm2).  If the 
efficiencies of Ir(L2)(dFppy)Cl (2) and Ir(L3)(dFppy)Cl (3) are both within the order 
of satisfactory values, Ir(L1)(dFppy)Cl (1), on the other hand, presents lower 
values of efficiency over this range of voltages.  On the contrary, for the 
complexes of series 1, relatively high performances are registered for all three 
complexes (see Figure 3.11).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: a) device efficiency (EL QE) vs potential (j); b) Luminance vs applied voltage for the 
complexes of series 1. 
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plots in Figure 3.12 show the dependence of the quantum yield and excited state 
lifetime in those samples on the estimated intermolecular distance.  The 
intermolecular distance is inversely proportional to the concentration of the 
complexes in PMMA.  Except for Ir(L1)(dFppy)Cl (1), the complexes show only 
small variations in the quantum yields and the lifetimes over different 
intermolecular distances, suggesting that self-quenching is of little importance 
even when molecules are lying close to each other.  On the other hand, for 
Ir(L1)(dFppy)Cl (1), a significant decrease of both quantum yields and lifetimes is 
observed by decreasing the intermolecular distance, suggesting the occurance of 
significant self-quenching at higher concentration, accounting for the lower device 
efficiencies recorded for this complex at high currents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: Quantum yields and lifetimes plotted against the estimated average intermolecular 
distance for Ir(L1)(dFppy)Cl (1) (green plot) and Ir(L2)(dFppy)Cl (2) (blue plot) 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0 5 10 15
Intermolecular distance (nm)
 
( 
s)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 5 10 15
Intermolecular distance(nm)
Q
ua
nt
um
 Y
ie
ld
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 5 10 15
Intermolecular distance (nm)
Q
ua
nt
um
 Y
ie
ld
0
0.2
0.4
0.6
0.8
1
1.2
0 5 10 15
Intermolecular distance (nm)
 
( 
s)
 136
3.2. Strategies for further emission tuning of the Ir(N^C^N)(N^C)Cl 
complexes 
 
 
 
Ir
H3C
H3C
N
N
Cl
N
F
F
Ir
F
F
N
N
Cl
N
F
F
Ir
F3C
F3C
N
N
Cl
N
Energy
MLCT
d
LUMO
HOMO
MLCT
d


MLCT
d

 
 
Figure 3.13: scheme of the substituent effect on the N^C^N ligand in tuning the colour of the 
emission in Ir(N^C^N)(N^C)Cl 
 
 
 
Figure 3.13 summarises the likely origin of the emission tuning of the six 
complexes described this far, in which the substituent of the central aryl ring of the 
N^C^N ligand was varied.  In order to further modulate the emission of the 
complexes, with the aim of achieving emission over a wider portion of the visible 
spectrum, other strategies can be deduced with the aid of DFT calculations.  As a 
reminder, Figure 3.14 shows the frontier orbitals of the blue emitter 
Ir(L2)(dFppy)Cl (2), which is essentially representative of all the complexes of this 
class. 
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Figure 3.14: Frontier orbitals of Ir(L2)(dFppy)Cl (2) obtained by DFT. 
 
 
 
 
For example, the significant contribution of the pyridyl 4-position to the LUMO and 
LUMO+1, but not in the occupied orbitals, suggests that substitution at this 
position might have a substantial effect on the HOMO-LUMO gap.  On the other 
hand, since the monodentate ancillary ligand participates significantly in the 
HOMO and HOMO-1 levels, but not in the LUMO, the introduction of different 
types of monodentate ligands in the sixth position of the coordination sphere of the 
metal might also lead to changes of the HOMO-LUMO energy gap, thus tuning the 
colour of the emission by ancillary effect.   
 
3.2.1. Effect of the substituents in the pyridyl ring of the N^C^N ligand 
 
An important goal in OLED research is to obtain efficient deep blue emitters.  
Based on the DFT analysis presented above, the introduction of electron-donating 
substituents into the 4-position of the N^C^N pyridyl rings should raise the LUMO 
without significantly affecting the HOMO, leading to a blue-shift.  Therefore, 
complexes of N^C^N ligands carrying methoxy (L5) or dimethylamino (L6) 
substituents in the pyridyl rings were prepared.  DFppy was selected as the 
HOMO-1 HOMO LUMO LUMO+1 
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bidentate ligand, as it has already been established from the work on series 2 vs. 
series 1 complexes that it leads to a further shift to the blue. 
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Figure 3.15: normalised absorption to the most intense low-enegy band in dichloromethane at 
room temperature of the complexes Ir(L2)(dFppy)Cl (2) (red line), Ir(L5)(dFppy)Cl (6) (green line), 
Ir(L6)(dFppy)Cl (blue line). 
 
 
 
The absorption spectra of the two new complexes are shown in Figure 3.15, 
together with that of the “L2” of the previously discussed complexes, namely 
Ir(L2)(dFppy)Cl (2).  Data are compiled in Table 3.5.  The complexes display the 
typical intense, high energy, π–π* bands at λ < 330 nm observed for all the bis-
cyclometallated Ir(III) complexes of this type in Section 3.1.  The lower-energy 
MLCT/LLCT bands at λ > 330 nm are slightly blue-shifted in the two new 
complexes carrying R substituents at position 4.  For the lowest-energy intense 
band, λ = 385 nm for R = -OMe and R = -NMe2, compared to 393 nm for R = -H, 
qualitatively as predicted by the DFT on the basis of the LUMO being destabilised 
by the electron-donating substituents.  The same effect is also observed for the 
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lower-energy MLCT band at λ = 433 nm for R = -H, in fact, those of R = -OMe and 
R = -NMe2 are both blue-shifted (respectively at λ = 426 nm and λ = 427 nm). 
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Figure 3.16: emission spectra in dichloromethane at room temperature of the complexes, 
Ir(L2)(dFppy)Cl (2) (green line), Ir(L5)(dFppy)Cl (6) (red line), Ir(L6)(dFppy)Cl (blue line). 
 
 
 
 
The emission of the complex with R = -NMe2 is also blue-shifted relative to R = -H.  
The emission maxima (0-0 bands) are at 472 nm and 476 nm respectively.  
Curiously, the emission of the complex with R = -OMe is essentially identical to 
that with R = -H (477 nm and 476 nm respectively).  Appearently, either the 
composition of the orbitals in the triplet mainfold is somewhat different from the 
singlets, or the extent of relaxation/reorganisation in the excited state prior to 
emission may differ. 
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Although the effect of the R substituent is thus rather minimal, it is noticeable that 
the quantum yield of the R = -NMe2 complex is substantially improved compared 
to that with R = -H (Φ = 0.41 and 0.20), this may be indicative of a less labile Ir-Cl 
bond or to less efficient population of the d-d state required for its cleavage.
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Table 3.5: Luminescence data in solution in dichloromethane at 298±3 K, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and 
Φlum values; estimated uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions.
Complex λmax / nm  degassed 
(aerated) 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 Absorption λmax 
/ nm 
(ε / mol-1 dm3 
cm-1) 
Ir(L2)(dFppy)Cl 
(2) 
R = -H 
476, 508 410 (120) 0.20 49 190 27 278 (21100), 351 
(4830), 375 
(5850), 393 
(6800), 433 
(1430), 467 (760) 
Ir(L5)(dFppy)Cl 
(6) 
R = -OMe 
477, 507 260(100) 0.15 58 94 27 233(13 300), 
286(6 700), 
385(2 300), 
426(300) 
Ir(L6)(dFppy)Cl 
R = -NMe2 
472, 497 550(80) 0.41 75 117 48 231 (24 600), 
269 (31 000), 
368 (6 700), 385 
(8 300), 427 (2 
000), 484 (300) 
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Based on the previously discussed DFT calculations, the introduction of electron-
withdrawing groups into the position 4 of the pyridyl rings of the N^C^N ligand 
should provoke an opposite effect to that observed in the complexes bearing 
electron-donating groups in the same position.  Therefore –CF3 groups may 
stabilise the LUMO with little effect on the HOMO level, leading to red-shifted 
emission.  Ligands bearing –CF3 groups on both the phenyl ring and the pyridyl 
rings of the N^C^N coordinating unit were selected for this purpose, combined with 
ppy bidentate ligand in the coordination sphere of the metal centre.  
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Figure 3.17: normalised absorption to the most intense low-enegy band in dichloromethane at 
room temperature of the complexes Ir(L4)(ppy)Cl (9) (red line), Ir(L3)(ppy)Cl (5) (black line) 
 
 
 
Figure 3.17 shows the absorption spectra of the complex Ir(L4)(ppy)Cl (9) in 
comparison with that of Ir(L3)(ppy)Cl (5) and their data are compiled in Table 3.6.  
Although it is not possible to conclude that the spectrum of the L4 complex is 
unequivocally red-shifted, especially since the profiles are different in the key 400-
500 nm region, it can be seen that the new complex has more prominent lower 
energy band at λ > 500 nm. 
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Figure 3.18: emission spectra in dichloromethane at room temperature of the complexes 
Ir(L3)(ppy)Cl (5) (black line), Ir(L4)(ppy)Cl (9) (red line). 
 
 
 
The emission band of Ir(L4)(ppy)Cl (9) (λMAX = 601 nm) is more clearly red-shifted 
compared to that of Ir(L3)(ppy)Cl (5) (λMAX = 590 nm) (Figure 3.18), suggesting 
that the trifluoro-methyl groups on the position 4 of the pyridyl rings of the N^C^N 
have the effect of stabilising the LUMO level with respect to the HOMO level. 
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Table 3.6: Luminescence data in solution in dichloromethane at 298±3 K, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and 
Φlum values; estimated uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions.
Complex λmax / nm  degassed 
(aerated) 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 Absorption λmax / 
nm 
(ε / mol-1 dm3 cm-1) 
Ir(L3)(ppy)Cl 
(5) 
R = -H 
590 3300 (1100) 0.46 14 16 28 260 (44 800), 280 
(40 300), 358 (9 
100), 381 (11 300), 
402 (14 000), 438 (3 
600), 473 (1 540) 
Ir(L4)(ppy)Cl 
(9) 
R = -CF3 
601 2800 (1200) 0.36 13 23 21 233 (19 500), 276 
(12 500), 399 (2 
600), 461 (3 800), 
523 (1 100), 562 
(900) 
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3.2.2. Effect of substituents in bidentate ligands 
 
The DFT analysis suggests that the N^C bidentate ligand in Ir(N^C^N)(N^C)Cl 
complex contributes significantly to the HOMO orbital, whereas it contributes only 
marginally to the other frontier orbitals.  Changing the nature of the bidentate 
ligand or introducing substituents into the position 4 of the N^C unit may influence 
the energy of the HOMO-LUMO energy gap.  In particular, with the intent of blue-
shifting the emission of the previously discussed blue-emitting complexes, 
electron-donating groups are introduced into the pyridyl ring of the bidentate.  
Moreover, phenyl pirazole as an N^C-oordinating ligand is here investigated to 
observe the effect of changing the nature of the N^C.   
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Figure 3.19: normalised absorption to the most intense low-enegy band in dichloromethane at 
room temperature of the complexes Ir(L2)(ppy)Cl (4) (green line), Ir(L2)(ppyz)Cl (12) (blue line) 
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Figure 3.20: normalised absorption to the most intense low-enegy band in dichloromethane at 
room temperature of the complexes Ir(L2)(dFppic)Cl (10) (green line), Ir(L2)(dFpOMepy)Cl (11) 
(blue line), Ir(L2)(dFppy)Cl (2) (red line). 
 
 
 
In Figure 3.19 the absorption spectrum of Ir(L2)(ppyz)Cl (12) is shown in relation 
to that of Ir(L2)(ppy)Cl (4) and the data compiled in Table 3.7.  In both complexes, 
the maximum of the MLCT/LLCT low-energy band is at 402 nm.  This suggests 
that the N^C ligand has little influence in affecting the HOMO-LUMO energy gap, 
confirming the indications provided by DFT calculations, in which the pyridyl ring of 
the N^C ligand has little contribution in the frontier orbitals.  As compiled in Table 
3.7, the emission of these two complexes is esseitially identical results only 
marginally shifted (respectively 486 and 487 nm), confirming the observations 
deduced in absorption.   
In Figure 3.20 the aborption speactra of the complexes Ir(L2)(dFppic)Cl (10) (RNC 
= -CH3), Ir(L2)(dFpOMepy)Cl (11) (RNC = -OMe) and Ir(L2)(dFppy)Cl (2) (RNC = -H) 
are compared to each other.  In the three complexes, the maximum of the 
MLCT/LLCT low-energy band is between 384 nm and 386 and, for identical 
reasons as for the phenylpyrazole containing complex, the absorption is not 
affected upon introduction of substituents into the pyridyl ring of the bidentate 
ligand.  Also in this case, by analysing the data compiled in Table 3.8, the 
emission reflects the behaviour observed in absorption for this series of three 
complexes (the maxima being within the range 477-478 nm). 
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In Table 3.7 the data for a complex bearing a benzothiopheneisoquinoline-based 
unit as bidentate ligand, namely Ir(L3)(btiq)Cl (11), are also compiled in 
comparison with Ir(L3)(ppy)Cl (5).  Figure 3.21 shows the absorption spectra for 
these complexes, in which the relatively intense low-energy MLCT state of the 
complex bearing the bidentate btiq (435 nm) is red-shifted in relation to that of the 
ppy coordinated species (429 nm).  Figure 3.22 shows the emission spectra in 
degassed solution of the same two complexes.  Here too, the red-shift, due to the 
introduction of the bidentate ligand btiq (λMAX = 667 nm) is observed with respect 
to the complex incorporating ppy (λMAX = 590 nm).  The significant red-shift 
observed can be attributed, according to the DFT on the Ir(N^C^N)(N^C)Cl, to the 
role of a more extended π system in destabilising the HOMO level, leading to a 
narrower HOMO-LUMO energy gap compared to that of systems bearing ppy 
bidentate ligands.  The relatively low, in relation to the previously studied red-
emitting complexes, measured quantum yields and the relatively long lifetimes 
suggest a weak participation of the metal centre to the excited states, which 
probably have significant LC character. 
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Figure 3.21: normalised absorption to the most intense low-enegy band in dichloromethane at 
room temperature of the complexes Ir(L3)(ppy)Cl (5) (red line) and Ir(L3)(btiq)Cl (11) (black line) 
 
 
 
 148
0
0,2
0,4
0,6
0,8
1
1,2
504 554 604 654 704 754
wavelength (nm)
no
rm
al
is
ed
 e
m
is
si
on
 
 
Figure 3.22: emission spectra in dichloromethane at room temperature of the complexes 
Ir(L3)(ppy)Cl (5) (red line) and Ir(L3)(btiq)Cl (11) (black line). 
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Table 3.7: Luminescence data in solution in dichloromethane at 298±3 K, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and 
Φlum values; estimated uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions.
Complex λmax / nm  
degassed 
(aerated) 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 Absorption λmax / nm 
(ε / mol-1 dm3 cm-1) 
Ir(L2)(ppy)Cl (4) 487, 516 390 (120) 0.20 51 210 26 260 (44 800), 280 (40 300), 358 (9 100), 381 
(11 300), 402 (14 000), 438 (3 600), 473 (1 
540 
Ir(L2)(ppyz)Cl (12) 486, 515 210(90) 0.16 76 103 27 239(24 600), 261(21 800), 361 (3 700), 384 (4 
200), 402 (5 900), 438 (1 500), 475 (1 000) 
Ir(L5)(dFppy)Cl (6) 
RNC = -H 
477, 507 260(100) 0.15 58 94 27 233(13 300), 286(6 700), 385(2 300), 426(300) 
Ir(L5)(dfpOMepy)Cl (8) 
RNC = -OMe 
477, 511 260 (90) 0.18 69 104 32 234 (40 700), 254 (29 000), 325 (4 800), 357 
(5 200), 386 (6 900), 460 (400) 
Ir(L5)(dfppic)Cl (7) 
RNC = -CH3 
478, 509 290 (100) 0.25 86 91 32 233 (33 500), 257 (24 600), 352 (4 200), 384 
(5 100), 450 (600) 
Ir(L3)(btiq)Cl (11) 667 3300 (700) 0.04 1.2 29 5 233 (57 000), 290 (29 200), 347 (13 000), 366 
(11 900), 435 (11 200), 463 (10 800), 546 (1 
400) 
Ir(L3)(ppy)Cl (5) 590 3300 
(1100) 
0.46 14 16 28 259 (45 600), 272 (45 300), 373 (8 900), 429 
(11 100), 461 (8 000), 506 (3 100), 541 (2 400) 
 150
3.2.3. Emission tuning through the ancillary ligand 
 
3.2.3.1. Complexes Ir(N^C^N)(N^C)CN and Ir(N^C^N)(N^C)SCN 
 
3.2.3.1.1. DFT calculations 
 
 
 
Figure 3.23: DFT calculations for the complexes Ir(L1)(dFppy)Cl (1), Ir(L1)(dFppy)CN and 
Ir(L1)(dFppy)SCN. 
 
 
 
DFT calculations on halide containing complexes, see Section 3.1.1., displayed 
the importance of the monodentate ancillary ligand in participating to the HOMO 
and HOMO-1 orbitals.  Thus, displacement of the Cl by different ligands would be 
anticipated to lead to a change in the energies of the MOs involved in the emission 
of the complexes.  Figure 3.23 shows the frontier orbitals of the complexes 
Ir(L1)(dFppy)CN (22) and Ir(L1)(dFppy)SCN (27) obtained by DFT.  The HOMO 
and HOMO-1 are comparable with those observed for the halide analogue, 
Complex HOMO-1 HOMO LUMO LUMO+1 
Ir(L1)(dFppy)CN 
(22) 
   
E(eV) -0.20444 -0.19742 -0.06234 -0.05712 
Ir 0.53 0.46 0.02 0.04 
N^C^N 0.18 0.41 0.90 0.10 
CN 0.09 0.07 0 0 
N^C 0.20 0.06 0.08 0.86 
Ir(L1)(dFppy)SCN 
(27) 
    
E(eV) -0.2074 -0.19202 -0.06575 -0.06072 
Ir 0.34 0.32 0.03 0.05 
N^C^N 0.35 0.10 0.86 0.19 
SCN 0.19 0.52 0.01 0.01 
N^C 0.11 0.05 0.10 0.75 
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although the cyano containing system presents a higher degree of participation of 
the metal to the HOMO-1 level than that of the complexes previously studied.  This 
effect is not observed for the -SCN containing complex, -SCN being a weaker-field 
ligand than -CN and its calculated frontier orbitals are identical to those of the –Cl 
based parent complex.  Comparing the LUMO and LUMO+1 levels, no significant 
differences are reported from those of Ir(L1)(dFppy)Cl (1).   
 
3.2.3.1.2. Photophysical studies 
 
Ground state absorption spectroscopy was carried out on the complexes, 
Ir(L1)(dFppy)CN (22), Ir(L1)(dFppy)SCN (27), Ir(L2)(dFppy)CN (23) and 
Ir(L5)(dFppy)CN in dichloromethane at room temperature.  All complexes show 
the typical band pattern at high energies described for the previously discussed 
iridium complexes.  The low-energy MLCT transitions of the complexes containing 
cyano and thiocyano ancillary ligands are all blue shifted in relation to those of the 
parent halide complexes, by 6-20 nm, the biggest shift being that of 
Ir(L5)(dFppy)CN (λMLCT = 364 nm) in respect to Ir(L5)(dFppy)Cl (6) (λMLCT = 384 
nm), suggesting a stabilisation of the HOMO and HOMO-1 energy levels due to 
the introduction of the cyano and thiocyano ancillary ligands.  Ir(L1)(dFppy)CN 
(22) and Ir(L1)(dFppy)SCN (27) display their highest-energy, even though not the 
most intensive, MLCT transitions at energies respectively 371 nm and 386 nm, 
both blue-shifted compared to that of Ir(L1)(dFppy)Cl (1) (λMLCT = 393 nm).   
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Figure 3.24: normalised absorption to the most intense low-enegy band in dichloromethane at 
room temperature of the complexes Ir(L1)(dFppy)CN (22) (green line), Ir(L1)(dFppy)SCN (27) (red 
line), Ir(L1)(dFppy)Cl (1) (bue line). 
 
 
 
The photoluminescence studies, data for which are compiled in Table 3.8, of the 
same complexes display structured MLCT character bands.  The order of the 
emission maxima reflect that observed in absorption spectroscopy, in fact all the 
complexes containing –CN or –SCN ancillary ligands are blue-shifted with respect 
to the –Cl analogues (Figure 3.26).  The shift caused by the introduction of the –
SCN ligand is, however, smaller than that caused by –CN, the shifts being 
respectively of 8 nm and 15 nm (relative to the corresponding chloro complex in 
the case of Ir(L1)(dFppy)X) (Figure 3.26).  The diplacement of the chlorine 
ancillary by –CN in the L2 -based species provokes a shift 14 nm, whereas a shift 
of 21 nm is observed for that related to the L5-based system.  Appearently, the 
introduction of the –CN ancillary somehow activated the effect of the methoxy 
substituents on the position 4 of the pyridyl-N^C^N, destabilising the LUMO level, 
this effect being only marginal in the chlorine coordinated complexes.  This led to 
an emission maximum at 456 nm for the complex Ir(L5)(dFppy)CN, which is the 
bluest-emitting complex discussed in this work (Figure 3.25).  Measured quantum 
yields of the L2-based complexes are similar to those reported in Section 3.1.4. for 
the previously reported blue emitters and similar considerations are valid here 
 153
relative to the radiative and non-radiative rate constants.  For the L1 -based 
systems, however, upon the introduction of the cyano and thiocyano groups, the 
increased stability of the Ir-ancillary bond leads to improved and very high 
quantum yields, as confirmed by the very low non-radiative rate constants 
calculated for these two complexes (see Table 3.8). 
  The improved performances of the complexes Ir(L1)(dFppy)CN (22) and 
Ir(L1)(dFppy)SCN (27) are also observed in their application in OLED devices, 
which were prapered following a method identical to that described in Section 
3.1.5.  Figures 3.27 and 3.28, show the increased efficiency of the devices doped 
with –CN and –SCN containing complexes over those of the –Cl analogues. 
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Figure 3.25: emission spectra in dichloromethane at room temperature of the complexes 
Ir(L2)(dFppy)CN (23) (red line), Ir(L5)(dFppy)CN (blue line) 
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Figure 3.26: emission spectra in dichloromethane at room temperature of the complexes 
Ir(L1)(dFppy)CN (22) (blue line), Ir(L1)(dFppy)SCN (27) (gree line), Ir(L1)(dFppy)Cl (1) (red line). 
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Table 3.8: Luminescence data in solution in dichloromethane at 298±3 K, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and 
Φlum values; estimated uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions.
Complex λmax / nm  degassed 
(aerated) 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 Absorption λmax / nm 
(ε / mol-1 dm3 cm-1) 
Ir(L1)(dFppy)Cl (1) 495, 529 1500 (160) 0.66 44 23 25 286 (50 600), 363 (11 600), 393 (13 
400), 412 (10 600), 451 (4 500), 488 (1 
800) 
Ir(L1)(dFppy)CN (22) 480, 515 300(30) 0.93 310 23 120 247(22 700), 281(16 900), 371 (4 300), 
406(4 900), 479 (700) 
Ir(L1)(dFppy)SCN (27) 487, 521 1900(190) 0.97 51 2 210 241(33 600), 287(23 100), 352 (4 800), 
386 (5 700),  406(6 700), 485 (700) 
Ir(L2)(dfppy)Cl (2) 476, 508 410 (120) 0.20 49 190 27 278 (21 100), 351 (4 800), 375 (5 800), 
393 (6 800), 433 (1 400), 467 (800) 
Ir(L2)(dFppy)CN (23) 462, 497 780 (200) 0.26 33 95 13 
 
232 (16 300), 274 (14 600), 340 (2 
500), 364 (2 700),  382 (4 400), 458 
(400) 
Ir(L5)(dFppy)Cl (6) 
 
477, 507 260(100) 0.15 58 94 27 233(13 300), 
286(6 700), 
385(2 300), 426(300) 
Ir(L5)(dFppy)CN 456, 486 460 (190) 0.14 30 187 15 232 (13 400), 270 (8 500), 307 (2 600), 
364 (2 500), 390 (1 800), 447 (100) 
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Figure 3.27: a) device efficiency (EL QE) vs potential (j); b) Luminance vs applied voltage for the 
complexes Ir(L1)(dFppy)CN (22) and Ir(L1-NCN)(dFppy)SCN (27) compared to that of 
Ir(L1)(dFppy)Cl (1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.28: EL spectra and CIE diagram for the complexes Ir(L1)(dFppy)CN (22) and 
Ir(L1)(dFppy)SCN (27) compared to that of Ir(L1)(dFppy)Cl (1). 
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3.2.3.2. Ir(N^C^N)(N^C)(acetylide) complexes 
 
Photophysical studies on complexes containing acetylides as the ancillary 
monodentate ligand are here discussed.  The data for Ir(L1)(dFppy)(A1) (30) (A1 
= 1,3-trifluoromethyl-phenylacetylide), Ir(L3)(ppy)(A5) (35) (A5 = 1-(4-
benzonitrile)acetylide) and Ir(L3)(ppy)(A1) (31) are summarised in Table 3.10.  
Absorption spectroscopy of all complexes is characterised by similar bands to 
those encountered in the previously studied complexes of the class 
Ir(N^C^N)(N^C)Cl, although only small shifts involving the energy of the MLCT 
transitions are observed upon introduction of the different acetylide ligands (see 
Table 3.9).  On the other hand emission spectroscopy displays more interesting 
points of discussion.  In fact, as shown in Figure 3.29, the emission maxima can 
be tuned by the introduction of different acetylide ligands.  Comparing, see Table 
3.9, the chloride and the differently substituted acetylide systems, all the species 
containing acetylide ligands display red-shifted emission in the order Cl < A5 < A1 
(respectively 590 nm, 598 nm and 606 nm).  The order observed can be explaned 
with the electron-withdrawing effect of the substituents on the phenyl ring of the 
acetylide, effect that presumably, in contrast to what was observed in the –CN 
coordinated complexes, leads to a destabilasation of the HOMO level or 
stabilasation of the LUMO level.   
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Figure 3.29: emission spectra in dichloromethane at room temperature of the complexes, 
Ir(L3)(ppy)(A5) (35) (blue line), Ir(L3)(ppy)(A1) (31) (red line), Ir(L3)(ppy)Cl (5) (black line).
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Table 3.9: Luminescence data in solution in dichloromethane at 298±3 K, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and 
Φlum values; estimated uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions.
Complex λmax / nm  degassed 
(aerated) 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 Absorption λmax / nm 
(ε / mol-1 dm3 cm-1) 
Ir(L1)(ppy)(A1) (30) 495, 527 1400 (90) 0.77 55 16 500 251(37 100), 295(36 100), 413(7 
900), 453(4 600), 489(1 600) 
Ir(L3)(ppy)(A1) (31) 606 4100 (960) 0.34 9 15 36 230(26 200), 270(24 700), 344(3 
300), 372(2 600), 421(2 100), 474(2 
000), 515(1 200), 548(1 100) 
Ir(L3)(ppy)(A5) (35) 598 5 300 (1 900) 0.25 5 47 21 234(39 800), 266(35 700), 321(24 
000), 370(8 700), 422(5 100), 473(4 
800), 556(2 000) 
Ir(L3)(ppy)Cl (5) 590 3300 (1100) 0.46 14 16 28 259 (45 600), 272 (45 300), 373 (8 
900), 429 (11 100), 461 (8 000), 506 
(3 100), 541 (2 400) 
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3.3. [Ir(N^C^N)(N^N)Cl]+ complexes 
 
3.3.1. DFT calculations and electrochemical studies of [Ir(N^C^N)(N^N)Cl]+ 
complexes 
 
The synthesis of [Ir(N^C^N)(bpy)Cl]+ complexes has been described in the 
previous Chapter, for [Ir(L3)(bpy)Cl]+ (13) and [Ir(L2)(bpy)Cl]+ (14).  
Electrochemical data for these two mono-cyclometallated complexes containing 
bpy as bidentate ligand are listed in Table 3.10. together with data for 
[Ir(L1)(bpy)Cl]+, for comparison. 
 
 
 
Complex Eox / V vs SCE Ered / V vs SCE 
[Ir(L1)(bpy)Cl]+ 1.28 E1/2 -1.52 E1/2 
[Ir(L2)(bpy)Cl]+ (14) 1.92 E1/2 -1.96 E1/2 
[Ir(L3)(bpy)Cl]+ (13) 1.24 Ep -1.85 E1/2 
 
Table 3.10: electrochemical data vs SCE for the mono-cyclometallated complexes with bpy as 
bidentate ligand  
 
 
 
[Ir(L1)(bpy)Cl]+ and [Ir(L2)(bpy)Cl]+ (14) exhibit reversible oxidations at similar 
potentials, respectively 1.28 V and 1.24 V, values comparable to that of 
[Ir(ppy)2(bpy)]+, which was reported at 1.28 V.(112)  Comparing these positively 
charged bpy containing mono-cyclometallated complexes with the neutral 
complexes Ir(N^C^N)(N^C)Cl, reported in the previous section, oxidation is located 
at higher potentials, reflecting their cationic nature.  The oxidation of 
[Ir(L3)(bpy)Cl]+ (13) occurs at even higher potentials, which would be consistent 
with an electron-withdrawing effect of the –CF3 groups, although care should be 
taken here in making a quantitative comparison, since the oxidation wave in this 
complex is not electrochemically reversible and the quoted value is the peak 
potential.   
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Based on the results of DFT calculations, the oxidation can again be attributed to 
the removal of an electron from an orbital spanning the iridium centre and the 
cyclometalating site of the N^C^N unit (Figure 3.30), as for the neutral bis-
cyclometallated complexes discussed earlier.  On the other hand, the LUMO levels 
of the two complexes (Figure 3.30) are located on the bpy ligand, in contrast to the 
previous set of complexes, where the LUMO was likely based on the N^C^N 
pyridyl rings.  The LUMO+1 is located on the N^C^N ligand in the –F substituted 
complex and on the bpy in the –CF3 substituted complex.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.32: DFT calculations for [Ir(L3)(bpy)Cl]+ (13) and [Ir(L2)(bpy)Cl]+ (14). 
 
 
 
3.3.2. Photophysical properties of [Ir(N^C^N)(N^N)Cl]+ complexes 
 
The absorption spectra of [Ir(L3)(bpy)Cl]+ (13) and [Ir(L2)(bpy)Cl]+ (14) (Figure 
3.31) display LC transitions below 300 nm and charge-transfer bands at lower 
energies.  With the support of the computational studies (Figure 3.30), the bands 
Complex HOMO-1 HOMO LUMO LUMO+1 
[Ir(L3)(bpy)Cl]
+ (13) 
E(eV) 
-0.32201 
-0.31928 -0.20253 -0.16794 
Ir 0.41 0.42 0.05 0.03 
N^C^N 0.17 0.3 0.02 0.07 
Cl 0.38 0.22 0 0 
N^N 0.04 0 0 0 
[Ir(L2)(bpy)Cl]
+ (14) 
E(eV) -0.32977 -0.32671 -0.20743 -0.19788 
Ir 0.43 0.42 0.04 0.03 
N^C^N 0.09 0.25 0.04 0.95 
Cl 0.04 0.06 0.91 0.02 
N^N 0.44 0.27 0 0 
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at 387 nm and 370 nm, respectively for the two complexes, are assigned as MLCT 
character, whereas those at lower in energy are assigned as being mixed 
MLCT/LLCT origin, according to the trend previously observed for [Ir(L1)(bpy)]+.(24)  
The higher energy that characterises the MLCT transitions of the bpy containing 
complexes, compared to those of Ir(N^C^N)(N^C)Cl, can be attributed to the lower 
energy of the metal d orbitals, reflecting the presence of only two rather than three 
anionic ligands in the coordination sphere ot the Ir(III).  Moreover, substituent 
effect on the terdentate ligand of [Ir(N^C^N)(N^C)Cl]+ systems has a similar 
outcome, to what was observed previously in Section 3.1.2. for bis-cyclometallated 
neutral complexes, in fact in the –F substituted complex the MLCT related band is 
blue shifted which respect to the analogous band of the –CF3 substituted parent 
complex. 
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Figure 3.31: normalised absorption spectra to the most intense low-enegy band in 
dichloromethane at room temperature for [Ir(L3)(bpy)Cl]+ (13) (red line) and [Ir(L2)(bpy)Cl]+ (14) 
(blue line). 
 
 
 
The emission spectra of [Ir(L3)(bpy)Cl]+ (13) and [Ir(L2)(bpy)Cl]+ (14) (Figure 3.32) 
in dichloromethane at room temperature are characterised by rather unusually 
shaped profiles, which appear to consist of a set of structured vibronically-resolved 
 163
bands to high energy, superimposed on a broader low-energy band.  Based on the 
DFT results presented above it is possible that this profile arises from dual 
emission from MLCT and LLCT states.  The emission maxima follow the sequence 
[Ir(L2)(bpy)Cl]+ (14) (484 nm) < [Ir(L1)(bpy)Cl]+ (502 nm) < [Ir(L3)(bpy)Cl]+ (13) 
(506 nm).  The excited state lifetimes of the cationic complexes are longer (in both 
degassed and aeretad solutions) than for the analogous containing ppy.  Indeed, 
the calculated kr values are an order of magnitude smaller than for the 
Ir(N^C^N)(N^C)Cl complexes, which is fully consistent with a lower degree of 
metal character in the excited state.  This observation reveals the importance of 
the effect of introducing a second cyclometallating unit in increasing metal 
participation in the excited states of the complex.  The quantum yields of the 
complexes bearing bpy bidentate ligands are an order of magnitude lower then 
those of Ir(N^C^N)(N^C)Cl (see Tables 3.11 and 3.4). 
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Figure 3.32: normalised emission spectra of [Ir(L3)(bpy)Cl]+ (13) (red line) and [Ir(L2)(bpy)Cl]+ (14) 
(blue line) in dichloromethane at room temperature, each compared with Ir(L3)(ppy)Cl (5) (green 
line) and Ir(L2)(ppy)Cl (4) (black line).
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Table 3.11: Luminescence data in solution in dichloromethane at 298±3 K, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and 
Φlum values; estimated uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions.
Complex λmax / nm degassed 
(aerated) 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 Absorption λmax / nm 
(ε / mol-1 dm3 cm-1) 
[Ir(L3)(bpy)Cl]+ (13) 506, 540, 580 4090 (1280) 0.06 1.4 23 24 248(97 600), 289(77 400), 
336(24 300), 387(11 400), 
426(3 700) 
[Ir(L2)(bpy)Cl]+ (14) 484, 518 2260 (1320) 0.03 1.3 43 14 254(15 100), 270(15 800), 
352(3 800), 370(4 200) 
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3.4. Ir(N^C^N)(pbi)Cl and [Ir(N^C^N)(Mepbi)Cl]+ complexes 
 
3.4.2. Photophysical studies 
 
Ground state absorption spectroscopy of both series of complexes, containing pbi 
and Me-pbi is summarised in Table 3.12.  The charge-neutral charged complexes 
(pbi coordinated) display the usual intense LC high-energy bands and the weaker, 
typical for cyclometallated complexes, bands at lower energies (Figure 3.33).  
Between 320 nm and 340 nm the Me-pbi coordinated complexes display relatively 
intense CT bands, whereas for the pbi coordinated systems the bands in the same 
regions are weaker.  At lower energies (between 350 nm and 400 nm) all four 
complexes show bands of mixed MLCT/LLCT character, with the Me-pbi 
incorporating systems displaying red-shifted bands compared to those of the pbi 
incorporating systems, suggesting, for the Me-pbi-based complexes, that the 
LUMO level may be on the Me-pbi instead of the N^C^N ligand.  At energies 
above 400 nm MLCT bands are shown by the complexes Ir(L3)(pbi)Cl (19) and 
[Ir(L3)(Me-pbi)Cl]+ (21). 
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Figure 3.33: normalised absorption spectra to the most intense low-enegy band in 
dichloromethane at room temperature for Ir(L1)(pbi)Cl (17) (green line), Ir(L3)(pbi)Cl (19) (red line), 
[Ir(L3)(Me-pbi)Cl]+ (21) (black line) and [Ir(L1)(Me-pbi)Cl]+ (20) (blue line). 
 
 166
 
 
Emission of the two Ir(N^C^N)(pbi)Cl complexes in degassed dichloromethane 
solution show emission of an MLCT character with Ir(L3)(pbi)Cl (19) (λMAX= 577) 
being red-shifted compared to Ir(L1)(pbi)Cl (17) (λMAX= 493) (Figure 3.34).  The 
two [Ir(N^C^N)(Me-pbi)Cl]+ complexes show structured bands of dual emission 
from MLCT and LLCT states, as previously observed for [Ir(N^C^N)(bpy)Cl]+ 
complexes.   
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Figure 3.34: normalised emission spectra in dichloromethane at room temperature for Ir(L1)(pbi)Cl 
(17) (blue line), Ir(L3)(pbi)Cl (19) (black line), [Ir(L3)(Me-pbi)Cl]+ (21) (red line) and [Ir(L1)(Me-
pbi)Cl]+ (20) (green line). 
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Table 3.12: Luminescence data in solution in dichloromethane at 298±3 K, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and 
Φlum values; estimated uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions.
Complex λmax / nm  degassed 
(aerated) 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 Absorption λmax / nm 
(ε / mol-1 dm3 cm-1) 
Ir(L1)(pbi)Cl (17) 493, 522 170 (90) 0.06 3.5 108 27 242(800), 298(600), 373(400), 
482 (100) 
Ir(L3)(pbi)Cl (19) 577 1 500 (950) 0.14 9 57 18 238(4 800), 290(2 300), 350(1 
300), 411(600), 441(300), 
502(100) 
[Ir(L1)(Mepbi)Cl]+ 
(20) 
506, 534 1300 (170) 0.04 3 74 25 243(3 800), 288(3 600), 320(1 
000), 390(1 000), 467(100) 
[Ir(L3)(Me-pbi)Cl]+ 
(21) 
516 220 (200) 0.21 95 360 23 242(4 900), 302(2 500), 338(1 
200), 390(900), 423(600), 
491(100) 
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3.5. Concluding remarks 
 
In this chapter photophysical and electrochemical properties of the complexes 
synthesised have been investigated.  Particular attention was given to strategies to 
tune the emission of Ir(N^C^N)(N^C)X complexes (X = -Cl or monodentate 
ancillary ligand) via modifications on the N^C^N, N^C and X ligands. 
 
Emission tuning by introduction of different substituents on the N^C^N ligand was 
achieved, in particular with substituents on the central phenyl ring (Y = -F, -CH3, –
CF3) and on the position 4 of the pyridyl rings (R = -H, -OMe, -NMe2, -CF3).  The 
effect of the substituents Y on complexes with R = -H, X = -Cl and ppy as a 
bidentate ligand led to a trend in the emission maxima of the complexes as 
follows: –F (λMAX = 487 nm) < -CH3 (λMAX = 503 nm) < –CF3 (λMAX = 590 nm).  This 
trend can be explained by mesomeric effect of the –F groups resulting in a 
stabilisation of the HOMO level in respect to the LUMO level, thus the HOMO-
LUMO energy gap is increased.  A different effect is provoked by the uniquely 
electron-withdrawing effect of the –CF3 groups which stabilise the energy of the 
LUMO with little effect on the HOMO level leading to a smaller HOMO-LUMO 
energy gap.  The effect of the groups R of the N^C^N ligand is investigated in 
complexes with Y = -F, X = Cl and dFppy as a bidentate ligand.  Blue-shifted 
emission is obtained when R = -NMe2 (λMAX = 472 nm) in respect to R = -H (λMAX = 
476 nm) and –OMe (λMAX = 477 nm).  The electron-donor effect of the -NMe2 is 
thought to destabilise the LUMO level with respect to the HOMO level. 
 
Blue-shifted emission was observed in complexes incorporating dFppy as N^C unit 
instead of ppy, the magnitude of which is around 500 cm-1 due to the mesomeric 
effect of the fluorine atoms on dFppy.  The complex bearing btiq as bidentate 
ligand and with X = -Cl, Y = -CF3 and R = -H displayed red-shifted emission (λMAX 
= 667 nm) compared to that of the ppy containing analogue (λMAX = 590 nm) due to 
a destabilisation of the HOMO level introduced by a more extended π system with 
btiq. 
 
Displacement of the chlorine atom in the sixth coordination site of 
Ir(N^C^N)(N^C)Cl complexes led to a blue-shift of the emission maxima in 
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complexes with –CN (λMAX = 480 nm) and –SCN (λMAX = 487 nm) as ancillary 
ligand compared to that of the complex with Y = -CH3, R = -H and dFppy as 
bidentate ligand (λMAX = 495 nm).  Coordination of A1 (1,3-trifluoromethyl-
phenylacetylide) as monodentate ancillary ligand on the complex Ir(L3)(ppy)Cl (5) 
(Y = -CF3, R = -H, λMAX = 590 nm) led to red-shifted emission with λMAX = 606 nm. 
 
It is possible to conclude that, following the emission tuning strategies adopted, 
the series of complexes investigated displays emission over a wide range of 
colours with the blue emission of Ir(L5)(dFppy)CN (Y = -F, R = -OMe, λMAX = 462 
nm) and the red emission of Ir(L3)(btiq)Cl (11) (Y = -CF3, R = -H, λMAX = 667 nm) 
as extremes. 
 
The measured quantum yields of the complexes Ir(N^C^N)(N^C)Cl synthesised 
range between 0.2 and 0.7, an order of magnitude higher compared to those of 
[Ir(N^C^N)(N^N)Cl]+ (ΦLUM = 0.03-0.06), due to the increased metal participation in 
the excited in complexes with a second cyclometallating ligand.  The complexes 
synthesised exhibit quantum yields comparable or, in some cases, higher  
compared to those of systems containing only bidentate ligands used for OLED 
applications such as Ir(ppy)3 (ΦLUM = 0.4).(87)  Ir(N^C^N)(dFppy)Cl and 
Ir(N^C^N)(ppy)Cl have been used as phosphorescent dopants in multi-layer 
OLEDs.  The devices manifested relatively high efficiencies (EL QE = 0.03-0.11) 
and stability over a wide range of current densities.  Among the most efficient 
iridium-based OLEDs are those with the green emitters Ir(ppy)3 and Ir(ppy)2(acac), 
with EL QE = 0.19.(149, 151)  In this work the most efficient device was the one 
incorporating Ir(L1)(ppy)Cl (1) (EL QE = 0.11).  It is worth highlighting the higher 
measured quantum yields of the complexes containing -CN and –SCN as 
monodentate ancillary ligand, in particular those of Ir(L1)(dFppy)CN (22) and 
Ir(L1)(dFppy)SCN (27).  These complexes in fact displayed, in both solution (ΦLUM 
= 0.9) and devices (EL QE = 0.08) improved emission properties compared to 
those of Ir(L1)(dFppy)Cl (ΦLUM = 0.7 and EL QE = 0.03). 
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4. Multimetallic complexes with cyclometallated Ir(III) units 
containing terdentate ligands 
 
4.1. Background and previous work 
 
Ir(III) complexes are potentially interesting components for the construction of 
supramolecular systems which can be used for collection and conversion of light 
energy.(87)  Multimetallic systems can manifest, in some cases, properties typical 
of the single units composing the assembly, or, in other cases, completely new 
properties, depending upon the degree of communication between the metal 
centres.  One of the most commonly adopted strategies for the synthesis of 
multimetallic complexes is to react metallic fragments, in which one of the ligands 
is easily replaceble, with a ditopic bridging ligand in a 2:1 stoichiometric quantity.  
Such strategies work well for homo-multimetallic systems, but the preparation of 
hetero-metallic systems requires a two step method, in which the bridging ligand is 
in excess, in order to favour coordination at one end of one metallic fragment and, 
in a second step, coordination of a different metal fragment through the other end 
(see Figure 4.1).   
 
 
 
2 M + M
a)
b)
M
M
M'
+ M
M + M'M
step 1
step 2
 
 
Figure 4.1: a) strategy for the synthesis of homometallic dinuclear systems; b) two-step strategy 
for the synthesis of heterometallic dinuclear systems using a preformed bridging ligand. 
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Many examples of binuclear homometallic Ir(III) systems are reported in literature.  
For example di-chloride-bridged dimers containing bidentate cyclometallating 
ligands, are obtained as intermediates in the synthesis of tris-chelate complexes.  
They have been found to be only poorly emissive at room temperature due to a 
rapid non-radiative decay that cleaves the dimer in the excited state.  However 
some improvements in emission are observed when strongly electron-withdrawing 
groups (such as –NO2) are attached to the cyclometallating ligands.  An increase 
of luminescence quantum yields is also observed in dimers containing isocyanate 
bridging ligands.(219)  Some examples of binuclear Ir(III) complexes with 
cyclometallating ligands of the ppy type and containing p-phenylene spacing units 
have also been reported.(220, 221)  In this case the photophysical properties of the 
complex are influenced by the length of the spacer and the presence of 
substituents on the cyclometallating ligands.  In general luminescence quantum 
yields for this class of complexes are found to be improved with respect to those of 
the chloride-bridged analogues.(87)  For this type of complex, luminescence 
originating from a 3MLCT excited state involving the bridging ligand is reported.   
 
Blue-shifted emission is observed, compared to that of Ir(ppy)3, when significant 
electronic comunication is present between the metal centres as in the case of 
[(ppy)2Ir(µ-bpt)Ir(ppy)2]+ (bpt shown in figure 4.2), where efficient mixing occurs 
between the d orbitals of the metal and the π of the bridging ligand.   
 
 
 
N N
N
N N
 
 
Figure 4.2: bpt bridging ligand 
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Polynuclear complexes containing Ir(III) centres and, in addition, other types of 
metals such as Os(II), Ru(II), Re(I) or Cu(I) linked by bridging ligands of different 
types show photoinduced processes, such as energy transfer between different 
metal centres.  
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Figure 4.3(122): examples of multicentered complexes that show energy transfer processes 
containing Ir(III) and Ru(II) units; a) [(bpy)2Ru-µ-(HAT)Ir(ppy)2]3+ and (b) [(bpy)2Ru(bpt)Ir(ppy)2]2+ 
 
 
 
For example the complex shown in Figure 4.3a), reported by Kirsch-De 
Mesmaeker and co-workers, emission was assigned to an iridium-centred state of 
SBLCT character.  In such complexes, absorption by a metal centre is observed 
and emission by another metal centre of the molecule occurs subsequently to an 
energy transfer process.  In the complex shown in Figure 4.3a) emission is 
identified on the Ir centre, following Ru→Ir energy transfer.  In Figure 4.3b) is 
shown an example reported by Reedijk and co-workers, in which the lowest-
energy MLCT state is localised on the iridium centre and the bridging ligand, the 
emission observed is instead characteristic of the ruthenium unit, due to energy 
transfer Ir→Ru.(222) 
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The research group of De Cola investigated some examples of heterometallic 
cyclometallated complexes containing Ir(III) and Ru(II) units in the presence of p-
phenylene spacers of various length in which the MLCT state is localised on one 
of the two metals and on the bridging ligand.  Energy transfer Ir→Ru occurs. 
(figure 4.4) 
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Figure 4.4(21): example of an heterometallic cyclometallated complex containing Ir(III) and Ru(II) 
units where energy transfer process occurs 
 
 
 
Another example of an energy transfer process is represented by the complex 
containing Ir(III) and Eu(III) units in Figure 4.5, from the Ir-based MLCT state to the 
5D0 of the Eu (III) ion, such that the emission spectrum contains contribution from 
both moieties (λMAX = 400, 491 for nm Ir and 615 nm for Eu).  The net effect is 
white light.(223) 
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Figure 4.5(87): partial energy transfer in a complex containing Ir(III) and Eu(III) units 
 
 
 
A different synthetic strategy was adopted by Constable and co-workers, in which 
the synthesis of multimetallic complexes is achieved by preparing complexes 
which can act as ligands.  In the presence of active functionalities on the complex, 
through appropriate reactions, fragments capable of coordinating other metal 
centres can be introduced in situ (Figure 4.6).(223)  For example, the ruthenium 
complex [Ru(Cltpy)2]2+, containing 4'-chloro-2,2':6',2''-terpyridine, was reacted with 
2,6-bis(2-pyridyl)-4-pyridone, leading to formation of species containing two vacant 
terpyridine coordination sites which were then in turn reacted with [Ru(tpy)Cl3] in 
order to obtain the tris-metallic species showed in Figure 4.6. 
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Figure 4.6(24): In situ elaboration of complexes 
 
 
 
Within our research group, synthetic pathways via in situ chemical reactions onto 
previously prepared building blocks have been carried out in order to synthesise 
both homo- and hetero- metallic multinuclear species. In particular, as building 
blocks, bis-terdentate complexes were chosen due to their achiral nature, yielding 
multimetallic species avoiding laborious separation processes between 
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stereoisomers that are obtained when chiral bidentate complexes are linked.  In 
the present work, particular attention is focused on homo-metallic dinuclear 
species.  In the work carried out by Whittle, a series of homo-metallic dinuclear 
complexes prepared via cross-coupling reactions was reported.(24)  Among them, 
as examples, the complexes [{Ir(dpydmb)}2µ-(mtbpy-3-mtbpy)][PF6]2 and 
[{Ir(dpydmb)}2µ-(mtbpy-4-mtbpy)][PF6]2 were afforded via Suzuki coupling of 
[Ir(dpydmb)(mtbpy--Br)]+, with aryl-diboronic acids in degassed DMSO and in 
presence of the catalyst Pd(PPh3)4, (Figure 4.7). 
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Figure 4.7(24): scheme for the synthesis of homo-metallic dinuclear complexes previously reported 
by our research group 
 
 
 
The photophysical properties of the homo-metallic dinuclear complexes were 
studied, displaying, in ground state absorption spectroscopy, intense transitions 
between 220 nm and 400 nm and weaker bands at lower energies, similar 
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behaviour to that observed for the mononuclear iridium complexes.  Within the 
region between 330 nm and 400 nm, the dinuclear species differ, from the 
mononuclear ones, by displaying CT transitions associated with the 1π–π* 
transitions involving the aromatic bridge.  Emission spectroscopy on the same 
systems was characterised by single structureless bands with lifetimes of the order 
of 140 ns, leading to the assignment of a charge transfer character of the excited 
states, although an additional very long component was observed at 77 K, 
possibly associated with a transition localised on the polyphenylene bridge. 
 
4.2. Synthesis of multimetallic complexes using acetylide and tetrazolate-
based bridging ligands 
 
This section reports on the utility of the Ir(N^C^N)(N^C)Cl unit in the preparation of 
homo-metallic dinuclear complexes.  The strategy envisaged exploits the ease 
with which the monodentate chloride ligand can be displaced, allowing one end of 
a ditopic bridging ligand to be coordinated to the [Ir(N^C^N)(N^C)]+ fragment.  Two 
classes of such bridging ligands are investigated.  One involves linear aryl bis-
acetylides H-C≡C-Ar-C≡C-H, exploiting the methodology discussed earlier for the 
preparation of mononuclear Ir(N^C^N)(N^C)(-C≡C-R) complexes.  The second 
involves bis-tetrazoles, in which tetrazolate anion will act as a monodentate ligand 
to each metal ion.  The synthetic strategy adopted, leading to formation of the 
multimetallic complexes, is to react a chosen metal fragment with a 2:1 
stoichiometric amount of the dianionic bridging ligand, giving formation of the 
desired symmetric species, similar to the scheme drawn in Figure 4.1a).  The 
reacting fragment selected for exploiting the build-up of such species is 
Ir(L3)(ppy)Cl (5), due to its ease of synthesis, the high solubility during the work-
up, facile purification method and the proven availability of the sixth coordination 
site under appropriate reaction conditions.  Preliminary studies of electrochemical 
and photophysical properties have been made in order to compare them with 
previously studied systems and observe the synergy of the two metal centres 
combined together and the role of the extended π system bridging the metal 
centres. 
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4.2.1. Synthesis of the bridging ligands 
 
For the first method, the synthesis of the requisite bis-acetylide proligand was 
performed using Sonogashira coupling conditions.(225)  The general mechanism of 
the Sonogashira coupling is illustrated in Figure 4.8.  The mechanism involves two 
cycles, one involving palladium and the other copper.  In the palladium cycle, 
oxidative addition of Pd(0) species occurs with the aryl halide to give Pd(II), which 
then reacts with a copper-acetylide species, produced in the copper cycle, 
producing an acetylide-coordinated palladium species and expelling copper iodide.  
The palladium-coordinated species, containing the organic substrates in mutually 
trans position to each other, undergoes trans-cis isomerisation.  Reductive 
elimination, during the final step of the palladium cycle, regenerates Pd(0) 
expelling the aryl-acetylide coupled compound.  The copper cycle involves 
formation of the organo-copper compound combined with deprotonation of the 
acetylide functionality to give the copper acetylide involved in the palladium cycle, 
which, by expelling CuI, regenerates the copper catalyst.   
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Figure 4.8: general scheme for the Sonogashira coupling of acetylides 
 
 
 
The synthesis of 4,4’-diethynyl-biphenyl (Figure 4.9) was performed by reaction of 
4,4’-diodo-1,1-biphenyl with trimethylsilyl acetylide (TMSA) using dry degassed 
Et3N in the presence of Pd(PPh3)2Cl2 and CuI.  A catalytic amount of the 
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intermediate compound bearing terminal ethynyl-tri-methylsilyl groups was purified 
by silica gel chromatography and, hydrolysed to the bis-acetylide in a solution of 
MeOH/NaOH, after which further purification by silica gel chromatography was 
required.  Formation of the desired bis-acetylide species, with an overall yield of 
33%, was confirmed by proton NMR and mass spectrometry with reference to 
literature data for the same molecule. 
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Figure 4.9: scheme for the synthesis of 4,4’-diethynyl-biphenyl 
 
 
 
The synthesis of an analogous biphenyl bearing tetrazolyl rings at the two 
extremes of the molecule was also carried out (Figure 4.10).  The synthesis of this 
molecule required two successive steps.  The first step comprised homo-coupling 
between two molecules of 4-bromo-benzonitrile, under conditions similar to those 
adopted for the Suzuki cross-coupling.  The reaction was carried out in DMF, 
using Pd(CH3CN)2Cl2 as a catalyst and in the presence of Et3N, giving the target 
compound in 22% yield, after silica gel purification. 
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Figure 4.10: scheme for the synthesis of 4,4’-bis-cyanobiphenyl 
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The 4,4-bis-cyano-biphenyl was then converted into a bis-tetrazolyl system (Figure 
4.11) by means of a 1,3-cycloaddition, with azide anion, performed by treatment of 
the nitrile with NaN3 in the presence of [Et3NH]+[Cl]- in toluene at 0°C.  The desired 
product was obtained as a precipitate from the reaction mixture upon protonation 
of the sodium tetrazolyl species, with a yield of 48% from the nitrile species. 
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Figure 4.11:scheme for the synthesis of 4,4’-tetrazolyl-biphenyl 
 
 
 
4.2.2. Synthesis of homo-metallic dinuclear complexes 
 
As discussed in Chapter 2, the chlorine atom in the sixth coordination site, in the 
Ir(N^C^N)(N^C)Cl class of complexes, can be easily displaced allowing 
introduction of monodentate ancillary ligands. There, we discussed the synthesis 
of cyano, thiocyano and acetylide complexes in this way.   
 
The synthesis of an aryl bis-acetylide bridged dinuclear complex was 
accomplished using the methodology described earlier for mononuclear acetylide 
adducts.  Thus, Ir(L3)(ppy)Cl (5) was treated with 4,4’-diethynyl-biphenyl (2:1 ratio) 
in the presence of KOH and CuI, to give the target complex in 53% yield (Figure 
4.12).  Its identity was confirmed by proton NMR, which showed a peak pattern 
characteristic of the previously studied iridium mononuclear complexes and two 
doublets for the protons located on the phenyl rings of the bridge.  Mass 
spectrometry revealed a peak corresponding to the desired dinuclear system with 
an isotopic pattern characteristic of dinuclear iridium complexes. 
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Figure 4.12: synthetic scheme for the synthesis of [{Ir(L3)(ppy)}2(µ-bpha)] (41). 
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Figure 4-13: 1H-NMR in CDCl3 of [{Ir(L3)(ppy)}2(µ-bpha)] (41).
 185
In order to investigate the possibility of introducing tetrazolyl type of monoanionic 
ancillary ligands onto the [Ir(L3)(ppy)]+ fragment, prior to working with the 
bistetrazole, the synthesis of Ir(L3)(ppy)(phtr) (36) (phtr = 5-phenyl-tetrazole) 
(Figure 4.15) and Ir(L3)(ppy)(Brphtr) (37) (Brphtr = 1-(4-bromo-phenyl-tetrazole)) 
was attempted.  Tetrazole-based monoanionic ancillary ligands have already been 
used in Ru(II) complexes by Stagni and co-workers.(226)  The tetrazole was first 
deprotonated, by treatment with Et3N, and reacted with a solvato-complex 
([Ru(tpy)(bpy)(acetone)]3+, prepared by pretreatment of the corresponding chloro 
complex with AgPF6 (Figure 4.14).  The same method was thus adopted to 
introduce monodentate phenyl tetrazole-based ancillary ligands onto the iridium 
coordination sphere. 
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Figure 4.14: synthesis of [Ru(tpy)(bpy)(thtr)]+ carried out by Stagni et al. 
 
 
3'
5'
3
4
56
6'
4'
4'
2''
6
54
3
3''
4''
Ir
F3C
F3C
N
N
Cl
N
Ir
F3C
F3C
N
N
NAgBF4
NN
HN N N
N N
N
Et3N
Acetone
(36)
 
Figure 4.15: scheme for the synthesis of Ir(L3)(ppy)(phtr) (36). 
 
 186
The synthetic route summarised in Figure 4.15 involves two steps.  In the first, the 
mononuclear species Ir(L3)(ppy)Cl (5) is treated with AgBF4 in a solution of 
acetone/water 2:1 (v/v) to remove the ancillary chlorine atom from the iridium 
coordination sphere.  During the second step, the so-formed solvato-complex is 
reacted with the anion of 5-phenyl tetrazole pre-formed by deprotonation with 
Et3N, giving the complex in 28% yield.  An identical method was adopted for the 
synthesis of Ir(L3)(ppy)(Brphtr) (37), obtained with a yield of 97%. 
 
Having established a reliable method for the introduction of the tetrazolate anion, 
the same approach was then applied to coordination of the bis-tetrazolate to two 
iridium fragments (1:2 stoichiometric ratio) to form homo-metallic dinuclear 
complex (Figure 4.16).  The target complex was purified by silica gel 
chromatography, with a yield of 10%.  
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Figure 4.16: scheme for the synthesis of [{Ir(L3)(ppy)}2(µ-bphtr)] (42). 
 
 
 
 
4.3. Electrochemistry and preliminary assessment of photophysical 
properties 
 
4.3.1. Electrochemical studies 
 
Electrochemical studies (Table 4.1), carried out in degassed dichloromethane 
solution, of the homo-metallic complexes synthesised in this work, revealed 
pseudoreversible oxidation at 1.11 V (vs SCE) for [{Ir(L3)(ppy)}2(µ-bpha)] (41) and 
an irreversible oxidation at 0.70 V for [{Ir(L3)(ppy)}2(µ-bphtr)] (42).  These values 
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are similar to those previously reported for homo-metallic iridium complexes (e.g. 
[{Ir(L1)}2µ-(mtbpy-n-mtbpy)]2+ Eox = 0.84 V and [{Ir(L1)}2µ-(mtbpy-4-mtbpy)][PF6]2 
Eox = 1.01 V (vs SCE)).(24)  As for the homo-metallic complexes studied previously 
by the research group, the weak electronic communication between the two 
iridium centres and the symmetry of the dinuclear complex lead to oxidations, for 
both complexes, at the same potential for each metallic unit of the complex.  
Comparing the oxidation of the tetrazolyl bridged species with the analogue 
monometallic complex Ir(L3)(ppy)(Brphtr) (37), due to the presence of the bridging 
ligand which probably allows a major delocalisation of the positive charge over the 
dinuclear complex, oxidation occurs at lower potentials.   
 
The presence of the bridging ligand influences also the reduction, which is located 
at more accessible potentials, compared with the processes relative to the 
mononuclear species reported in Table 4.1 and with Ir(L3)(ppy)Cl (5), which 
displayed a reduction process at –1.97 V vs SCE. 
 
 
 
Complex Eox / V vs SCE Ered / V vs SCE 
Ir(L3)(ppy)Cl (5) 1.02 E1/2 –1.97 E1/2 
Ir(L3)(ppy)(Brphtr) (37) 1.35 Ep -1.76 E1/2 
[{Ir(L3)(ppy)}2(µ-bpha)] (41) 1.11 E1/2 -0.51 Ep 
[{Ir(L3)(ppy)}2(µ-bphtr)] (42) 0.70 Ep -1.45 E1/2 
 
Table 4.1: electrochemical data cyclic voltammetry in degassed solution of dichloromethane 
 
4.3.2. Ground state absorption 
 
Ground state absorption data are summarised in Table 4.2 with the spectra 
portrayed in Figure 4.17.  The dinuclear complexes here discussed display intense 
bands between 225 nm and 360 nm, similar behaviour to that observed for 
previously studied homo-metallic dinuclear iridium complexes.  The bands 
between 225 nm and 300 nm are assigned as π-π* transitions, whereas the 
transitions between 300 nm and 360 nm are assigned as CT transitions related to 
the bridging ligand, which are significantly more intense for the dinuclear species 
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than those of the analogous mononuclear complexes Ir(L3)(ppy)(phtr) (36) and 
Ir(L3)(ppy)Cl (5) (Figure 4.17).  At lower energies, the dinuclear complexes display 
MLCT/LLCT bands.  Comparing the MLCT/LLCT bands of [{Ir(L3)(ppy)}2(µ-bphtr)] 
(42) and Ir(L3)(ppy)(phtr) (36), the bands relative to the dinuclear complex are 
slightly blue-shifted compared to those of the mononuclear by around 5-10 nm.  
Both [{Ir(L3)(ppy)}2(µ-bphtr)] (42) and [{Ir(L3)(ppy)}2(µ-bpha)] (41) display 
MLCT/LLCT bands blue-shifted to those of Ir(L3)(ppy)Cl (5) of around 10-20 nm.  
The dinuclear species also display weaker MLCT bands above 500 nm, as 
observed in the mononuclear species.   
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Figure 4.17: normalised absorption spectra to the most intense low-enegy band in 
dichloromethane at room temperature for Ir(L3)(ppy)(phtr) (36) (green line), Ir(L3)(ppy)Cl (5) (blue 
line), [{Ir(L3)(ppy)}2(µ-bphtr)] (42) (red line) and [{Ir(L3)(ppy)}2(µ-bpha)] (41) (black line). 
 
 
 
4.3.3. Emission and excited states 
 
Emission of the dinuclear complexes in degassed dichloromethane solution at 
ambient temperature (Figure 4.18) displays broad structureless bands for both 
complexes, with emission maxima respectively at 602 nm and 556 nm for the 
diethynyl bridged and the tetrazolyl bridged species.  The emission is assigned as 
 190
mixed CT and LC character and each of the dinuclear complexes has an emission 
maximum at similar energies in relation to that of the mononuclear complexes 
containing the corresponding homotopic ancillary ligand.  In fact, [{Ir(L3)(ppy)}2(µ-
bpha)] (41) displays a maximum at 602 nm, similar to that of Ir(L3)(ppy)(A1) (31) 
(λmax = 606 nm) and [{Ir(L3)(ppy)}2(µ-bphtr)] (42) with emission maximum at 556 
nm, similar to that of Ir(L3)(ppy)(Brphtr) (37) (λmax = 553 nm).  Comparing the two 
dinuclear species with Ir(L3)(ppy)Cl (5) (λmax = 590 nm), [{Ir(L3)(ppy)}2(µ-bpha)] 
(41) is red-shifted and [{Ir(L3)(ppy)}2(µ-bphtr)] (42) blue-shifted.  These values 
suggest only weak participation of the bridging ligand in the excited states of the 
complexes.  This is supported by the similarity in the lifetimes of the dinuclear and 
mononuclear species.  The calculated luminescence quantum yields of the 
dinuclear complexes are respectively 0.15 for [{Ir(L3)(ppy)}2(µ-bpha)] (41) and 
0.40 for [{Ir(L3)(ppy)}2(µ-bphtr)] (42), values similar to those measured for the 
mononuclear anologues.   
 
 
-0,2
0
0,2
0,4
0,6
0,8
1
1,2
500 550 600 650 700 750 800
wavelength (nm)
no
rm
al
is
ed
 e
m
is
si
on
 
 
Figure 4.18: normalised emission spectra in dichloromethane at room temperature of 
[{Ir(L3)(ppy)}2(µ-bphtr)] (42) (red line) and [{Ir(L3)(ppy)}2(µ-bpha)] (41) (black line), Ir(L3)(ppy)Cl (5) 
(blue line) and Ir(L3)(ppy)(phtr) (36) (green line).
 191
Complex λmax / nm  degassed 
(aerated) 
ΦLUM in 
degassed 
solution 
kr /104 s-1 Σknr / 104 s-1 kQ /108 M-1s-1 Absorption λmax / nm 
(ε / mol-1 dm3 cm-1) 
Ir(L3)(ppy)Cl (5) 590 3300 (1100) 0.46 14 16 28 259 (45 600), 272 (45 300), 373 (8 900), 
429 (11 100), 461 (8 000), 506 (3 100), 
541 (2 400) 
Ir(L3)(ppy)(phtr) (36) 556 5 300 (1 800) 0.34 6.4 13 16 233(48 400), 262(46 500), 306(18 600), 
362(6 800), 413(7 600), 452(6 100), 
491(3 000), 527(1 600) 
Ir(L3)(ppy)(Brphtr) (37) 553 5 300 (1 900) 0.32 6 13 15 235(38 400), 264(42 900), 304(15 100), 
360(4 900), 412(5 500), 450(4 400), 
493(1 900), 515(1 400) 
[{Ir(L3)(ppy)}2(µ-bpha)] (41) 602 1 500 (600) 0.15 10 56 45 232(52 900), 265(45 600), 342(25 400), 
424 (6 500), 482(3 600), 529(2 100), 
570(1 600) 
[{Ir(L3)(ppy)}2(µ-bphtr)] (42) 556 5 200 (1 900) 0.40 8 11 14 231(52 300), 268(44 000), 299(37 200), 
351(15 300), 405 (7 100), 441(5 800), 
480(3 200), 513(2 000) 
 
Table 4.2: Luminescence data in solution in dichloromethane at 298±3 K, where; radiative (kr) and non-radiative (Σ knr) rate constants are calculated from  and 
Φlum values; estimated uncertainty ±20%; kQ, bimolecular rate constant for quenching by O2, estimated from  values in degassed and aerated solutions.
 192
4.4 Concluding remarks 
 
In Chapter 2 the availability of the sixth coordination site of Ir(L3)(ppy)Cl (5) has 
been confirmed by the introduction, of acetylide-type monodentate ancillary 
ligands into this position displacing the Cl atom.  In this Chapter, the synthesis of a 
dinuclear homo-metallic complex ([{Ir(L3)(ppy)}2(µ-bpha)]) (41) is reported, which 
was obtained from Ir(L3)(ppy)Cl (5) as “building block” and a linear bis-acetylide 
as a bridging ligand with a yield of 53%.   
 
Also the reactivity of Ir(L3)(ppy)Cl (5) towards tetrazoles was investigated.  The 
synthesis of [{Ir(L3)(ppy)}2(µ-bphtr)] (42) (Y = 10%) is also reported by using 
Ir(L3)(ppy)Cl (5) as a “building block” and a bis-tetrazole bridging ligand. 
 
The complexes synthesised in Chapter 2, whose photophysical properties are 
discussed in Chapter 3, can thus also be used as “building blocks” for the 
preparation of multimetallic systems. 
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CHAPTER  5 
 
Experimental 
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5. Experimental 
 
5.1. Synthetic procedures and characterisation 
 
The solvents used throughout were of Analar quality and used as supplied, 
except for acetonitrile which was HPLC grade.  Water was purified using the 
PuriteSTILL Plus™ system having conductivity of ≤ 0.04 S cm–1.  All reagents were 
used as supplied. 
 
Thin layer chromatography was carried out using silica plates (Merck Art 5554) or 
neutral aluminium oxide plates (Merck Art 5550), both types being fluorescent 
upon irradiation at 254 nm.  Preparative column chromatography was carried out 
using silica (Merck Silica Gel 60, 230-400 mesh), or neutral alumina (Merck 
Aluminium Oxide 90, Brockman activity 2-3). 
 
NMR spectra were recorded on a Varian Mercury-200 spectrometer (200 MHz for 
1H, 50 MHz for 13C and 188 MHz for 19F), Varian Unity-300 spectrometer (300 
MHz for 1H), Varian Mercury-400 spectrometer (400 MHz for 1H and 101 MHz for 
13C), Bruker Advance-400 spectrometer (400 MHz for 1H), Varian Inova-500 
spectrometer (500 MHz for 1H, 126 MHz for 13C and 470 MHz for 19F) or Varian 
DD-700 spectrometer (700 MHz for 1H, 176 MHz for 13C and 658 MHz for 19F), and 
were referenced to residual protiosolvent resonances.  All NMR data is reported 
with chemical shifts (δ) quoted in ppm and coupling constants (J) in Hz.  1H-NMR 
spectra were assigned with assistance from 1H-1H COSY (correlation 
spectroscopy, through-bond interactions) and 1H-1H NOESY (nuclear Overhauser 
effect spectroscopy, through-space interactions) spectra.  13C-NMR spectra were 
recorded with proton decoupling and were assigned with assistance from 1H-13C 
HSQC (heteronuclear single quantum correlation) and 1H-13C HMBC 
(heteronuclear multiple bond correlation) spectra.  
 
Electrospray ionisation mass spectra (ES+ MS and ES– MS) were recorded with a 
Micromass LCT spectrometer or Thermo-Finnigan LTQ FT spectrometer with 
methanol or acetonitrile as the carrier solvent.  MALDI mass spectra were 
recorded with a Voyager-DE STR BioSpectrometry Workstation or a Thermo-
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Finnigan LTQ FT spectrometer.  High resolution mass spectra were recorded with 
a Micromass LCT spectrometer at 5000 resolution using sodium iodide as the 
reference, or a Thermo Finnigan LTQ FT spectrometer at 100000 resolutions with 
external calibration.  Electron ionisation, EI, mass spectra and the corresponding 
high resolution mass spectra were recorded by the EPSRC National Mass 
Spectrometry Service at the University of Wales, Swansea.  Gas chromatography-
mass spectra (GC-MS) were recorded using a Thermoquest Trace mass 
spectrometer.  Accurate ASAP spectra were recordered with Xevo QtoF mass 
spectrometer (Waters, Ltd, UK). 
 
C, H and N analysis was performed using an Exeter Analytical E-440 elemental 
analyser.  Melting points were determined on a Gallenkamp 889339 capillary 
melting point apparatus and are quoted to the nearest 1oC. 
 
5.2. Photochemical and photophysical measurements 
 
UV-visible absorption spectra were measured using a Biotek Instruments XS 
spectrometer operating with LabPower software.  All samples were contained in 
quartz cuvettes of 1 cm pathlength, and run against a reference of pure solvent 
contained within a matched cuvette.  Extinction coefficients were determined by 
dilution technique and graphical application of the Beer-Lambert law.   
 
A() = ()cl 
 
A() is the absorbance at a specified wavelength, () is the extinction coefficient 
at that wavelength (dm3 mol–1 cm–1), c is the concentration of the species that is 
absorbing (mol dm–3) and l is the pathlength (cm). 
    
Steady-state luminescence spectra were recorded using a Jobin Yvon FluoroMax-
2 spectrofluorimeter, equipped with a red-sensitive Hamamatsu R928 
photomultiplier tube (PMT), and operated with DataMax software.  Samples for 
emission measurements were contained within quartz fluorescence cuvettes of 1 
cm pathlength and the absorbance of each solution at the excitation wavelength 
was kept below 0.1 to minimise inner filter effects.  Emission was detected at right 
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angles to the emission source, with appropriate filters used where required to 
remove second order peaks.  All emission spectra were corrected after data 
acquisition for the dark count and for the wavelength dependent spectral response 
of the detector.  All quoted emission maxima refer to the values after correction.  
Excitation spectra were automatically corrected for lamp output, through use of a 
beam splitter, which directs 8% of the excitation light to a reference photodiode.   
 
Luminescence quantum yields were recorded with respect to a standard of 
ruthenium(II) tris(2,2'-bipyridine) chloride in aqueous solution, where st= 0.028 
and solution containing 2,6-di(2-pyridyl)benzene-1-platinum(II) chloride in 
degassed CH2Cl2 ( = 0.60 ref) as standards; estimated uncertainty in  is ± 20% 
or better(226)  The luminescence quantum yield of the sample () is calculated 
relative to the standard using the following equation.(227) 
 
 = st 
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Where I is the integrated emission intensity at a given excitation wavelength, A is 
the absorbance at that wavelength and n is the refractive index of the solvent.  The 
symbols with the subscript ‘st’ are the respective values for the standard.  
 
The quartz cuvettes of 1 cm pathlength used for emission measurements were 
modified with appropriate glassware to allow connection to a high-vacuum line.  
The degassing of samples was achieved by a minimum of three freeze-pump-thaw 
cycles, whilst connected to the high-vacuum line.  A final vapour pressure of < 5 x 
10–2 mbar at 77 K was achieved, monitored using a Pirani gauge.  
 
Low temperature (77 K) measurements of the samples were obtained as EPA 
glasses (EPA = diethyl ether-isopentane-ethanol, 2:2:1 by volume).  The sample 
as a solution in EPA was placed in a 4 mm diameter glass tube; then lowered 
inside a glass Dewar of liquid nitrogen where it remained whilst the measurements 
were taken. 
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The excited state lifetime measurements were measured using time-correlated 
single-photon counting (TCSPC).  The samples were excited in 1 cm pathlength 
quartz fluorescence cuvettes at 374.0 nm with an EPL-375 pulsed-diode laser.  
The emitted light passed through a monochromator and was detected at 90o using 
a Peltier-cooled R928 photomultiplier tube.  The estimated uncertainty in these 
lifetimes is < 10%. Longer lifetimes, > ~ 10 s, were measured using multi-channel 
scaling following excitation by a pulsed xenon lamp.  
 
5.3. Electrochemical measurements 
 
Cyclic voltammetry was carried out in a background electrolyte of 
tetrabutylammonium tetrafluoroborate (0.1 or 0.02 M) in acetonitrile.  A Autolab 
type III potentiostat was used with computer control and data storage via GPES 
Manager.  A three electrode assembly was employed, consisting of a platinum 
wire counter electrode, platinum flag reference electrode and a platinum working 
electrode.  The measurements were carried out in a glass cell charged with 2 mg 
of complex in 2 mL of electrolyte and purged with nitrogen.  
 
5.4. Density functional theory calculations 
 
B3LYP density functional theory, DFT, calculations were performed using the 
Gaussian98(228) and Gaussian03(229) software packages.  “Double-” quality basis 
sets were employed for the ligands (6-31G) and the iridium and rhodium metal 
centres (LANL2DZ).(230)  The inner core electrons of iridium were replaced with a 
relativistic effective core potential (ECP), leaving the outer core [(5s)2(5p)6] 
electrons and the (5d)6 valence electrons of iridium(III).  Likewise for rhodium(III) 
the inner core electrons were replaced leaving the outer core [(4s)2(4p)6] electrons 
and the (4d)6 valence electrons.  The geometries were fully optimised without 
symmetry constraints. 
 
5.5. X-ray crystallography 
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The single crystal X-ray diffraction experiments were carried out at 120 K, using 
graphite monochromated Mo Kα radiation (λ = 4.855 Å) on a Bruker SMART 1K 
area detector diffractometer, equipped with a Oxford Cryosystems N2 open-flow 
cooling device.  Series of narrow ω-scans (0.3˚) were performed at several φ-
settings in such a way as to cover a sphere of data to a maximum resolution 
between 0.70 and 0.77 Å.  Cell parameters were determined and refined using the 
Bruker SMART software, and raw frame data were integrated using the Bruker 
SAINT program.  The structure was solved by direct methods and refined by full-
matrix least squares on F2 using SHELX.  Reflection intensities were corrected by 
numerical integration using SADABS.  All non-hydrogen atoms were refined with 
anisotropic displacement parameters and the hydrogen atoms were positioned 
geometrically and refined using a riding model.  Crystal data and structure 
refinement parameters: Ir(L1)(dFppy)Cl (1): C62H50N6Ir2Cl10F4; Mr = 1693.98.55; 
triclinic, space group P-1, a = 9.0957(7), b = 11.7420(10), c = 15.0721(12) Å, a = 
102.7213(14), β = 93.4583(14), g = 102.1817(14)˚; V = 1525.2(3) Å3; Dc = 1.844 
mg mm-3; Z = 1; µ = 4.855 mm-1; reflections collected/unique 19537 / 7357 [Rint =  
0.0665]; final R indices [I > 2σ(I)]: R1 =  0.0450 and wR2  = 0.0949; R indices (all 
data): R1 =  0.0673 and wR2  = 0.1029.  Ir(L3)(ppy)Cl (5): C33H27ON3IrClF6; Mr = 
823.23; T = 120 K; triclinic, space group P-1, a = 8.8709(15), b = 11.996(2), c = 
14.940(3) Å, a = 85.119(6), β = 89.961(6), g = 75.957(6)˚; V = 1536.4(4) Å3; Dc = 
2.007 mg mm-3; Z = 2; µ = 4.501 mm-1; reflections collected/unique 21764 / 8106 
[Rint =  0.0368]; final R indices [I > 2σ(I)]: R1 =  0.0299 and wR2  = 0.0648; R 
indices (all data): R1 =  0.0406 and wR2  = 0.0682. 
 199
5.6. Synthesis of bidentate ligands (N^C) 
 
Synthesis of 2-(4,6-difluorophenyl)-pyridine(208) [dFppyH] 
 
 
 
N Br F F
B(HO)2
Pd(Ph3)4
DME N
F
F
+
3
4
5
6
2'
3'
5'
 
 
 
 
A mixture (2.9 ml, 3.0 mmol) of 2-bromo-pyridine, 525 mg (3.3 mmol) of 2,4-
difluoro-phenyl boronic acid, K2CO3 (1.24 g, 9.0 mmol) in 0.2 mL of water was 
dissolved in 10 mL of DME, was degassed via three freeze-pump-thaw cycles and 
Pd(PPh3)4 (173 mg, 0.15 mmol) was added under nitrogen.  The reaction mixture 
was then refluxed under nitrogen atmosphere for 22 hours and cooled to room 
temperature.  The DME was removed under reduced pressure and DCM was 
added to the residue and the solution was washed with 3*100 mL of aqueous 
solution of NaOH 1M.  The organic layer was collected and dried over MgSO4.  
Purification was achieved by silica gel chromatograohy (from 100% hexane up to 
98% hexane, 2% ether). The product was a white solid 280 mg (1.47 mmol, 49%).  
1H-NMR (CDCl 3, 400 MHz): δ 8.72 (d, 1H, 3J = 4.5, H6), 8.00 (td, 1H, 3J = 8.8, 6.7, 
H2’), 7.77-7.40 (m, 2H, H4 and H3), 7.27 (ddd, 1H, 3J = 8.7, 4.8, 0.9, H5), 7.07 
(dddt, 1H, 3J = 8.8, 8.0, 2.4, 1.2, H3’), 6.92 (dddd, 1H, 3J = 11.2, 8.8, 2.4, 0.8, H1’).  
13C-NMR (CDCl 3, 400 MHz): δ 164.6-159.4 (C4’, C6’), 152.6 (C1), 149.9 (CH6), 
136.6 (CH4), 124.3 (CH3), 123.8 (C1’), 122.6 (CH2’), 112.0 (CH3’), 104.5 (CH5’).  
19F-NMR (CDCl 3, 400 MHz): δ -109.7 (1F, m), -113.4 (1F, m).  Mass Spectrometry 
(ES+) : m/z 192 [M+H]+. 
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Synthesis of 2-(2-pyridyl-N-methyl)benzimidazole(231) [Mepbi] 
 
 
 
N
N
HN NaH
CH3I
N
N
N
6
5
4
3
2' 3'
4'
5'
 
 
 
 
To a suspension of dried THF (~10 ml) and NaH (34 mg, 0.85 mmol) was added a 
solution of 2-(2-pyridyl)benzimidazole (150 mg, 0.77 mmol).  The mixture was 
strirred for 20 minutes then a solution of MeI (119 mg, 0.85) in THF (~5 ml) was 
added and stirred overnight.  The resulting mixture was then washed with 1M 
NaOH aqueous solution.  The combined organic layer was dried under vacuum 
evaporation and the product obtained as a yellow/brown solid (77 mg, 48%).  H1-
NMR (CDCl3, 400 MHz): δ 8.69 (d, 1H, 3J = 3.6, H6), 8.38 (d, 1H, 3J = 7.6, H3), 
7.85-7.80 (d+t, 2H, H2’+H3’), 7.43 (d, 1H, 3J = 8.0, H5’), 7.34-7.28 (t+t+t, 3H, 
H5+H4+H4’).  Mass spectrometry (ES+): m/z: 210 [M]+. 
 
 
 
Synthesis of 2-Bromo-pyridine-N-oxide(202) 
 
 
 
N Br N Br
O
CPBA
6
5
4
3
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3-Chloroperoxybenzoic acid (4.25 g, 70% pure, 19 mmol) was dissolved in 
chloroform (50 ml).  Then 2-bromopyridine was added (2.5 g, 15.8 mmol) and the 
mixture stirred at room temperature for 3 days.  The resulting mixture was 
extracted with H2SO4 (15%, 3 x 50ml). Sodium thiosulphate was added to the 
aqueous phase and a yellow precipitate was observed.  The solution was 
neutralised by using Na2CO3 and extractions with chloroform were carried out, at 
this point the solution turned pink.  After drying over MgSO4 the solvent was 
eliminated by vacuum evaporation.  The crude product was a purple oil (1.75g, 
64%) and was used without purification in the next step.  1H-NMR (CD3Cl, 400 
MHz): δ 8.37 (1H, dd, 3J = 6.7, H6), 7.65 (1H, dd, 3J = 8.0, H3), 7.26 (1M, m, H4), 
7.11(1H, td, J=8, H5). 
 
 
 
Synthesis of 2-Bromo-4-nitropyridine-N-oxide(202) 
 
 
 
N Br
O
N Br
O
NO2
H2SO4
HNO3 6
5 3
 
 
 
 
2-Bromopyridine-N-oxide (1.75 g, 8 mmol) was added to aqueous H2SO4 (96%, 15 
ml) at 0°C. Fuming nitric acid (98%, 5ml) was added to the solution still at 0°C.  
The resulting mixture was heated at 130°C for 3 hours.  After cooling to room 
temperature the mixture was poured into ice (the solution turned from yellow to 
green at this stage) and neutralised with Na2CO3 and a precipitate was formed, 
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wich was washed with water.  The solid was then dissolved in dichloromethane, 
dried over MgSO4 and the solvent removed under reduced pressure after filtration.  
The product was a yellow solid (0.6 g, 2.7 mmol, 27%) and was used without 
further purification.  1H-NMR (CDCl3, 400 MHz): δ 8.08 (1H, dd, 3J = 7.2, 4J = 3.3, 
H6), 8.41 (1H, dd, 3J = 7.2, 4J = 0.4, H3), 8.52 (1H, d, 3J = 3.1, H5). 
 
 
 
Synthesis of 2-Bromo-4-nitropyridine(202) 
 
 
 
N Br
O
NO2
N Br
NO2
PBr3
6
5 3
 
 
 
 
2-Bromo-4-nitropyridine-N-oxide (0.6 g, 2.7 mmol) and PBr3 (1.1 g, 4.1 mmol) 
were dissolved in 25 ml of chloroform and refluxed for 2 hours.  The resulting 
mixture then poured into ice and neutralised with Na2CO3.  Extractions with 
chloroform were then performed and the organic layer dried over MgSO4.  After 
vacuum evaporation the product was obtained (444 mg, 2.2 mmol, 81%).  1H-NMR 
(CDCl3, 400 MHz): δ 8.00 (1H, dd, 3J = 5.4, 2.0, H6), 8.22 (1H, d, 3J = 1.9, H3), 
8.68 (1H, d, 3J = 5.4, H5). 
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Synthesis of 2-Bromo-4-methoxypyridine(202) [Br-OMepy] 
 
 
 
N Br
NO2
N Br
OMe
Na
MeOH
6
5 3
 
 
 
 
2-Bromo-4-nitropyridine (444 mg, 2.2 mmol) was added to a solution of sodium 
(0.97 g, 4.4 mmol) in methanol (25 ml).  The mixture was stirred at room 
temperature overnight, then 10ml of water were added and the solvent removed 
under reduced pressure to give the product as a yellow oil (307 mg, 1.7 mmol, 
75%).  1H-NMR (CDCl3, 400 MHz): б 6.78 (1H, dd, 3J = 5.9, H6), 7.00 (1H, d, 2.3, 
H3), 8.17 (1H, d, 3J = 5.8, H5). 
 
 
 
Synthesis of 2-tri-n-butyl-stannyl-4-methylpyridine(232) 
 
 
 
N
SnBu3Cl
N SnBu3
n-BuLi
6
5 3
 
 
 
 
2-(Dimethylamino)ethanol (0.8 ml, 8mmol) and 4-methyl-pyridine (0.39 ml, 4 
mmol) were placed in a 100 ml two necked round bottom flask fitted with 
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condenser and suba seal.  Dry hexane was added (25 ml) under nitrogen 
atmosphere.  The solution was cooled to –78°C and a 2.5 M solution of n-BuLi in 
hexane (10 ml, 16 mmol) was added dropwise over 30 minutes.  A solution of 
Bu3SnCl ( 2.8 ml, 4mmol) in 6 ml of THF was then added dropwise over 20 
minutes.  The mixture was then stirred at –78°C for 90 minutes and allowed to 
warm to room temperature.  To this, 30 ml of water were added and the reaction 
mixture was stirred at room temperature for 10 minutes.  The crude product was 
extracted in diethyl ether and dried over MgSO4 and the solvent evaporated under 
vacuum.  The product was a brown oil (0.5 g, 1.8 mmol, 45%).  1H NMR (CDCl3, 
400 MHz) δ 8.57 (d, 1H, H6), 7.20 (s, 1H, H3), 6.93 (d, 3J = 2.9, H5), 2.28 (s, 3H, 
HMe). 
 
 
 
Synthesis of 2-(2,4-difluorophenyl)-4-methyl-pyridine(208) [dFp-Mepy] 
 
 
 
N SnBu3
F F
Br Pd(Ph3)2Cl2
toluene N
F
F
+ 6
5 3
2'
3'
5'
 
 
 
 
In a Schlenk were added  of 2-tri-n-butyl-stannyl-4-methylpyridine 112 mg (0.29 
mmol), 2,6-di-Bromo-m-xylene (58 mg, 0.29 mmol), 
bis(triphenylphosphine)Palladium Chloride (25 mg, 0.1 mmol), triphenyl phosphine 
(8 mg, 0.028 mmol) dissolved in 5 mL of xylene.  The reaction mixture was 
degassed via five freeze-pump-thaw cycles and heated until reflux temperature 
was reached for 48 hours.  After cooling to room temperature the mixture was 
added to 20 mL of saturated aqueous solution of KF and stirred for 30 minutes, the 
solution was then filtered and the solid washed several times with water and 
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toluene.  The filtrate was added to a solution of NaHCO3 (100 mL, 10% w/w) and 
extracted with DCM (2x100 mL).  The combined organic layer was dried over 
MgSO4 and purified by silica gel separation chromatography (from 100% hexane 
to 50% ether, 50% hexane).  The product was a pale yellow solid 44 mg 
(0.21mmol, 74%).  1H NMR (CDCl3, 400 MHz): δ 8.58 (d, 3J = 5.3, 1H, H6), 7.98 
(m, 1H, H3), 7.58 (s, 1H, H5’), 7.17 – 6.78 (m, 3H, H5+H2’+H3’), 2.46 (s, 3H, HMe).  
19F-NMR: -110.04 (1F, s), -113.38 (1F, s).  Mass spectroscopy (ES+): m/z 206 
[M+H]+. 
 
 
 
Synthesis of 2-(2,4-difluoro-phenyl)-4-methoxy-pyridine(208) [dFp-OMepy] 
 
 
 
N Br F F
(HO)2B
Pd(PPh3)4
DME N
F
F
+
OMe OMe
6
5 3
2'
3'
5'
 
 
 
 
A mixture  of 2-bromo-4-methoxypyridine (150 mg, 0.8 mmol), 2,4-difluoro-phenyl 
boronic acid (126 mg, 0.8 mmol), aqueous K2CO3 (300 mg, 2.2 mmol) in 0.2 mL of 
water, all dissolved in 10 mL of DME was degassed via three freeze-pump-thaw 
cycles and Pd(PPh3)4 (58 mg, 0.05 mmol) was added under nitrogen.  The reaction 
mixture was then refluxed under nitrogen atmosphere for 22 hours and cooled to 
room temperature.  The DME was removed under reduced pressure and DCM 
was added. The solution was washed with 3*100 mL of aqueous solution of NaOH 
1M, the organic layer was collected and dried over MgSO4.  Purification was 
achieved by silica gel chromatograohy (from 100% hexane up to 80% hexane, 
20% ether).  The product was a white solid 150 mg (0.64mmol, 80%).  1H NMR 
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(CDCl3, 400 MHz) δ 8.50 (d, 3J = 5.7, 1H, H6), 8.08–7.87 (m, 1H, H5’), 7.34–7.18 
(m, 1H, H3), 7.02–6.93 (m, 1H, H5), 6.88 (d, 3J = 2.5, 1H, H3’), 6.81–6.72 (m, 1H, 
H2’), 3.87 (s, HMe).  19F-NMR: -109.8 (1F, m), -113.1 (1F, m).  Mass spectrometry 
(ES+): m/z 220 [M+H]+. 
 
 
 
Synthesis of 1-benzo[b]thiophene1-isoquinoline(208) [btiq] 
 
 
 
Pd(Ph3)Cl2
DME
S
B(OH)2 N
Cl
SN6
5
5''
4'' 3''
2''
2'
3'
4'
5'
 
 
 
 
4-Benzo[b]thiophene boronic acid (177 mg, 1 mmol) and 1-chloroisoquinoline (68 
mg, 0.42 mmol) were dissolved in a mixture of toluene (3ml), ethanol (3ml) and 
aqueous solution of Na2CO3 (2M, 1.5 ml).  The mixture was degassed through four 
freeze-pump-thaw cycles. Pd(Ph3P)4 (20 mg, 0.017 mmol) was then added under 
nitrogen and the solution was heated at reflux temperature for 42 hours.  After 
cooling to room temperature, 5 ml of water was added and the product extracted in 
dichloromethane, then dried over MgSO4 and filtered.  Purification of the target 
compound was achieved via silica gel chromatography (hexane/ diethyl ether 
90/10).  The product is a pale yellow solid (78 mg, 0.30 mmol, 30%).  1H NMR 
(CDCl3, 400 MHz): δ 8.53 (s, Hth) 8.52 (d, 3J = 5.7, 1H, H6), 8.13 (d, 3J = 8.5, 1H, 
H2’’), 7.91 (d, 3J = 8.2, 1H, H5’’), 7.78 – 7.64 (d+d+t, 3H, H5+H5’+H3’’), 7.61 – 7.45 
(t+d+t+t, 4H, H4’’+H4’+H3’+H2’).  Mass Spectrometry (ES+): m/z 262 [M+H]+ 
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5.7. Synthesis of terdentate ligands (N^C^N) 
 
Synthesis of 2,4-di-bromo-m-xylene(199) 
 
 
 
Br2
BrBr 3
6
 
 
 
 
In a 250 ml flask, bromine (21.9 g, 137 mmol) was added to m-xylene (7.5 g, 111 
mmol) over 5 minutes.  Then iodine (0.25 g, 1 mmol) was added over 30 minutes, 
the resulting mixture was stirred for 3 hours.  An aqueous solution of NaOH (4M, 
50 ml), was added and the precipitate formed was filtered and dried under 
vacuum.  The product was purified by recrystallization from ethanol (6.39 g, 
24mmol, 22%).  1H-NMR (CDCl3, 300 MHz): δ 7.67 (s 1H, H3), 7.10 (s, 2H, H6).   
13C-NMR(CDCl3, 300 MHz): δ 136.9 (C2), 134.9 (CH3), 132.6 (C1), 122.0 (CH6), 
22.2 (CMe).  Mass spectrometry (ES+): m/z 264 [M]+. 
 
 
 
Synthesis of 2-tri-n-butyl-stannyl-pyridine(232) 
 
 
 
N Br
n-BuLi
THF
-78°C N Li
SnBu3Cl
N SnBu3
6
5
4
3
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2-Bromopyridine (3ml, 31.6 mmol) was placed in a 100 ml two necked round 
bottom flask fitted with condenser and suba seal.  Dry THF was added (25 ml) 
under nitrogen atmosphere.  The solution was cooled to –78°C and n-Buli (21ml of 
a 2.5 M solution in hexane, 34.8 mmol) was added dropwise over 30 minutes.  A 
solution of Bu3SnCl ( 10.29 ml, 34mmol) in 6 ml of THF was then added dropwise 
over 20 minutes.  The mixture was then stirred at –78°C for 90 minutes and 
allowed to warm to room temperature.  To this 30 ml of water was added and the 
reaction mixture was stirred at room temperature for 10 minutes.  The product was 
extracted in diethyl ether and dried over MgSO4 and the solvent evaporated under 
vacuum.  The product was a brown oil (6.5 g, 17.8 mmol, 56%).  1H NMR (400 
MHz, CDCl3) δ 8.81 – 8.67 (m, 1H, H6), 7.49 (td, 3J = 7.5, 1.8 Hz, 1H, H4), 7.40 
(ddd, 3J = 7.4, 1.5, 1.0 Hz, 1H, H3), 7.11 (ddd, 3J = 7.6, 4.9, 1.5 Hz, 1H, H5). 
 
 
 
Synthesis of 1,3-di-(2-pyridyl)-4,6-dimethylbenzene [L1](197) 
 
 
 
BrBr N SnBu3 NN
+ 2
Pd(Ph3P)2Cl2
LiCl
toluene 6
5
4
1'
4'
 
 
 
 
In a Schlenk were added  2-tri-n-butyl-stannyl-pyridine (4.09 g, 9.00 mmol), 2,6-di-
bromo-m-xylene (1.00 g, 3.79 mmol), bis(triphenylphosphine)Palladium chloride 
(106 mg, 0.40 mmol), lithium chloride (1.34 g, 31.6 mmol) of dissolved in 25 mL of 
toluene.  The reaction mixture was degassed via five freeze-pump-thaw cycles 
and heated until reflux temperature was reached for 24 hours.  After cooling to 
room temperature the mixture was added to a saturated aqueous solution of KF 
(20 ml) and stirred for 30 minutes.  The solution was then filtered and the solid 
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washed several times with water and toluene, the filtrate was added to a solution 
of NaHCO3 (100 mL, 10% w/w) and extracted with DCM (2x100 mL).  The 
combined organic layer was dried over MgSO4 and purified by silica gel separation 
chromatography ( from 100% hexane to 90% ether, 10% hexane).  The product 
was a pale yellow solid 214 mg (0.08mmol, 26%).  1H-NMR (CDCl3, 200 MHz): δ 
8.61 (d, 2H, 3J = 4.9, H6), 7.63 (td, 3J = 7.7, 2H, H5), 7.44 (s, 1H, H4’), 7.36 (d, 2H, 
3J = 7.7, H3), 7.15 (s, 1H, H1’), 6.91 (t, 2H, 3J = 7.5, H4), 2.40 (s, 6H, HMe).  13C-
NMR (CDCl3, 400 MHz): δ 159.7 (C2), 149.1 (CH6), 138.1 (C2’), 136.1 (C4), 135.8 
(C3’), 133.3 (CH4’), 131.1 (CH1’), 124.2 (CH3), 121.6 (CH5), 20.0 (CMe).  Mass 
spectrometry (ES+): m/z 261 [M]+. 
 
 
 
Synthesis of 2,6-di-bromo-3,5-(bis-trifluoromethyl)aniline(201) 
 
 
 
CF3 CF3
NH2
Br2
CF3CF3
BrBr
NH2
Na2CO3
 
 
 
 
Dichloromethane (100 mL) was added to a mixture of bis(trifluoromethyl)aniline 
(1.0 g, 4.4 mmol), Na2CO3 (467 mg, 5.6 mmol) and iron filings (0.128 g, 2.18 
mmol) in a 250 mL round-bottom flask.  A solution of bromine (1 mL) in 
dichloromethane (30 ml) was added with stirring, and the mixture then heated at 
reflux temperature for 3 d with stirring.  Upon cooling, saturated Na2CO3(aq) (150 
mL) was added, the mixture was extracted with diethyl ether (3 x 100 mL), the 
combined organic phase dried over anhydrous MgSO4, and the solvent removed 
under reduced pressure.  The crude product was purified by chromatography on 
silica (100% hexane to 80% hexane / 20% ether), to give a yellow solid (1.30 g, 
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3.4 mmol, 77%).  1H-NMR (CDCl3, 400 MHz): δ 7.37 (1H, s, H4), 5.24 (2H, s, 
HNH2). 
 
 
 
Synthesis of 1,3-di-bromo-3,5-bis-(trifluoromethyl)benzene(201] 
 
 
 
CF3 CF3
NH2
CF3CF3
BrBr
BrBr
1.HSO4/EtOH
2.NaNO2 at 0°C
 
 
 
 
2,6-Dibromo-3,5-bis(trifluoromethyl)aniline (1.30 g, 3.4 mmol) from step (i) was 
dissolved in hot ethanol (20 mL) and concentrated sulfuric acid (2.55 mL, 95%) 
was added to the boiling solution.  The mixture was then cooled to 0C, and 
sodium nitrite (2.56 g, 0.037 mol) was added.  The mixture was allowed to warm to 
room temperature and stirring continued for 15 min.  It was then refluxed until gas 
evolution ceased.  The solvent was removed under reduced pressure, and the 
crude product was purified by chromatography on silica (hexane) to give the 
product as a colourless solid (460 mg, 1.24 mmol, 37%).  1H-NMR (400 MHz, 
CDCl3): δ 8.11 (1H, s, H4), 7.95 (1H, s, H1). 
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Synthesis of 1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene [L3] 
 
 
 
CF3 CF3
BrBr N SnBu3
CF3CF3
NN
+ 2
Pd(Ph3P)2Cl2
LiCl
toluene 6
5
4
4'
1'
 
 
 
 
Toluene (25 mL) was added to a mixture of 2-tri-n-butyl-stannyl-pyridine (2.2 g, 6.0 
mmol),1,3dibromo-4,6-bis(trifluoromethyl)benzene (840 mg, 2.3 mmol), 
Pd(PPh3)2Cl2 (200 mg, 0.29 mmol), and lithium chloride (1.2 g, 28 mmol).  The 
mixture was degassed via five freeze-pump-thaw cycles and then heated at reflux 
under an atmosphere of nitrogen for 24 h.  After cooling to room temperature, the 
mixture was added to a saturated aqueous solution of KF (20 mL) and stirred for 
30 min.  The solution was filtered and the solid residue washed with water and 
toluene.  The combined filtrate and washings was added to a solution of NaHCO3 
(100 mL, 10% w/w) and extracted into dichloromethane (2  100 mL).  The organic 
phase was dried over MgSO4 and the solvent then removed to yield a brown 
residue, which was purified by silica gel separation chromatography (gradient 
elution from 100% hexane to 20% hexane / 80% diethyl ether), leading to the 
product as a pale yellow solid (210 mg, 0.56 mmol, 25%).  1H NMR (CDCl3, 700 
MHz): δ 8.70 (2H, dd, 3J = 5.0, 4J = 1.5, H6), 8.17 (1H, s, 8.17, H4’), 7.78 (2H, ddd, 
3J = 7.0, 7.0, 1.5, H3), 7.71 (1H. s, H1’), 7.49 (2H, t, 3J = 7.5, H4), 7.35 (2H, td, 3J = 
7.5, 5.0, 4J = 1.5, H5).  13C NMR (CDCl3, 175.9 MHz): δ 156.0 (C2), 149.5 (CH6), 
143.2 (CH3), 136.2 (CH4), 135.3 (CH4’), 128.4 (q, 2JC–F = 31, CH1’), 125.0 (septet, 
3JC–F = 5, C3’), 124.0 (s, CH5), 123.3 (q, 1JC–F = 274, CF3), 123.2 (s, C2).  19F NMR 
(CDCl3, 282.2 MHz): δ –57.5.  MS (ES+): m/z 369 [M+H]+.  HRMS (ES+): m/z 
369.0818.  Calcd for C18H11N2F6: m/z 369.0826.  Elemental analysis: C, 57.7; H, 
3.9; N, 6.2 %.  Calcd for C18H10N2F6: C, 58.7; H, 2.7; N, 7.6 %. Melting Point: 
106°C. 
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Synthesis of 1,3-di-bromo-4,6-difluorobenzene 
 
 
 
F F FF
BrBrBr
Br2
NaOH
 
 
 
 
2,4-Difluorobromobenzene (7.53 g, 39 mmol) and iron filings (100 mg) were 
placed in a two-necked round-bottomed flask equipped with an addition funnel and 
a condenser holding a drying tube filled with KOH pellets.  The flask was heated to 
60C.  Bromine (9.33 g, 59 mmol) was added dropwise via the funnel over 1 h, 
and the mixture then allowed to stir for an additional 1.5 h.  The solution was 
poured into aqueous NaOH (10%, 30 mL) with stirring.  The organic layer was 
collected and the aqueous layer was extracted twice with toluene.  The combined 
organic layers were combined and dried with anhydrous Na2SO4.  The solvent was 
removed under reduced pressure to give the product as a light cream solid (7.24 
g, 26.8 mmol, 68%).  1H NMR (CDCl3, 300 MHz): δ 7.75 (1H, td, 3J = 7.0, 5J = 2.0, 
H1), 6.97 (1H, td, 4J = 8.0, 5J = 2.0, H4).  19F NMR (CDCl3, 400 MHz): δ –103.8 (dd, 
3JF–H = 7.5, 4JF–H = 7.5). 
 
 
 
Synthesis of 1,3-di-(2-pyridyl)-4,6-difluorobenzene[L2] 
 
 
 
F F
BrBr N SnBu3
FF
NN
+ 2
Pd(Ph3P)2Cl2
LiCl
toluene
6
5
4
3
4'
1'
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2-(Tributyltin)pyridine (4.17 g, 85% purity by 1H NMR, 9.62 mmol), 1,3-dibromo-
4,6-difluorobenzene (1.09 g, 4.01 mmol), Pd(PPh3)2Cl2 (0.104 g, 0.15 mmol), LiCl 
(1.24 g, 29.3 mmol) and toluene (6 mL) were placed in a Schlenk tube.  The 
mixture was degassed by four freeze-pump-thaw cycles, then heated under a 
nitrogen atmosphere to 120C for 48 h.  After cooling to room temperature, 
saturated aqueous KF (10 mL) was added and the mixture stirred for 30 min.  The 
precipitated solid was removed by filtration and washed with water (25 mL) and 
toluene (30 mL).  The filtrate was added to NaHCO3 solution (10%, 50 mL) and the 
resulting mixture extracted with dichloromethane (2 x 100 mL).  The organic phase 
was dried over MgSO4, and the solvent was removed under reduced pressure to 
leave a pale brown residue.  Purification by column chromatography (silica, 
hexane/ether gradient elution from 100/0 to 25/75) led to the desired product, 1,3-
di(2-pyridyl)-4,6-difluorobenzene, as a pale yellow solid (570 mg, 2.13 mmol, 
53%).  Rf = 0.55 (silica, hexane/ether 25/75). M.p. = 156–158C.  1H NMR (CDCl3, 
500 MHz): δ 8.72 (2H, dd, 3J = 5.0, 4J = 1.0, H6), 8.62 (1H, t, 4JH–F = 9.0, H4’), 7.76 
(4H, m, H4 and H3), 7.26 (2H, m, H5), 7.03 (1H, t, 3JH–F = 10.5, H1’).  13C NMR 
(CDCl3, 125.7 MHz): δ 160.7 (dd, 1JC–F = 255, 3JC–F = 12, CH3), 152.8 (C2’), 150.1 
(CH1’), 136.7 (C3’), 133.9 (t, 3JC–F = 4.5, CH5), 124.7 (dd, 2JC–F = 10, 4JC–F = 5.5, 
CH6), 124.5 (t, 4JC–F = 9.0, C4’), 122.8 (C2), 105.2 (t, 2JC–F = 27, C2’).  19F-NMR 
(CDCl3, 188 MHz): δ -113.3 (t, 2F, JF-H = 10).  HRMS (ES+) m/z = 269.0886 
[M+H]+; calcd for C16H11F2N2 = 269.0890.  Anal. calcd for C16H10F2N2 = C, 71.63; 
H, 3.76; N, 10.44%.  Found C, 71.52; H, 3.81; N, 10.43%. 
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Synthesis of 1,3-di-(4-pinacolatoboron)-4,6-difluorobenzene 
 
 
 
F F
BB
+
O
OO
O
F F
BrBr
B
O
O
B
O
O
Pd(dppf)Cl2
KOAc
DMSO
 
 
 
 
A Schlenk tube was charged with Pd(dppf)Cl2 (32mg, 0.039mmol), KOAc (379mg, 
3.86mmol) and bis(pinacolato)diboron (344mg, 1.35mmol) dissolved in 5ml of 
dried DMSO.  The mixture was degassed through several vacuum-nitrogen cycles 
before adding 1,3-di-bromo-4,6-di-fluoro–benzene (400mg, 0.65mmol), after which 
the mixture was strirred overnight at 80°C under nitrogen.  After coling to room 
temperature 50ml of toluene were added and the solution was washed with water 
in order to remove the DMSO from the organic layer.  The latter was dried over 
MgSO4.  Separation chromatography on silica gel (hexane/diethyl ether 60/40) 
yielded the desired product (125mg, 0.34mmol, 53%).  1H-NMR (CDCl3, 400 MHz): 
δ 8.07 (1H, t, J = 8.0, H4), 6.61 (1H, t, J = 10.0, H1) 1.33 (24H, s, HMe). 
 
 
 
Synthesis of 1,3-di-(4-methoxy-2-pyridyl)-4,6-difluorobenzene[L5] 
 
 
 
F F
BB
N Br
FF
NN
+ 2
OMe
O
OO
O
MeO OMe
Na2CO3/H2O
DME
6
5
3
4'
1'
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A schlenk was charged with 1,3-di-(4-methoxy-2-pyridyl)-4,6-di-fluoro-benzene 
(154 mg, 0.42 mmol), 2-bromo-4-methoxypyridine (150 mg, 0.84 mmol), 
dimethoxyethane (4mL) and Na2CO3.H2O (1 M, 4 mL) and was degassed by three 
freeze-pump-thaw cycles.  [Pd(PPh3)4] (0.0389 g, 0.034 mmol) was added under a 
positive flow of N2 and the reaction was left stirring at 80ºC for 48 hours.  DCM (70 
mL) was added to the solution which then was washed with 3 x 100 mL NaOH 
solution (1 M).  The DCM layer was separated and dried (MgSO4) and the solvent 
removed under reduced pressure.  The resulting black oily solid was purified by 
flash column chromatography (alumina, hexane/ethyl actetate, gradient elution 
from 100/0 to 60/40) giving the desired product as a white solid (43 mg, 33%).  1H-
NMR (CDCl3, 400 MHz): δ 8.60 (2H, t, J = 8.4, H6), 8.57 (1H, d, J = 5.2, H1’), 7.95 
(2H, d, J = 1.6, H4), 7.08 (1H, t, J = 10.0, H4’), 6.86 (2H, dd, 3J = 5.2, 4J = 2.6, H5), 
4.01 (6H, s, HOMe).  
 
 
 
Synthesis of 2-tri-n-butyl-stannyl-4-(trifluoromethyl)pyridine(232) 
 
 
 
N
n-BuLi
THF
-78°C N Li
SnBu3Cl
N SnBu3
CF3 CF3 CF3
6
5 3
 
 
 
 
2-(dimethyl amino)ethanol (0.8 ml, 8mmol) and 4-trifluoromethyl-pyridine (0.4 ml, 
3.2 mmol) were placed in a 100 ml two necked round bottom flask fitted with 
condenser and suba seal.  Dry hexane was added (25 ml) under nitrogen 
athmosphere.  The solution was cooled to –78°C and a solution of n-BuLi 2.5 M in 
hexane (10 ml, 16 mmol) was added dropwise over 30 minutes.  A solution of 
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Bu3SnCl ( 2.8 ml, 4mmol) in 6 ml of THF was then added dropwise over 20 
minutes.  The mixture was then stirred at –78°C for 90 minutes and allowed to 
ward to room temperature.  To this, 30 ml of water was added and the reaction 
mixture was stirred at room temperature for 10 minutes.  The product was 
extracted in diethyl ether and dried over MgSO4 and the solvent evaporated under 
vacuum.  The product was a brown oil (0.5 g, 1.6 mmol, 50%).  1H NMR (400 MHz, 
CDCl3) δ 8.88 (d, 1H, J=5.2, H6), 7.88 (s, 1H, H3), 7.27 (d, 1H, J = 4.8, H5).   
 
 
 
Synthesis of 1,3-bis-(4-(trifluoromethyl)-2-pyridyl)-4,6-bis-
(trifluoromethyl)benzene [L4] 
 
 
 
CF3 CF3
BrBr N SnBu3
CF3CF3
NN
+ 2
CF3
F3C CF3
Toluene
Pd(PPh3)2Cl2
LiCl
6
5
3
4'
1'
 
 
 
 
Toluene (25 mL) was added to a mixture of 2-tri-n-butyl-stannyl-4-tri-fluoro-methyl-
pyridine (1.0 g, 3.2 mmol), 2,6-dibromo-3,5-bis(trifluoromethyl)benzene (300 mg, 
0.8 mmol), Pd(PPh3)2Cl2 (100 mg, 0.15 mmol), and lithium chloride (0.4 g, 7 
mmol).  The mixture was degassed via five freeze-pump-thaw cycles and then 
heated at reflux under an atmosphere of nitrogen for 24 h.  After cooling to room 
temperature, the mixture was added to a saturated aqueous solution of KF (20 
mL) and stirred for 30 min.  The solution was filtered and the solid residue washed 
with water and toluene.  The combined filtrate and washings was added to a 
solution of NaHCO3 (100 mL, 10% w/w) and extracted into dichloromethane (2  
100 mL).  The organic phase was dried over MgSO4 and the solvent then removed 
to yield a brown residue, which was purified by silica gel separation 
chromatography (gradient elution from 100% hexane to 20% hexane / 80% diethyl 
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ether), leading to the product as a pale yellow solid (35 mg, 0.07 mmol, 25%).  1H 
NMR (CDCl3, 400 MHz): δ 8.84 (2H, d, 3J = 5.2, H6), 8.17 (1H, s, H4’), 7.66 (3H, 
s+s, H3+H1’), 7.54 (2H. dd, J=4.0, 1.2, H5).  13C NMR (CDCl3, 400 MHz): δ 157.2, 
150.9, 150.8, 135.3, 126.3, 122.8, 119.9, 119.3, 119.2.  19F NMR (CDCl3, 282.2 
MHz): δ –57.5 (3F), -65.2 (3F).  MS (ES+): m/z 504 [M+H]+. 
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5.8. Synthesis of bridging ligands 
 
Synthesis of 4,4’-diethynylbiphenyl(233) [bpha] 
 
 
 
I I
1. Et3N, CuI, Pd(Ph3P)2Cl2
2. TMSA
MeOH/NaOH  
 
 
 
In a schlenk under nitrogen, 4,4’-diodobiphenyl (362 mg, 0.90 mmol) was 
dissolved in triethylamine (15 ml).  To the mixture, CuI (5 mg), Pd(Ph3P)2Cl2 (50 
mg) and TMSA (0.4 g, 4 mmol) were added.  After heating to 50° C overnight, the 
mixture was cooled to room temperature and the formed precipitate was filtered 
and washed with ether (100 ml).  Purification was perfomed via silica gel 
separation chromatography (hexane) to give the intermediate compound 4,4’-
bis[(trimethylsilyl)ethynyl] biphenyl.  The latter was deprotected by stirring at room 
temperature with a solution of MeOH/NaOH ( 100 ml, 1:1).  Extraction of the 
resulting solution was carried out in ether (3x100 ml) and the organic layer was 
dried over MgSO4 then filtered. After removal of the solvent by vacuum 
evaporation the product was purified by silica gel chromatography (petroleum 
ether).  The product was a white solid (60 mg, 0.3 mmol, 33%).  1H-NMR (CDCl3, 
400 MHz): δ 7.48 (d, 4H, J= 3.2, Hphen), 7.46 (d, 4H, J= 3.2 Hphen), 3.07 (s, 2H, 
Hacetylide). 
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Synthesis of 4,4’-bis-cyano phenyl(234) 
 
 
 
Br CN2
Pd(CH3CN)2Cl2
Et3N
DMF
NC CN
 
 
 
 
In a 100 ml round bottom flask was added 4-bromo-1-cyano-phenyl (367 mg, 2.17 
mmol), Pd(CH3CN)2Cl2 (115 mg, 0.30 mmol), Et3N (1.5 ml) and 10 ml of DMF.  
The mixture was refluxed at 110° C for 48 hours.  After cooling to room 
temperature the mixture was diluted with 20 ml of water and extracted with ether 
(3x100 ml).  The organic layer was dried over MgSO4 and filtered.  Silica gel 
separation chromatography (hexane, ethyl acetate 3:1) gave the pure product as a 
white solid (98 mg, 0.48 mmol, 22%).  1H-NMR (CDCl3, 400 MHz): δ 7.69 (d, 2H, 
J=8.0, Hphen), 7.78 (d, 2H, J=8.0, Hphen). 
 
 
 
Synthesis of 4-4’ tetrazolyl-bis-phenyl [btrph](235) 
 
 
 
N NH
NNNHN
N N
CNNC
toluene
1.HCl/Et3N
2.NaN3  
 
 
 
In a 100 ml round bottom flask with 30 ml of toluene stirring at 0°C were added 
HCl(aq) 1.3 ml (14.1 mmol) and Et3N 2.1 ml (14.1 mmol).  The solution was allowed 
to warm up to room temperature then addition of 202 mg (1.12 mmol) of 4-4’-bis 
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cyano-phenyl and 385 mg (4.48 mmol) of sodium azide was carried out.  The 
solution was heated for 20 hours at 110°C.  After cooling to room temperarue the 
solvent was removed by vacuum evaporation and the residue dissolved in water 
(20 ml).  HCl (3M) was added dropwise to the solution causing precipitation of a 
white solid at pH=4.  The solid was then filtered and washed with 1M solution of 
HCl.  The product was obtained as a white solid (156 mg, 0.54 mmol, 48%).  1H-
NMR (d6-DMSO, 400 MHz): δ 8.29 (2H, d, J=8.4, Hphen), 8.11 (2H, d, J=8.4, Hphen). 
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5.9. Synthesis of Iridium di-chloro bridged dimers 
 
Synthesis of 1,3-di-(2-pyridyl)-4,6-dimethylbenzene di-chloro bridged Iridium 
dimmer(24) [Ir(L1)Cl(µ-Cl)]2  
 
 
 
N N
+ IrCl3*H2O2
NN
Ir
Cl
Cl
Ir
Cl
N N
2
4'
6
5
4
3
 
 
 
 
A suspension of 1,3-di-(2-pyridyl)-4,6-dimethyl-benzene (214 mg, 0.82 mmol) and 
iridium chloride monohydrate (258 mg, 0.82mmol) in a mixture of 2-ethoxyethanol 
(21 ml) and water (9ml) was refluxed for 24 hours under nitrogen atmosphere.  A 
yellow solid formed in the solution, which after cooling to room temperature, was 
collected by centrifuge, washed with water (3*5ml), ethanol (3*5 ml) and ether (3*5 
ml), and finally dried under vacuum.  The product was a yellow solid 240 mg 
(0.23mmol, 56%).  1H-NMR (DMSO-d6): δ 9.20 (2H, d, J=5.6, H6), 8.16 (2H, d, 
J=8.4, H3), 8.05 (2H, td, J=8.4, J=1.6, H4), 7.53 (2H, d, J=6.0, H5), 6.97 (1H, s, 
H4’), 2.75 (6H, s, HMe). 
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Synthesis of 1,3-di-(2-pyridyl)-4,6-bis-(trifluoromethyl)benzene di-chloro 
bridged Iridium dimer [Ir(L3)Cl(µ-Cl)]2 
 
 
 
CF3F3C
N N
+ IrCl3*H2O2
CF3F3C
NN
Ir
Cl
Cl
Ir
Cl
CF3F3C
N N
2
4'
6
5
4
3
 
 
 
 
A suspension of HL3 (155 mg, 0.42 mmol) and IrCl3.3H2O (145 mg, 0.42 mmol) in 
a mixture of 2-ethoxyethanol (14 mL) and water (6 mL) was refluxed for 24 h under 
a nitrogen atmosphere.  The solvent was removed under reduced pressure, to 
yield the product as an orange solid which was used in subsequent reactions 
without further purification (173 mg, 77%).  1H NMR (200 MHz, CD3CN): δ 9.25 
(2H, d, J=5.1, H1py), 8.48 (2H, d, J=9.7, H6), 8.09 - 7.97 (3H, t+s, H4+H4’), 7.65 (2H, 
d, J= 5.7, H5).  19F NMR (200 MHz, CD3CN): δ –60.1 (s, 6F, CF3).  
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Synthesis of 1,3-di-(2-pyridyl)-4,6-difluorobenzene di-chloro bridged Iridium 
dimer[Ir(L2)Cl(µ-Cl)]2 
 
 
 
FF
N N
+ IrCl3*H2O2
FF
NN
Ir
Cl
Cl
Ir
Cl
FF
N N
2
4'
6
5
4
3
 
 
 
 
A suspension of HL2 (250 mg, 0.93 mmol) and IrCl3.3H2O (327 mg, 0.93 mmol) in 
a mixture of 2-ethoxyethanol (14 mL) and water (6 mL) was refluxed for 24 h under 
a nitrogen atmosphere.  After cooling to room temperature, the yellow solid that 
formed was separated by centrifugation, washed successively with water, ethanol 
and diethyl ether (3  5 mL of each), and finally dried under vacuum.  This solid 
(383 mg, 78%) has low solubility in all common solvents, and was used in 
subsequent reactions without further purification. 
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Synthesis of 1,3-di-(4-methoxy-2-pyridyl)-4,6-difluorobenzene di-chloro 
bridged Iridium dimer[Ir(L5)Cl(µ-Cl)]2 
 
 
 
2IrCl3
FF
NN
MeO OMe2
FF
NN
MeO OMe
Ir
ClCl
Cl
Ir
F F
N N
OMeMeO
Cl
6
4
3
4'  
 
 
 
A suspension of 1,3-di-(4-methoxy-2-pyridyl)-4,6-difluorobenzene (50 mg, 0.15 
mmol) and iridium chloride monohydrate (53 mg, 0.15mmol) in a mixture of 2-
ethoxyethanol (7 ml) and water (3ml) was refluxed for 24 hours under nitrogen 
atmosphere.  A yellow solid formed in the solution, which after cooling to room 
temperature, was collected by centrifuge, washed with water (3*5ml), ethanol (3*5 
ml) and ether (3*5 ml), and finally dried under vacuum.  The product obtained was 
55 mg (0.047, 62%).  1H-NMR (DMSO-d6):  8.93(2H, d, H6), 7.55-7.60 (3H, s+s, 
H3+H4’), 7.10 (2H, d, H5), 3.34 (6H, s, HOMe). 
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Synthesis of 1,3-di-(4-(trifluoromethyl)2-pyridyl)-4,6-bis-
(trifluoromethyl)benzene di-chloro bridged Iridium dimer [Ir(L4)Cl(µ-Cl)]2 
 
 
 
2IrCl3
CF3F3C
NN
F3C CF32
CF3F3C
NN
F3C CF3
Ir
ClCl
Cl
Ir
F3C CF3
N N
CF3F3C
Cl
6
4
3
4'  
 
 
 
A suspension of HL4 (35 mg, 0.07 mmol) and IrCl3.3H2O (28 mg, 0.08 mmol) in a 
mixture of 2-ethoxyethanol (7 mL) and water (3 mL) was refluxed for 24 h under a 
nitrogen atmosphere.  The solvent was removed under reduced pressure, to yield 
the product as an orange solid which was used in subsequent reactions without 
further purification (45 mg, 0.03 mmol, 42%).  1H NMR (400 MHz, CDCl3): δ 8.64 
(2H, d, appears as a broad singlet, H6), 8.06 (1H, s, H4’), 7.70 (3H, d+s, H5+H3). 
19F NMR (376 MHz, CDCl3): δ –57.5 (s, 12 F), -59.8 (s, 12 F).  
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5.10. Synthesis of rhodium di-chloro bridged dimers 
 
Synthesis of 1,3-di-(2-pyridyl)-4,6-dimethylbenzene di-chloro bridged 
rhodium dimer [Rh(L1)Cl(µ-Cl)]2 
 
 
 
N N
+ RhCl3*H2O2
NN
Rh
Cl
Cl
Rh
Cl
N N
2
4'
6
5
4
3
 
 
 
 
A suspension of 1,3-di-(2-pyridyl)-4,6-dimethylbenzene (256 mg, 0.98 mmol) and 
rhodium chloride monohydrate (191 mg, 1mmol) in a mixture of 2-ethoxyethanol 
(21 ml) and water (9ml) was refluxed for 24 hours under nitrogen atmosphere.  A 
pale brown solid formed in the solution, which after cooling to room temperature, 
was collected by centrifuge, washed with water (3*5ml), ethanol (3*5 ml) and ether 
(3*5 ml), and finally dried under vacuum.  The product was a yellow solid 240 mg 
(0.28 mmol, 56%). 
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Synthesis of 1,3-di-(2-pyridyl)-4,6-difluorobenzene di-chloro bridged rhodium 
dimer [Ir(L2)Cl(µ-Cl)]2 
 
 
 
FF
N N
+ RhCl3*H2O2
FF
NN
Rh
Cl
Cl
Rh
Cl
FF
N N
2
4'
6
5
4
3
 
 
 
A suspension of 1,3-di-(2-pyridyl)-4,6-difluorobenzene (60 mg, 0.22 mmol) and 
rhodium chloride monohydrate (43 mg, 0.22) in a mixture of 2-ethoxyethanol (14 
ml) and water (6ml) was refluxed for 24 hours under nitrogen atmosphere.  A pale 
brown solid formed in the solution, which after cooling to room temperature, was 
collected by centrifuge, washed with water (3*5ml), ethanol (3*5 ml) and ether (3*5 
ml), and finally dried under vacuum.  The product obtained was 58 mg (0.067 
mmol, 60%).  
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Synthesis of 1,3-di-(2-pyridyl)-4,6-bis-(trifluoromethyl)benzene di-chloro 
bridged rhodium dimer [Ir(L3)Cl(µ-Cl)]2 
 
 
 
CF3F3C
N N
+ RhCl3*H2O2
CF3F3C
NN
Rh
Cl
Cl
Rh
Cl
CF3F3C
N N
2
4'
6
5
4
3
 
 
 
 
A suspension of 1,3-di-bromo-4,6-bis-(trifluoromethyl)benzene (280 mg, 0.76 
mmol) and rhodium chloride monohydrate (193 mg, 0.76) in a mixture of 2-
ethoxyethanol (21 ml) and water (9ml) was refluxed for 24 hours under nitrogen 
atmosphere.  After cooling down to room temperature an orange solid formed in 
the solution.  The solid was collected by centrifuge, washed with water (3*5ml), 
ethanol (3*5 ml) and ether (3*5 ml), and finally dried under vacuum.  61 mg (0.057 
mmol, 14%). 19F-NMR (CDCl3): -67.8. 
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5.11. Synthesis of iridium complexes 
 
Synthesis of Ir(1,3-di(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2') chloride [Ir(L1)(dFppy)Cl] (1) 
 
 
 
N
N
Ir N
F
F
Cl
NN
Ir
Cl
Cl
Cl
Ir
Cl NN
+ N
F F
2 2
6
54
3
4'
6 5
4
3
4'
6'
 
 
 
 
A mixture of [Ir(L1)Cl(µ-Cl)2] (50 mg, 0.048 mmol), dFppyH (19 mg, 0.096 mmol) 
and silver triflate (57 mg, 0.22 mmol) in toluene (4 mL) was refluxed for 24 h under 
a nitrogen atmosphere.  The precipitated AgCl was removed by centrifuge and 
washed with acetonitrile.  The filtrate and washings were combined, the solvent 
removed under reduced pressure, and the residue purified by chromatography 
(silica gel, CH2Cl2/MeOH, gradient elution from 100/0 to 98/2), leading to the 
product as a yellow solid (61 mg, 0.090 mmol, 94%).  1H-NMR (700 MHz, CDCl3): 
δ 10.15 (1H, dd, 3J = 4.9, 4J = 0.7, H6-NC), 8.42 (d, 1H, 3J = 8.4, H3-NC), 8.01 (d, 
2H, 3J = 8.4, H6-NCN), 7.97 (td, 1H, 3J = 7.0, 4J = 1.4, H4-NC), 7.58-7.52 (5H, H4-
NCN+H3-NCN+H5-NC), 6.88 (s, 1H, H4’-NCN), 6.78 (td, 2H, 3J = 7.7, 4J = 1.4, H5-
NCN), 6.18 (m, 1H, 3J = 11.9, 4J = 2.8, H4’-NC), 5.51 (dd, 1H, 3J = 9.1, 4J = 2.1, 
H6’-NC), 2.82 (s, 6H, HMe). 1H-NMR (700 MHz, CD3CN): δ 9.44 (1H, d, 3J = 5.4, 
H6-NC), 8.55 (d, 1H, 3J = 8.3, H3-NC), 8.26 (t, 1H, 3J = 7.9, H4-NC), 8.22 (d, 2H, 3J 
= 8.3, H6-NCN), 7.86 (t, 2H, 3J = 7.4, H4-NCN), 7.79 (t, 1H, 3J = 7.7, H5-NC), 7.70 
(d, 2H, 3J = 6.2, H3-NCN), 7.14 (s, 1H, H4’-NCN), 7.05 (t, 2H, 3J = 7.4, H5-NCN), 
6.42 (m, 1H, 3J = 11.9, 4J = 2.5, H4’-NC), 5.43 (dd, 1H, 3J = 12.0, 4J = 2.6, H6’-NC), 
2.87 (s, 6H, HMe).  13C-NMR (CDCl3, 176 MHz) δ 187.2 (C1’-NC or C1’-NCN), 182.5 
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(C1’-NC or C1’-NCN), 170.0 (C2-NCN), 153.3 (CH4-NCN), 151.2 (C6-NC), 149.7 
(C1-NC), 138.1 (CH5-NC), 137.5 (C2’-NCN), 137.3 (CH6-NC or CH5’-NC), 136.5 
(CH3-NCN), 129.9 (C3’-NCN and CH4’-NCN), 123.2 (C4’-NC), 123.0 (CH3-NC), 
122.9 (CH6-NCN), 122.9 (CH5-NCN), 121.6 (C6’-NC or C4’-NC), 121.5 (C2-NC), 
118.4 (CH5’-NC), 97.5 (CH3’-NC), 22.3 (CMe).  19F NMR (CDCl3, 376 MHz): δ –
108.7, (1F, NC), -109.4 (1F, NC).  MS (ES+): m/z 642, [M–Cl]+, 682 [M–
Cl+CH3CN]+.  HRMS (ES+): m/z 642.1314 [M+H]+. Calcd for C29H22N3F2191Ir: m/z 
641.1411. Elemental analysis. found: 46.57% C, 2.91% H, 6.39% N, calculated: 
51.48% C, 3.11 H%, 6.21%.  
 
 
 
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2') chloride [Ir(L2)(dFppy)Cl] (2) 
 
 
 
F
F
N
N
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Cl
Cl
Cl
Ir
Cl
FF
NN
+ N
F F
2 2 4'
3
4 5
6 6 5
4
3
4'
6'
 
 
 
 
Prepared from [Ir(L2)Cl(µ-Cl)]2 (50 mg, 0.047 mmol) and dFppyH (19 mg, 0.095 
mmol) in the presence of AgOTf (50 mg, 0.18 mmol) in toluene (4 mL), using the 
procedure described above for Ir(L1)(dFppy)Cl (1).  The product was purified by 
chromatography (silica, CH2Cl2/MeOH, gradient elution from 100/0 to 96/4), 
leading to the product as a yellow solid (25 mg, 0.034 mmol, 39%).  1H NMR 
(CDCl3): δ (CDCl3, 700 MHz): δ 9.52 (1H, d, 3J = 5.0, H6-NC), 8.49 (1H, d, 3J = 7.5, 
H3-NC), 8.12 (2H, d, 3J = 7.5, H6-NCN), 8.08 (1H, d, 3J = 7.5, H4-NC), 7.72 (2H, 
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dd, 3J = 7.5, 4J = 1.5, H4-NCN), 7.68 (1H, m, H4’-NC), 7.50 (2H, d, 3J = 5.0, H3-
NCN), 6.94 (2H, ddd, 3J = 7.5, 4J = 1.5, H5-NCN), 6.84 (1H, m, 3J = 12, H5-NC), 
6.27 (1H, dd, 3J = 13, 4J = 2.5, H5’-NC), 5.44 (1H, dd, 3J = 9.0, 4J = 2.5, H3’-NC). 
13C-NMR (CDCl3, 176 MHz) δ 165.8, 164.3, 161.5 (C1’-NC or C2-NCN or C1’-NCN), 
159.5 (C2’-NC), 151.3 (C2’-NCN and C3’-NCN), 149.5 (CH6-NC), 145.7 (C4’-NC), 
143.4 (C6’-NC), 137.7 (C2-NC), 137.6 (CH4-NC), 136.9 (CH3-NCN), 133.9 (C5’-NC), 
131.9 (CH4-NCN), 127.0 (CH3’-NC), 123.9 (CH5-NC), 122.8 (CH6-NCN), 122.2 
(CH5-NCN), 121.7 (CH4’-NCN), 188.9 (CH3-NC). 19F NMR (CDCl3, 376.3 MHz): δ –
107.7 (2F, d, 3JF–H = 12, NCN), –107.9 (1F, ddd appears as q, 3JF–H = 4JF–F = 9, 
F5'-NC), –109.4 (1F, dd, J = 11, F3'-NC).  MS (ES+): m/z 683 [M]+, 648 [M–Cl]+.  
HRMS (ES+): m/z 689.1073 [M–Cl+CH3CN]+.  Calcd for C29H18N4F4191Ir: m/z 
689.1077. Elemental analysis: found C 43.06%, N 5.77%, H 2.31%, calculated for 
ClC27H15N3F4191Ir: C 47.37%, N 6.14% , H 2.19%.  
 
 
 
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2') chloride [Ir(L3)(dFppy)Cl] (3) 
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F3C
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This complex was prepared from [Ir(L3)Cl(µ-Cl)]2 (42 mg, 0.033 mmol) and 
dFppyH (13 mg, 0.066 mmol) in the presence of silver triflate (35 mg, 0.14 mmol) 
in toluene (4 mL), as described above for Ir(L1)(dFppy)Cl (1).  The crude product 
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was purified by chromatography (silica gel, CH2Cl2/MeOH, gradient elution from 
100/0 to 99/1), giving an orange solid (18 mg, 0.023 mmol, 35%).  1H NMR 
(CDCl3, 700 MHz): δ 10.17 (1H, d, 3J = 5.5, H6-NC), 8.49 (1H, d, 3J = 8.5, H3-NC), 
8.42 (2H, d, 3J = 8.0, H6-NCN), 8.09 (1H, s, H4’-NCN), 8.07 (1H, td, 3J = 8.0, 4J = 
1.2, H4-NC), 7.76 (4H, m, H4-NCN and H5-NCN), 7.62 (1H, dd, 3J = 7.0, 4J = 1.2, 
H5-NC), 6.25 (1H, m, 3J = 12, 4J = 2.5, H5’-NC), 5.21 (1H, dd, 3’J = 9.0, 4J = 2.5, 
H3’-NC).  19F NMR (CDCl3, 376.4 MHz): δ –59.2 (6F, s, CF3), –108.0 (1F, m, 4J = 
9.0, F5'-NC), –109.4 (1F, dd, 3J = 11, 4J = 2.4, F3'-NC). 13C-NMR (CDCl3, 176 MHz) 
δ 183.9 (C4’-NC or C1’-NC), 175.0 (CH3’-NC or C1’-NC), 165.1 (C2-NCN), 160.1 
(C2’-NC), 153.5 (C1’-NCN or C3’-NCN), 151.3 (CH3-NCN), 149.6 (CH6-NC), 141.9 
(C2’-NC), 138.9 (CH4-NC), 137.3 (CH4-NCN), 125.1 (CH6-NCN), 124.6 (CH5-NCN), 
123.7 (C2-NC), 123.3 (CH3-NC), 122.9 (CH5-NC), 122.9 (C1’-NCN or C3’-NCN), 
118.7 (CH4’-NCN), 117.6 (C6’-NC), 98.5 (C4’-NC), 15.7 (CCF3).  1H NMR (CD3CN, 
500 MHz): δ 10.02 (1H, d, 3J = 5.5, H6-NC), 8.49 (1H, d, 3J = 8.5, H3-NC), 8.43 
(2H, d, 3J = 9.0, H6-NCN), 8.18 (1H, dd, 3J = 7.5, 3J = 7.5, H4-NC), 8.11 (1H, s, H4’-
NCN), 7.91 (2H, ddd, 3J = 9.0, 3J = 9.0, 4J = 1.5, H3-NCN), 7.87 (2H, t, 3J = 5.5, 
H4-NCN), 7.75 (1H, dd appears as t, 3J = 6.5, H5-NC), 7.16 (2H, dd, 3J = 6.5, H5-
NCN), 6.35 (1H, dd, 3J = 13, 4J = 2.5, H5’-NC), 5.20 (1H, dd, 3J = 9.0, 4J = 2.5, H3’-
NC).  MS (ES+): m/z 791 [M–Cl+CH3CN]+.  HRMS (ES+): m/z 789.1042 [M–
Cl+CH3CN]+.  Calcd for C31H18N4F8Ir: m/z 789.1013.  Elemental analysis: Found 
C, 43.3%; H, 2.5%; N, 4.61 %.  Calcd for C29H15N3F8IrCl·H2O: C, 43.4%; H, 2.1%; 
N, 5.2 %. 
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Synthesis of Ir(1,3-di(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2-
phenylpyridine-N,C2') chloride [Ir(L1)(ppy)Cl]  
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[Ir(L1)Cl(µ-Cl)]2 (35 mg, 0.033 mmol) and silver(I) trifluoromethanesulfonate (44 
mg, 0.17 mmol) in 2-phenylpyridine (ppyH) (250 µl, 1.75 mmol) were heated to 
110°C under a nitrogen atmosphere for 24 h.  After cooling to room temperature, 
dichloromethane (25 ml) was added and the remaining solid removed by filtration. 
Washing of the filtrate with HCl (1 M, 3 × 25 ml), drying over MgSO4, and removal 
of solvent under reduced pressure gave a yellow residue.  This was purified by 
column chromatography (silica, dichloromethane/methanol, gradient elution from 
100/0 to 99.75/0.25) to give the desired product as a yellow solid (25 mg, 0.036 
mmol, 59%).  1H-NMR (CDCl3, 500 MHz) δ = 10.12 (1H, d, 3J = 5.3, H6-NC), 8.07 
(1H, d, 3J = 8.0, H3-NC), 8.00 (2H, d, 3J = 8.4, H6-NCN), 7.96 (1H, td, 3J = 8.0, 1.4, 
H4-NC), 7.65 (2H, d, 3J = 5.6, H3-NCN), 7.59 (1H, t, 3J = 7.7, H5-NC), 7.51-7.55 
(3H, m, H3’-NC+H4-NCN), 6.88 (1H, s, H4’-NCN), 6.75 (2H, ddd, 3J = 7.2, 4J = 5.9, 
5J = 1.0, H5-NCN), 6.71 (1H, td, 3J = 7.4, 4J = 1.2, H5’-NC), 6.54 (1H, td, 3J = 7.5, 
4J = 1.0, H4’-NC), 6.00 (1H, d, J = 7.7, H6’-NC), 2.83 (6H, s, HMe).  Mass 
Spectrometry MS (ES+) m/z 606 ([M – Cl]+), 638 ([M –Cl + MeOH]+).  
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-difluoromethylbenzene-N,C2',N)(2-
phenylpyridine-N,C2') chloride [Ir(L2)(ppy)Cl] (4) 
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This complex was prepared from [Ir(L2)Cl(µ-Cl)]2 (50 mg, 0.047 mmol) and ppyH 
(15 mg, 0.095 mmol) in the presence of AgOTf (50 mg, 0.18 mmol) in toluene (4 
mL), using the procedure described above for Ir(L1)(dFppy)Cl (1).  The product 
was purified by chromatography (silica, CH2Cl2/MeOH, gradient elution from 100/0 
to 96/4), leading to the product as a yellow solid (54 mg, 0.083 mmol, 88%).  1H 
NMR (CDCl3, 500 MHz): δ 10.12 (1H, dd, 3J = 5.5, 4J = 1.0, H6-NC), 8.10 (3H, 3J = 
5.0, H3-NC+6-NCN), 8.01 (1H, td, 3J = 8.0, 4J = 1.5, H4-NC), 7.64 – 7.56 (6H, m, 
H3-NCN+H4-NCN+H5-NC+H3’-NC), 6.84 (2H, ddd, 3J = 7.0, 4J = 1.5, H5-NCN), 
6.79 (1H, t, 3J = 11, H5’-NCN), 6.78 (1H, m, H4’-NC), 6.63 (1H, ddd, 3J =7.5, 4J = 
1.0, H4’-NC), 6.07 (1H, dd, 3J = 7.5, 4J = 1.0, H6’-NC). 13C-NMR (CDCl3, 176 MHz) 
δ 184.8 (C1’-NCN), 177.2 (C2’-NC), 166.4 (C2-NCN), 164.7 (C3’-NCN+C2’-NCN), 
150.9 (CH6’-NC, C4-NCN CH4-NC or CH3-NCN), 149.2 (CH6-NC), 137.8 (CH4’-
NCN), 136.7 (CH6’-NC, CH4-NC, CH4-NCN or CH3-NCN), 135.6 (CH3’-NC), 129.4 
(CH4’-NC), 123.8 (CH6’-NC, CH4-NCN CH4-NC or CH3-NCN), 122.9 (C6-NCN), 
122.8 (C1’-NCN), 122.8 (C1’-NC), 122.6 (C2-NC), 122.4 (CH5-NCN, C5-NC or CH5’-
NC), 121.7 (CH5-NCN, CH5-NC or CH5’-NC), 118.8 (CH3-NC), 96.9 (CH5-NCN, C5-
NC or CH5’-NC).  19F NMR (CDCl3, 376 MHz): δ –109.0 (2F, d, 3J = 12, NCN).  MS 
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(ES+): m/z 655 [M–Cl+CH3CN]+.  HRMS (ES+): m/z 653.1267 [M–Cl+CH3CN]+.  
Calcd for C29H20N4F2191Ir: m/z 653.1265. Elemental analysis. found: 50.09% C, 
3.58% H, 4.29% N, calculated: 50.00% C, 2.62 H%, 6.48%. 
 
 
 
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
phenylpyridine-N,C2') chloride [Ir(L3)(ppy)Cl] (5) 
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A mixture of [Ir(L3)Cl(µ-Cl)]2 (30 mg, 0.028 mmol), ppyH (0.25 mL, 270 mg, 1.74  
mmol) and AgOTf (30 mg, 0.12 mmol) in toluene (4 mL) was heated at reflux 
under an atmosphere of nitrogen for 24 h.  After cooling to room temperature, the 
precipitated AgCl was removed by centrifuge and washed with acetonitrile.  The 
filtrate and washings were combined, and the solvent removed under reduced 
pressure.  The residue was taken up into CH2Cl2 (15 mL) and the solution washed 
with HCl(aq) (1M, 3  10 mL), followed by water (10 mL).  After drying over MgSO4, 
the solvent was removed under reduced pressure, and the residue purified by 
chromatography (silica, CH2Cl2/MeOH, gradient elution from 100/0 to 95/5), to give 
the product as an orange-red solid (19 mg, 0.051 mmol, 91%).  1H NMR (CDCl3, 
500 MHz): δ 10.12 (1H, dd, 3J = 5.5, 4J = 1.0, H6-NC), 8.39 (2H, d, 3J = 8.0, H6-
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NCN), 8.11 (1H, d, H3-NC), 8.06 (1H, s, H4’-NCN), 8.04 (1H, td, 3J = 8.0, 4J = 1.0, 
H4-NC), 7.83 (2H, dd, 3J = 6.0, 4J = 1.0, H3-NCN), 7.71 (2H, ddd, 3J = 8.0, 8.0, 4J = 
1.0, H4-NCN), 7.61 (2H, m, H4-NC+H5-NC), 6.99 (2H, ddd, 3J = 8.0, 4J = 1.0, H3’-
NCN), 6.76 (1H, ddd, 3J = 7.5, 4J = 1.0, H5’-NC), 6.62 (1H, ddd, 3J = 7.5, 4J = 1.0, 
H4’-NC), 6.07 (1H, dd, 3J = 5.5, 4J = 1.0, H6’-NC).  13C-NMR (CDCl3, 125 MHz) δ 
184.9 (CH6’-NCN), 165.2 (C2-NC), 164.9 (C2-NCN), 164.7 (C2’-NCN), 151.2 (C2’-
NC), 143.2 (C1’-NC), 136.9 (CH3-NCN), 136.7 (C3’-NC), 136.4 (CH6’-NC), 130.1 
(CH5’-NC), 125.8 (C6-NCN), 124.6 (CH5-NC), 124.5 (CH5-NCN), 123.5 (CH4-NCN), 
123.3 (CH4’-NC), 122.7 (CH3’-NCN), 122.4 (CH5’-NC), 119.6 (CH3-NC), 119.3 
(CH4’-NCN), 118.4 (CH4-NC), 31.2 (CCF3).  19F NMR (CDCl3, 376.4 MHz): δ –59.1 
(6F, s, NCN).  Mass Spectrometry (ES+): m/z 755 [M-CH3CN].  HRMS (ES+): m/z 
753.1198 [M–Cl+CH3CN]+.  Calcd for C31H20N4ClF6191Ir: m/z 753.1201.  Elemental 
analysis: found: 46.54% C, 2.46% H, 6.15% N, calculated: C 46.52%, N=5.61%, 
H=2.27%. 
 
 
 
Synthesis of Ir(1,3-di-(4-methoxy-2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,4-
difluorophenylpyridine-N,C2’) chloride [Ir(L5)(dFppy)Cl] (6) 
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This complex was prepared from [Ir(L5)Cl(µ-Cl)]2 (20 mg, 0.017 mmol), dFppyH (7 
mg, 0.038 mmol) and Silver triflate (9 mg, 0.034 mmol) in 3 ml of toluene, using 
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the procedure described above for Ir(L1)(dFppy)Cl (1), purification was achieved 
via silica gel separation chromatography (from DCM 100% to DCM 98%, MeOH 
2%).  The product was a yellow solid (17 mg, 0.022, 65%).  1H NMR (400 MHz, 
CDCl3) δ 10.11 (dd, 3J = 5.5, 4J = 1.0, 1H, H6-NC), 8.4 (dd, 3J = 8.4, 4J = 1.2, 2H, 
H6-NCN), 7.96 (td, 3J = 7.8, 4J = 1.6, 1H, H3-NC), 7.65 – 7.38 (m, 4H, H3-NCN+H5-
NC+H3-NC), 6.72 (t, 3J = 11.6 Hz, 1H, H4’-NCN), 6.41 (ddd, 3J = 14.2, 4J = 6.6, 5J 
= 2.8, 2H, H5-NCN), 6.22 (ddd, 3J = 13.0, 4J = 9.0, 5J = 2.4 Hz, 1H, H3’-NC), 5.56 
(dd, 3J = 9.0, 4J = 2.5 Hz, 1H, H6’-NC), 3.84 (s, 7H, HOMe).  19F-NMR (400 MHz, 
CDCl3) δ:-108.8 (2F, J=11.8, NCN), -109.2 (1F, NC), 110.5 (1F, NC).  Mass 
Spectrometry (MALDI+):  m/z 751 [M-CH3CN]+.  HRMS (ASAP+): m/z 744.0790 
[M+H]+. Calculated for C29H20N3O2F4Cl191Ir: m/z 744.0786. 
 
 
 
Synthesis of Ir(1,3-di-(4-methoxy-2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,4-
(difluorophenyl)-4-methylpyridine-N,C2') chloride [Ir(L5)(dFppic)Cl] (7) 
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This complex was prepared from [Ir(L5)Cl(µ-Cl)]2 (20 mg, 0.017 mmol), dFppyH (8 
mg, 0.039 mmol) and Silver triflate (9 mg, 0.034 mmol) in 3 ml of toluene, using 
the procedure described above for Ir(L1)(dFppy)Cl (1), purification was achieved 
via silica gel separation chromatography (from DCM 100% to DCM 98%, MeOH 
2%).  The product was a yellow solid (17 mg, 0.022, 65%).  1H NMR (CDCl3, 400 
MHz) δ 9.96 (d, 3J = 5.7, 1H, H6-NC), 8.26 (s, 1H, H3-NC), 7.62 (d, 3J = 8.8, 2H, 
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H6-NCN), 7.39–7.12 (m, 5H, H3-NCN+H3-NCN+H5-NC), 6.76 (t, 3J = 11.6, 1H, H4’-
NCN), 6.44 (dd, 3J = 6.6, 4J = 2.9 Hz, 2H, H5-NCN), 6.25 (ddd, 3J = 13.0, 4J = 9.0, 
5J = 2.4, 1H, H4’-NC), 5.58 (dd, 3J = 8.9, 4J = 2.5, 1H, H6’-NC), 3.88 (s, 6H, HOMe).  
Mass Spectrometry (MALDI+): m/z 759 [M]+, m/z 724 [M-Cl]+. HRMS (ASAP+): 
m/z 757.0865 [M]+.  Calculated for C30H21N3O2F4Cl191Ir: 757.0864 m/q. 
 
 
 
Synthesis of Ir(1,3-di-(4-methoxy-2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,4-
(difluorophenyl)-4-methoxypyridine-N,C2') chloride [Ir(L5)(dFpOMepy)Cl] (8) 
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This complex was prepared from [Ir(L5)Cl(µ-Cl)]2 (50 mg, 0.047 mmol), dFppyH 
(21 mg, 0.095 mmol) and Silver triflate (58 mg, 0.219 mmol) in 3 ml of toluene, 
using the procedure described above for Ir(L1)(dFppy)Cl (1), purification was 
achieved via silica gel separation chromatography (from DCM 100% to DCM 98%, 
MeOH 2%).  The product was a yellow solid (19 mg, 0.024, 26%).  1H NMR (400 
MHz, CDCl3) δ 9.89 (d, 3J = 6.4, 1H, H6-NC), 7.93 (s, 1H, H3-NC), 7.59 (d, 3J = 2.7, 
2H, H6-NCN), 7.45 – 6.97 (m, 3H, H3-NCN+H5-NC), 6.73 (t, 3J = 11.6, 1H, H4’-
NCN), 6.43 (dd, J = 6.6, 4J = 2.9, 2H, H5-NCN), 6.22 (m, 1H, H4’-NC), 5.55 (dd, 3J 
= 9.0, 4J = 2.4, 1H, H6’-NC), 4.07 (s, 3H, HOMe-NC), 3.86 (s, 6H, HOMe-NCN).  19F-
NMR (CDCl3, 376 MHz): δ -108.9 (2F, 3J=11.2, NCN), -109.48, 110.5 (2F, s, NC).  
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Mass Spectrometry (ASAP+): 740 m/z [M-Cl]+, m/z 775 [M]+.  HRMS (ASAP+): m/z 
773.0820 [M]+.  Calculated for C30H21N3O3F4Cl191Ir: m/z 773.0814. 
 
 
 
Synthesis of Ir(1,3-di-(4-(trifluoromethyl)-2-pyridyl)-4,6-bis-
(trifluoromethyl)benzene-N,C2',N)(2-phenylpyridine-N,C2') chloride  
[Ir(L4)(ppy)Cl] (9) 
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A mixture of [Ir(L4)Cl(µ-Cl)]2 (15 mg, 0.010 mmol), ppyH (0.25 mL, 270 mg, 1.74  
mmol) and AgOTf (10 mg, 0.04 mmol) was heated at reflux under an atmosphere 
of nitrogen for 24 h.  After cooling to room temperature, the solution was diluted in 
DCM (5 ml) and the precipitated AgCl was removed by centrifuge and washed with 
DCM.  The filtrate and washings were combined, and the solvent removed under 
reduced pressure.  The residue was taken up into CH2Cl2 (15 mL) and the solution 
washed with HCl(aq) (1M, 3  10 mL), followed by water (10 mL).  After drying over 
MgSO4, the solvent was removed under reduced pressure, and the residue 
purified by chromatography (silica, CH2Cl2/MeOH, gradient elution from 100/0 to 
95/5), to a give the product as an orange-red solid (7 mg, 0.008 mmol, 40%).  1H 
NMR (CDCl3, 400 MHz): δ 10.01 (d, 1H, 3J = 5.6, H6-NC), 8.63 (d, 2H, appears as 
a singlet, H6-NCN), 8.17-8.09 (d+s, 3H, H3-NC+H4-NCN), 8.02 (d, 2H, 3J = 5.6, H5-
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NCN), 7.99 (d, 1H, 3J = 8.0, H3’-NC), 7.76-7.59 (t+s, 2H, H4’-NCN+H4-NC), 7.44 (t, 
1H, 3J = 6.8, H5-NC), 6.82 (t, 1H, 3J = 7.6, H5’-NC), 6.61 (t, 1H, 3J = 7.6, H4’-NC), 
5.58 (d, 1H, 3J = 7.6, H6’).  19F-NMR (CDCl3, 376 MHz): δ -59.5 (6F, NCN), 65.4 
(6F, NCN).  Mass Spectrometry (MALDI+): m/z 891 [M+CH3CN]+.  HRMS 
(ASAP+): m/z 883.0328 [M]+. Calculated for C31H15N3F12Cl191Ir: m/z 883.0369. 
 
 
 
Synthesis of Ir(1,3-di-(4-(trifluoromethyl)-2-pyridyl)-4,6-bis-(trifluoromethyl)-
benzene-N,C2',N)(2-(1-benzo[b]thiophene)iso-1-quinoline-N,C2')chloride 
[Ir(L4)(btiq)Cl] (10) 
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A mixture of [Ir(L4)Cl(µ-Cl)]2 (15 mg, 0.010 mmol), btiqH (7 mg, 0.027  mmol) and 
AgOTf (10 mg, 0.04 mmol) in 3 ml of toluene was heated at reflux under an 
atmosphere of nitrogen for 24 h.  After cooling to room temperature, the 
precipitated AgCl was removed by centrifuge and washed with DCM.  The residue 
was taken up into CH2Cl2 (15 mL) and the solution washed with HCl(aq) (1M, 3  10 
mL), followed by water (10 mL).  After drying over MgSO4, the solvent was 
removed under reduced pressure, and the residue purified by chromatography 
(silica, CH2Cl2/MeOH, gradient elution from 100/0 to 95/5), to a give the product as 
an orange-red solid (3 mg, 0.003 mmol, 15%).  1H NMR (CDCl3, 400 MHz): δ 
10.04 (d, 1H, 3J = 6.0, H6-NC), 9.19 (d, 1H, 3J = 8.8, H3’’-NC), 8.62-8.61 (d+.d, 3H, 
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H6’’-NC+H6-NCN), 8.28 (s, 1H, H4’-NCN), 8.11 (d, 1H, 3J = 10.0, H6’’’-NC), 7.95 – 
7.60 (m, 7H, H4’’-NC+H5’’-NC+H5-NC+H5’’-NC+H5-NCN), 7.10 (dd, 3J = 11.0, 4J = 
4.1, 1H, H6’’’-NC), 6.96 (dd, 3J = 9.5, 4J = 3.7, 2H, H3-NCN), 6.80 (dd, 1H, 3J = 
11.3, 4J = 4.1, H4’’-NC), 5.99 (d, 3J = 8.3, 1H H3’’-NC).  19F-NMR (CDCl3, 376 MHz): 
δ -59.5 (s, 6F), -65.4 (s, 6F). 
 
 
 
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-(1-
benzo[b]thiophene)iso-1-quinoline-N,C2') chloride [Ir(L3)(btiq)Cl] (11) 
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A mixture of [Ir(L3)Cl(µ-Cl)]2 (33 mg, 0.030mol), btiqH (7 mg, 0.28 mmol), and 
silver triflate (33mg, 0.14mmol) in 4 ml of toluene was heated at reflux 
temperature, using the procedure described above for Ir(L1)(dFppy)Cl (1), 
purification was achieved via silica gel separation chromatography ( from 100% 
DCM to 95% DCM; 5% MeOH).  The product was a reddish solid (44 mg, 0.051 
mmol, 86%).  1H NMR (400 MHz, CDCl3) δ 10.12 (d, 3J = 6.3,H6-NC), 9.22 (d, 3J = 
8.1, 1H, H3’’-NC), 8.39 (d, J = 8.6, 2H, H6-NCN), 8.22 (s, 1H, H4’-NCN), 8.10 (d, J = 
7.8, 1H, H6’’-NC), 7.95 – 7.60 (m, 8H, H4’’-NC+H5’’-NC+H3’’’-NC+H3-NCN+H4-
NCN+H5-NC), 7.10 (dd, 3J = 11.0, 4J = 4.1, 1H, H5’’’-NC), 6.96 (dd, 3J = 9.5, 4J = 
3.7, 2H, H25-NCN), 6.80 (dd, 3J = 11.3, 4J = 4.1, 1H, H4’’’-NC), 5.99 (d, 3J = 8.3, 1H 
H6’’’-NC).  19F-NMR (CD3Cl, 660 MHz): δ –108.6 (6F, d, 3J = 11.2, NCN).  Mass 
 242
Spectrometry (ASAP+): = m/z 855 [M]+. HRMS (ASAP+): m/z 853.0515 [M]+.  
Calculated for C35H19N3F6SCl191Ir: m/z 853.0498. 
 
 
 
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-difluorobenzene-N,C2',N)(1-
phenylpyrrazole-N,C2') chloride [Ir(L2)(ppyz)Cl] (12) 
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A mixture of [Ir(L2)Cl(µ-Cl)]2 (40 mg, 0.038 mmol), 1-phenylpyrrazole (11 mg, 
0.071 mmol) and silver triflate (39 mg, 0.15 mmol) in 4 ml of toluene was refluxed 
for 24 hours under nitrogen atmosphere.  The solution was cooled to room 
temperature and the precipitated AgCl was removed by centrifuge and washed 
with acetonitrile.  The combined organic layer was dried under reduced pressure.  
The product was purified via silica gel chromatography (from 100% DCM to 96% 
DCM; 4% MeOH), and obtained as a yellow solid (29 mg, 0.045mmol, 62%).  1H-
NMR (CDCl3, 400 MHz): δ 8.56 (dd, 1H, 3J = 2.0, 4J = 0.8, H5-NC), 8.17 (dd, 1H, 3J 
= 2.8, 4J = 0.8, H3-NC), 8.01 (d, 2H, 3J = 8.8, H6-NCN), 7.68 (ddd, 2H, 3J = 5.6, 4J 
= 1.6, 5J = 0.8, H3-NCN), 7.54 (td, 2H, 3J = 8.0, 4J = 1.6, H4-NCN), 7.01 (dd, 1H, 3J 
= 8.4, 4J = 1.6, H3’-NC), 6.85-6.80 (t+t, 3H, H5-NC+H5-NCN), 6.73-6.66 (t+t, 2H, 
H4’-NC+H4’-NCN), 6.45 (td, 1H, 3J = 8.8, 4J = 1.6, H5’-NC), 5.88 (dd, 1H, 3J = 4.0, 
4J = 1.6, H6’-NC).  19F-NMR (CDCl3, 660 MHz): δ -108.6 (2F, J=11.9, NCN).  Mass 
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Spectrometry (MALDI+): m/z 603 [M-Cl]+, m/z 638 [M]+.  HRMS (ASAP+): m/z 
637.0726 [M+H]+. Calculated for C25H17N4F2Cl191Ir: m/z 637.0716. 
 
 
 
Synthesis of [Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2,2’-
bipyridine-N,N) chloride]+[PF6]- [Ir(L3)(bpy)Cl]+ (13) 
 
 
 
F3C
F3C
N
N
Ir N
N
Cl
CF3F3C
NN
Ir
Cl
Cl
Cl
Ir
CF3F3C
NN
+ N
N2 2
Cl
4'
3
5
6
6 5
4
3
6'
5' 4'
3'
+
4
 
 
 
 
A mixture of [Ir(L3)Cl(µ-Cl)]2 (30 mg, 0.029 mmol), bipyridine (10 mg, 0.060 mmol) 
and silver triflate (45 mg, 0.18 mmol) in 3 ml of ethylene glycol was refluxed for 24 
hours and then cooled down to room temperature, 20 mL of saturated aqueous 
solution of KPF6 was added and the precipitate collected by centrifuge.  The solid 
was dissolved in acetonitrile and dried under reduced pressure.  Purification was 
achieved by silica gel chromatography (100 % DCM to 99.5% DCM/ 0.5% MeOH). 
The product is an orange solid 26 mg (0.036 mmol, 76%).  1H-NMR (CD3CN, 700 
MHz): δ 9.88 (ddd, 1H, 3J = 5.3, 4J = 1.7, 5J = 0.8, H6-NN), 8.67 (d, 1H, 3J = 8.3, 
H3-NN), 8.54-8.48 (s+d, 3H, H6-NCN+H4’-NCN), 8.40 (d, 1H, 3J = 8.5, H3’-NN), 
8.23-8.15 (d+t, 3H, H3-NCN+H5-NN), 7.87 (td, 2H, 3J = 8.0, 4J = 1.6, H4-NCN), 
7.57 (td, 2H, 3J = 7.9, 4J = 1.4, H5-NCN), 7.20-7.00 (d+t+t, 4H, H4’+H5’+H6’-NN).  
13C-NMR (CD3CN, 176 MHz) δ 175.3, 164.0, 157.7, 155.5, 153.9, 153.0, 149.3, 
142.7, 141.0, 140.5, 139.9, 129.5, 128.4, 126.4, 126.3, 126.2, 126.1, 125.1, 124.3, 
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54.6 (CCF3).  19F-NMR (CD3CN, 188 MHz): δ –60.1 (6F, s, NCN), -71.5 and -75.2 
(6F, s, PF6).  Mass Spectrometry (ES+): m/z 751 [M-Cl]+.  HRMS (ES+): m/z 
751.0670 [M-Cl]+.  Calculated for C28H17N4F6Cl191Ir: m/z 751.1332.  Elemental 
analysis: 38.54% C, 2.13% H, 6.68% N, calculated: 44.80% C, 2.27% H, 7.47% N. 
 
 
 
Synthesis of Ir[(1,3-di-(2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,2’-bipyridine-
N,N) chloride]+[PF6]- [Ir(L2)(bpy)Cl]+ (14) 
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A mixture of  [Ir(L2)Cl(µ-Cl)]2 (30 mg, 0.029 mmol), bipyridine (10 mg, 0.060 mmol) 
and silver triflate (45 mg, 0.18 mmol) in 3 ml of ehtylene glycol, using identical 
synthetic procedure as for [Ir(L3)(bpy)Cl]+ (13), purification was achieved by silica 
gel chromatography (100 % DCM to 99.5% DCM/ 0.5% MeOH).  The product is an 
orange solid 26 mg (0.074 mmol, 62%).  1H-NMR (CD3CN, 400 MHz): δ 9.79 (d, 
1H, 3J = 5.2, H6-NN), 8.61 (d, 1H, 3J = 8.0, H3-NN), 8.35 (d, 2H, 3J = 8.4, H6-NCN), 
8.19-8.15 (s+t, 2H, H4’-NCN+H4-NN), 7.74-7.64 (t+t+d, 5H, H3-NCN+H5-NCN+H5-
NN), 7.45 (d, 1H, 3J = 8.0, H3’-NN), 7.01 (t, 2H, 3J = 7.6, H3-NCN), 6.85 (t, 1H, 3J = 
7.6, H4’-NN), 6.56 (t, 1H, 3J = 7.6, H5’-NN), 5.30 (d, 1H, 3J = 8.4, H6’-NN).  19F-
NMR(CD3CN): -59.39 (2F, 3J = 11.6, NCN), -71.5 and -75.2 (6F, s, PF6).  Mass 
 245
Spectrometry (ES+): m/z 651 [M-Cl]+.  HRMS (ES+): m/z 651.0732 [M-Cl]+.  
Calculated for C26H17N4F2Cl191Ir: m/z 651.1176.  Elemental analysis: 39.44% C, 
2.19% H, 6.89% N, calculated: 45.48% C, 2.48% H, 8.16% N. 
 
 
 
5.12. [Ir(N^C^N)(N^C^N)]+ and [Ir(N^C^N)2]+ complexes 
 
Synthesis of [Ir(1,3-di-(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(1,3-di-(2-
pyridyl)-4,6-difluorobenzene-N,C2',N)]+[PF6]- [Ir(L1)(L2)]+ (15) 
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A mixture of  [Ir(L1)Cl(µ-Cl)]2 (20 mg, 0.019 mmol), HL2 (13 mg, 0.038 mmol) and 
silver triflate (30 mg, 0.11 mmol) in 4 ml of toluene was refluxed for 24 hours under 
nitrogen atmosphere.  The solution was cooled to room temperature and the 
precipitated AgCl was removed by centrifuge and washed with acetonitrile.  The 
combined organic layer was dried under vacuum and dissolved in DCM and 20 mL 
of saturated aqueous solution of KPF6 was added and the precipitate collected by 
centrifuge.  The combined organic layer was dried under reduced pressure and 
purification was achieved via silica gel separation chromatography (from DCM 
100% to DCM 97%, MeOH 3%).  The product was a yellow solid (28 mg, 0.032 
mmol, 84%).  1H-NMR (CD3CN, 400 MHz): δ 8.12-8.18 (d+d, 4H, H6+H6’’), 7.40-
7.69 (t+t, 4H, H4+H4’’), 7.40 (d, 2H, 3J = 5.6, H3”), 7.32 (d, 2H, 3J = 5.2, H3), 7.23 (s, 
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1H, H4’’’), 7.15 (t, 1H, 3J = 6.0, H4’), 6.85-6.76 (t+t, 4H, H5+H5’’), 2.91 (s, 6H, HMe).  
19F-NMR (CD3CN, 400 MHz) : δ -108.5 (d, 2F, 3J = 12.4, NCN), -71.5 and -75.2 
(6F, s, PF6).  Mass Spectrometry (ES+):  m/z 719 [M]+.  HRMS (ASAP+): m/z 
717.1590 [M]+. Calculated for C34H24N4F2191Ir: m/z 717.1517. 
 
 
 
Synthesis of [Ir-di-(1,3-di(2-pyridyl)-4,6-di-fluoro-benzene-N,C2',N)]+[PF6]- 
[Ir(L2)2]+ (16) 
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A mixture of  [Ir(L2)Cl(µ-Cl)]2 (30 mg, 0.029 mmol), HL2 (16 mg, 0.058 mmol) and 
Silver triflate (45 mg, 0.18 mmol) in 4 ml of toluene was heated at reflux 
temperature, using the same method adopted for the synthesis of [Ir(L1)(L2)]+ 
(15), purification was achieved via silica gel chromatography (from DCM 100% to 
DCM 94%, MeOH 6%).  The product was a yellow solid (14 mg, 0.017 mmol, 
27%).  1H-NMR (CD3CN, 400 MHz): δ 8.19 (dd, 4H, 3J = 8.4, H6), 7.69 (td, 4H, 3J = 
8.0, H4), 7.41 (dd, 2H, 3J = 4.8, H3), 7.15 (s, 2H, H4b), 6.87 (td, 4H, 3J = 8.0, H5).  
19F-NMR (CD3CN, 400 MHz): δ -108.3 (d, 4F, J=12.0, NCN), -71.5 and -75.2 (6F, 
s, PF6).  Mass Spectrometry (ES+):  m/z 727 [M]+.  
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5.13. Complexes with pyridylbenzimidazole as bidentate ligand 
 
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2-(2-
pyridyl)benzimidazole) chloride [Ir(L1)(pbi)Cl] (17) 
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A mixture of  [Ir(L1)Cl(µ-Cl)]2 (50 mg, 0.047 mmol), pbiH (20 mg, 0.1 mmol) and  
silver triflate (50 mg, 0.18 mmol) in 4 ml of toluene was refluxed for 24 hours under 
nitrogen atmosphere.  The solution was cooled to room temperature and the 
precipitated AgCl was removed by centrifuge and washed with acetonitrile.  The 
combined organic layer was dried under reduced pressure, dissolved in 
dichloromethane and washed with 1M aqueous solution of HCl and dried over 
MgSO4.  The product was purified via silica gel separation chromatography (from 
100% DCM to 98.5% DCM; 1.5% MeOH).  The product was a yellow solid (18 mg, 
0.026 mmol, 28%).  1H-NMR (CDCl3, 500 MHz): δ 8.73 (d, 1H, 3J = 8.5, H6-pbi), 
8.39 (d, 1H, 3J = 7.5, H3’-pbi), 8.07 (d, 2H, 3J = 8.5, H6-NCN), 8.01 (d, 1H, 3J = 8.5, 
H5’-pbi), 7.94 (d, 2H, 3J = 8.6, H3-NCN), 7.64 (td, 2H, 3J = 9.5, 4J = 2.0, H4-NCN), 
7.51 (t, 1H, 3J = 9.5, 4J = 1.7, H4’-pbi), 7.41 (t, 1H, 3J = 8.0, H4-pbi), 7.32 (t, 1H, 3J 
= 7.0, H5-pbi), 7.09 (d, 1H, 3J = 5.5, H3-pbi), 6.97 (s, 1H, H4’-NCN), 6.90 (td, 2H, 3J 
= 7.0, 4J = 1.0, H5-NCN), 6.71 (t, 1H, 3J = 8.0, 4J = 1.7, H6’-pbi), 2.86 (s, 6H, HMe).  
Mass Spectrometry (ES+): m/z  682 [M+H]+.  HRMS (ES+): m/z 680.1339 [M+H]+.  
Calcd for C30H24N5Cl191Ir: m/z 680.1349.  Elemental analysis: 48.19% C, 3.17% H, 
9.03% N, calculated: 52.78% C, 3.37% H, 10.26% N 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-difluorobenzene)(2-(2-
pyridyl)benzimidazole-N,C2',N) chloride [Ir(L2)(pbi)(Cl] (18) 
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A mixture of  [Ir(L2)Cl(µ-Cl)]2 (50 mg, 0.047 mmol), pbiH (20 mg, 0.1 mmol) and 
silver triflate (50 mg, 0.15 mmol) in 4 ml of toluene was heated at reflux 
temperature, using the same synthetic method as for Ir(L1)(pbi)Cl (17).  The 
product was purified via silica gel separation chromatography (from 100% DCM to 
97% DCM; 3% MeOH), and obtained as a yellow solid (27 mg, 0.040 mmol, 42%). 
1H-NMR (CDCl3, 500 MHz): δ 9.88 (d, 1H, 3J = 4.5, H6-pbi), 8.65 (d, 1H, 3J = 8.5, 
H3-pbi), 8.20 (t, 1H, 3J = 6.5, H4-pbi), 8.12 (d, 2H, 3J = 8.0, H6-NCN), 7.62 (td, 1H, 
3J = 6.0, 4J = 1.0, H5-pbi), 7.61 (td, 2H, 3J = 7.5, 4J = 1.0, H4-NCN), 7.50-7.32 (t+d, 
3H, H3-NCN+H3’-pbi), 6.98-6.91 (t+d+t, 4H, H4’-pbi+H5-NCN+H4’-NCN), 6.71 (t, 1H, 
3J = 7.5, H5’-pbi), 5.82 (d, 1H, 3J = 8.5, H6’-pbi).  19F-NMR(CDCl3, 376 MHz): δ -
107.6 (2F, d, 3J = 11.3, NCN).  Mass Spectrometry (ES+): m/z 690 [M+H]+.  HRMS 
(ES+): m/z 688.0824 [M+H]+.  Calcd for C28H18N5ClF2191Ir: m/z 688.0848.  
Elemental analysis: 46.67% C, 2.64% H, 9.03% N, calculated: 48.76% C, 2.61% 
H, 10.16% N 
 
 
 
 249
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-(2-
pyridyl)bezimidazol) chloride [Ir(L3)(pbi)Cl] (19) 
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A mixture of [Ir(L3)Cl(µ-Cl)]2 (30 mg, 0.024 mmol), pbiH (12 mg, 0.06 mmol) and 
silver triflate (30 mg, 0.1 mmol) in 4 ml of toluene was heated at reflux 
temperature, using the same synthetic method as for Ir(L1)(pbi)Cl (17).  The 
product was purified via silica gel chromatography (from 100% DCM to 99% DCM; 
1% MeOH), and obtained as a yellow solid (14 mg, 0.018 mmol, 37%). 1H-NMR 
(CDCl3, 400 MHz): δ 9.79 (d, 1H, 3J = 5.2, H6-pbi), 8.61 (d, 1H, 3J = 8.0, H3-pbi), 
8.35 (d, 2H, 3J = 8.4, H6-NCN), 8.19-8.15 (s+t, 2H, H4’-NCN+H4-pbi), 7.74-7.64 
(t+t+d, 5H, H3-NCN+H4-NCN+H5-pbi), 7.45 (d, 1H, 3J = 8.0, H3’-pbi), 7.01 (t, 2H, 3J 
= 7.6, H5-NCN), 6.85 (t, 1H, 3J = 7.6, H4’-pbi), 6.56 (t, 1H, 3J = 7.6, H5’-pbi), 5.30 
(d, 1H, 3J = 8.4, H6’-pbi).  19F-NMR (CDCl3): δ -59.39.  Mass Spectrometry (ES+): 
m/z 790 [M+H]+.  
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Synthesis of [Ir(1,3-di-(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2-(2-pyridyl-N-
methyl)benzimidazole) chloride]+[PF6]- [Ir(L1)(Me-pbi)Cl]+ (20) 
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A mixture of [Ir(L1)Cl(µ-Cl)]2 (28 mg, 0.027 mmol), Me-pbiH (12 mg, 0.54 mmol) 
and silver triflate (28 mg, 0.11 mmol) in 4 ml of toluene was heated at reflux 
temperature.  The solution was cooled to room temperature and the precipitated 
AgCl was removed by centrifuge and washed with acetonitrile.  The combined 
organic layer was dried under reduced pressure, dissolved in the minimum amount 
of acetonitrile and a saturated aqueous solution of KPF6 was added, the 
precipitated complex was isolated by centrifuge, washed with water and dried 
under vacuum.  The product was purified via silica gel separation chromatography 
(from 100% DCM to 98% DCM; 2% MeOH), and obtained as a yellow solid (12 
mg, 0.029 mmol, 53%).  1H-NMR (CD3CN, 500 MHz): δ 10.06 (d, 1H, 3J = 5.0, H6-
pbi), 8.73 (d, 1H, 3J = 8.0, H3-pbi), 8.53 (td, 1H, 3J = 8.5, 4J = 2.0, H4-pbi), 8.21-
8.17 (d+t, 3H, H5-pbi+H6-NCN), 7.78 (t, 2H, 3J = 8.5, H4-NCN), 7.64 (d, 2H, 3J = 
6.0, H3-NCN), 7.53 (d, 1H, 3J = 8.0, H3’-pbi), 7.33 (t, 1H, 3J = 7.0, H4’-PBI), 7.23 (s, 
1H, H4’-NCN), 7.05 (td, 2H, 3J = 7.0, 4J = 1.0, H5-NCN), 6.93 (t, 1H, 3J = 7.5, H5’-
pbi), 6.87 (d, 1H, 3J = 8.5, H6’-pbi), 2.91 (s, 6H, HMe).  Mass Spectrometry (ES+): 
[M]+ 696 m/z.  HRMS (ES+): m/z 694.1470 [M]+.  Calcd for C31H26N5Cl191Ir: m/z 
694.1506. 
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Synthesis of [Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
(2-pyridyl-N-methyl)bezimidazol) chloride]+[PF6]- [Ir(L3)(Me-pbi)Cl]+ (21) 
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A mixture of [Ir(L3)Cl(µ-Cl)]2 (30 mg, 0.024 mmol), Me-pbiH (12 mg, 0.54 mmol) 
and silver triflate (28 mg, 0.11 mmol) in 4 ml of toluene was heated at reflux 
teperature.  Same procedure was adopted as for [Ir(L1)(Me-pbi)Cl]+ (20).  The 
product was purified via silica gel chromatography (from 100% DCM to 98% DCM; 
2% MeOH), and obtained as a yellow solid (12 mg, 0.025 mmol, 53%).  1H-NMR 
(CD3CN, 400 MHz): δ 10.01 (dd, 1H, 3J = 6.0, 3J = 0.8, H6-pbi), 8.74 (d, 1H, 3J = 
7.2, H3-pbi), 8.56 (td, 1H, 3J = 4.0, 4J = 1.6, H3py-pbi), 8.31(s, 1H, H4’-NCN), 8.21 
(td, 1H, 3J = 5.6, 4J = 1.6, H5-pbi), 7.95 (td, 2H, 3J = 7.6, 4J = 1.6, H4-NCN), 7.79 
(dd, 2H, 3J = 6.4, 4J = 0.4, H3-NCN), 7.53 (d, 1H, 3J = 8.8, H3’-pbi), 7.32 (td, 1H, 3J 
= 5.2, 4J = 0.8, H4’-pbi), 7.26 (td, 2H, 3J = 5.6, 4J = 1.2, H5-NCN), 6.97 (td, 1H, 3J = 
5.6, 4J = 0.8, H5’-pbi), 5.65 (d, 1H, 3J = 7.6, 3J = 0.4, H6’-pbi).  19F-NMR (CD3CN, 
376 MHz): δ -60.15 (6F, NCN), -71.5 and -75.2 (6F, s, PF6).  Mass Spectrometry 
(ES+): m/z 804 [M]+.  HRMS (ES+): m/z 802.0901 [M]+.  Calcd for 
C31H20N5F6Cl191Ir: m/z 802.0940. 
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5.14. Ligand metathesis 
 
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2') cynide [Ir(L1)(dFppy)CN] (22) 
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In Schlenk 15mg (0.022 mmol) of Ir(L1)(dFppy)Cl (1) and 8mg (0.3mmol) of 
silver triflate were dissolved in 2ml of acetone and refluxed for 6 hours.  After 
cooling to room temperature the precipitated AgCl was removed by centrifuge and 
the combined organic layers dried under vacuum.  The resulting solid was 
dissolved in methanol and was added to a solution of KCN (3mg, 0.05mmol) in 3 
ml in methanol and strirred overnight.  The resulting solution was then extracted in 
dichloromethane and washed with water and dried over MgSO4.  The product was 
obtained as a yellow solid (10 mg, 0.015 mmol, 68%).  1H-NMR (CDCl3, 400 MHz): 
δ 9.99 (d, 1H, 3J = 5.2, H6-NC), 8.40 (d, 1H, 3J = 9.2, H3-NC), 7.98-7.94 (t+d, 3H, 
H4-NC+H6-NCN), 7.60 (d, 2H, 3J = 6.0, H3-NCN), 7.53 (td, 2H, 3J = 7.6, 4J = 1.6, 
H4-NCN), 7.43 (t, 1H, 3J = 5.6, H5-NC), 6.86 (s, 1H, H4’-NCN), 6.72 (m, 2H, 3J = 
6.8, 4J = 2.8, H5-NCN), 6.15 (dd, 3J = 11.2, 4J = 2.0, 1H, H4’-NC), 5.41 (dd, 1H, 3J = 
8.0, 4J = 2.0, H6’-NC), 2.77 (s, 6H, HMe).  19F-NMR (CDCl3, 376 MHz): δ -109.0 (2F, 
3J = 11.6, NCN), -109.7 (2F, NC).  Mass Spectrometry (MALDI+): m/z 668 [M]+, 
m/z 642 [M-(CN)]+.  HRMS (ASAP+): m/z 666.1357 [M]+. Calcd for C30H21N4F2191Ir: 
m/z 666.1340. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2') cyanide [Ir(L2)(dFppy)CN] (23) 
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This complex prepared in the same way, starting from Ir(L2)(dFppy)Cl (2) (36mg, 
0.052 mmol) leading to the product (22mg, 0.033 mmol, 63%).  1H-NMR (CDCl3, 
700 MHz): δ 10.08 (d, 1H, 3J = 4.9, H6-NC), 8.44 (d, 1H, 3J = 9,1, H3-NC),8.12 (d, 
2H, 3J = 7.7, H6-NCN), 8.04 (t, 1H, 3J = 7.0, H4-NC), 7.65 (t, 2H, 3J = 7.0, H4-NCN), 
7.60 (d, 2H, 3J = 4.9, H3-NCN), 7.51 (t, 1H, 3J = 6.3, H5-NC), 6.86-6.83 (t+t, 3H, 
H5-NCN+H4’-NCN), 6.20 (m, 1H, 3J = 11.2, 4J = 1.4H4’-NC), 5.46 (dd, 1H, 3J = 7.7, 
4J = 0.7, H6’-NC).  19F-NMR (CDCl3, 660 MHz): δ –107.6 (2F, d, 3J = 6.0, NCN), -
108.3 (1F, NC), -109.1 (1F, NC).  Mass Spectrometry (MALDI+): m/z 676 [M]+, m/z 
650 [M-(CN)]+.  HRMS (ASAP+): m/z 674.0860. Calculated for C28H15N4F4191Ir: 
m/z 674.0862. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2') cyanide [Ir(L2)(ppy)CN] (24) 
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This complex prepared in the same way, starting from Ir(L2)(ppy)Cl (4) (36mg, 
0.052 mmol) leading to the product (22mg, 0.033 mmol, 63%).  1H-NMR (CDCl3, 
400 MHz): δ 9.96 (dd, 1H, 3J = 4.8, H6-NC), 8.62 (d, 1H, 3J = 5.2, H3-NC), 8.03(d, 
2H, 3J = 5.7, H6-NCN), 7.98-7.91 (td+d, 2H, H4-NC+H3’-NC), 7.67 (t, 1H, 3J=6.4, 
H4-NC), 7.59-7.53 (td+d, 4H, H3-NCN+H4-NCN), 7.46-7.38 (t+t+t, 3H, H4’-NC+H4’-
NCN+H5-NC), 6.75 (td, 2H, 3J = 9.6, 4J = 1.6, H5-NCN), 6.20 (td, 1H, 3J = 6.0, 4J = 
1.2H4’-NC), 5.46 (dd, 1H, 3J = 7.2, 4J = 0.8, H6’-NC).  19F-NMR (CDCl3, 376 MHz): 
δ –108.6 (2F, d, 3JF–H = 12, NCN).  Mass Spectrometry (MALDI+): m/z 640 [M]+. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-bis-(trifluoromethyl)benzene-N,C2',N) 
(2,4-(difluorophenyl)pyridine-N,C2') cyanide [Ir(L3)(dFppy)CN] (25) 
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This complex prepared in the same way, starting from Ir(L3)(dFppy)Cl (3) (15 mg, 
0.019 mmol) leading to the product (8mg, 0.010 mmol, 54%).  1H-NMR (CDCl3, 
400 MHz): δ 10.03 (dd, 1H, 3J = 4.4, 4J = 0.8, H6-NC), 8.45 (dd, 1H, 3J = 8.4, 4J = 
1.6, H3-NC),8.37 (d, 2H, 3J = 8.8, H6-NCN), 8.07-8.01 (t+s, 2H, H4-NC+H4’-NCN), 
7.77-7.70 (d+t, 4H, H4-NCN+H3-NCN), 7.50 (td, 1H, 3J = 6.0, 4J = 1.2, H5-NC), 
6.97 (td, 2H, 3J = 6.3, 4J = 0.8, H5-NCN), 6.20 (m, 1H, 3J= 13.2, 4J = 2.4, 5J = 
1.4H4’-NC), 5.15 (dd, 1H, 3J= 8.0, 4J=2.4, H6’-NC).  19F-NMR (CDCl3, 376 MHz): δ -
59.2 (6F, NCN), -70.7 and -83.1 (2F, NC).  Mass Spectrometry (ASAP+): m/z 775 
[M]. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2-
phenylpyridine-N,C2') cyanide [Ir(L1)(ppy)CN] (26) 
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This complex prepared in the same way, starting from Ir(L1)(ppy)Cl (10 mg, 0.030 
mmol) leading to the product (10mg, 0.016 mmol, 84%).  1H-NMR (CDCl3, 400 
MHz): δ 9.84 (d, 1H, 3J = 6.0, H6-NC), 8.03 (d, 1H, 3J = 8.4, H3-NC), 7.97 (d, 2H, 3J 
= 8.4, H6-NCN), 7.65 (d, 2H, 3J = 4.4, H3-NCN), 7.59-7.49 (t+d, 6H, H4-NCN+H3’-
NC), 7.43 (td, 1H, 3J = 5.6, 4J = 0.8, H4-NC), 6.88 (s, 1H, H4’-NCN), 6.76-6.66 (t+t, 
3H, H5-NCN+H5-NC), 6.55 (td, 2H, 3J = 7.6, 4J = 0.8, H4’-NC), 6.47 (td, 1H, 3J = 
7.2, 4J = 1.2, H5’-NC), 5.90 (dd, 1H, 3J=7.2, 4J = 0.8, H6’-NC), 2.78 (6H, s, HMe).   
Mass Spectrometry (ASAP+): 632 m/z [M]+. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2') thiocynide [Ir(L1)(dFppy)SCN] (27) 
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Ir(L1)(dFppy)Cl (1) (10 mg, 0,02mmol) and silver triflate (10 mg 0.03 mmol) were 
dissolved in acetone (2 ml) in a Schlenk, and the solution was heated at reflux for 
6 hours.  After cooling to room temperature, the precipitated AgCl was removed by 
centrifuge and the combined organic layers dried under vacuum.  The resulting 
solid was dissolved in methanol and was added to a solution of NH4SCN in 
methanol (10mg, 0.13mmol in 3 ml) and strirred overnight.  Dichloromethane (5 
ml) was added, and the solution was washed with NaOH (1M, 3*5 ml) followed by 
water, and dried over mgSO4. Removal of solvent gave the product as a yellow 
solid (15 mg, 0.021 mmol, 95%).  1H-NMR (CDCl3, 400 MHz): δ 9.59 (dd, 1H, 3J = 
5.6, 4J = 0.8, H6-NC), 8.44 (dd, 1H, 3J = 8.4, 4J = 1.2, H3-NC), 8.02-8.00 (t+d, 3H, 
H4-NC+H6-NCN), 7.52 (d, 2H, 3J = 6.0, H3-NCN), 7.70-7.60 (t+t, 3H, H4-NCN+H5-
NC), 6.92 (s, 1H, H4’-NCN), 6.81 (t, 2H, 3J = 6.4, H5-NCN), 6.18 (m, 1H, 3J = 13.2, 
4J = 2.4, H4’-NC), 5.41 (dd, 1H, 3J = 11.2, 4J = 2.4, H6’-NC), 2.82 (s, 6H, HMe).   19F-
NMR (CDCl3, 376 MHz): δ -108.8 (1F, NC), -109.7 (1F, NC).  Mass Spectrometry 
(MALDI+): m/z 700 [M]+, m/z 642 [M-(SCN)]+.  HRMS (ASAP+): m/z 698.1048 
[M]+.  Calculated for 191IrC30H21F2SN4: m/z 698.1034. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2-
phenylpyridine-N,C2') thiocynide [Ir(L1)(ppy)SCN] (28) 
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The title complex was prepared from Ir(L1)(ppy)Cl (10 mg, 0.016 mmol) using the 
same procedure, leading to the product as a yellow solid (6 mg, 0.009 mmol, 
56%).  1H-NMR (CDCl3, 400 MHz): δ 9.50 (d, 1H, 3J = 5.6, H6-NC), 8.01 (d, 1H, 3J 
= 8.0, H3-NC), 7.96-7.92 (d+t, 3H, H6-NCN+H4-NC), 7.54-7.50 (t+d+d, 6H, H5-
NC+H4-NCN+H3-NCN+H3-NC), 6.85 (s, 1H, H4’-NCN), 6.71 (td, 2H, 3J = 5.6, 4J = 
2.0, H5-NCN), 6.65 (td, 1H, 3J = 7.6, 4J = 0.8, H4’-NC), 6.47 (td, 1H, 3J = 7.2, 4J = 
1.2, H5’-NC), 5.46 (dd, 1H, 3J = 7.2, 4J = 0.8, H6’-NC), 2.78 (6H, s, HMe).   Mass 
Spectrometry (ASAP+): m/z 606 [M-Cl]+, m/z 663 [M]+. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2-
phenylpyridine-N,C2') thiocynide [Ir(L2)(ppy)SCN] (29) 
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The title complex was prepared from Ir(L2)(ppy)Cl (4) (16 mg, 0.025 mmol) using 
the same procedure, leading to the product as a yellow solid (9 mg, 0.013 mmol, 
52%).  1H-NMR (CDCl3, 400 MHz): δ 9.50 (d, 1H, 3J = 5.6, H6-NC), 8.01 (d, 1H, 3J 
= 8.0, H3-NC), 7.96-7.92 (d+t, 3H, H6-NCN+H4-NC), 7.54-7.50 (t+d+d, 6H, H5-
NC+H4-NCN+H3-NCN+H3’-NC), 6.85 (s, 1H, H4’-NCN), 6.71 (td, 2H, 3J = 5.6, 4J = 
2.0, H5-NCN), 6.65 (td, 1H, 3J = 7.6, 4J = 0.8, H4’-NC), 6.47 (td, 1H, 3J = 7.2, 4J = 
1.2, H5’-NC), 5.46 (dd, 1H, 3J = 7.2, 4J = 0.8, H6’-NC).   19F-NMR (CDCl3, 660 
MHz): δ -108.0 (2F, d, J=7.2).  Mass Spectrometry (ASAP+): m/z 614 [M-Cl]+, m/z 
672 [M]+. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2')(3,5-bis(trifluoromethyl)benzene-1-
acetylide) [Ir(L1)(dFppy)(A1)] (30) 
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1-Ethynyl-3,5-bis(trifluoromethyl)benzene (8 mg, 0.032 mmol) and KOH (30 mg, 
0.5mmol) in 5 ml of methol were stirred for 1 hour.  After that a solution of 
Ir(L1)(dFppy)Cl (1) (15 mg, 0.022 mmol) and CuI (3 mg, 0.017) in methanol was 
added and the combined solutions were stirred overnight.  The target complex 
precipitated from the solution and is isolated by cenerfuge and washed with 
methanol (10 mg, 0.011, 50%).  1H-NMR (CDCl3, 400 MHz): δ 10.18 (dd, 1H, 3J = 
4.4, 4J = 1.2, H6-NC), 8.45 (d, 1H, 3J = 8.0, H3-NC) 8.05 (d, 2H, 3J = 8.4, H6-NCN), 
7.98 (t, 3H, 3J = 9.6, H4-NC), 7.74 (d, 2H, 3J = 5.6, H3-NCN), 7.59 (t, 2H, 3J = 8.0, 
H4-NCN), 7.49 (t, 1H, 3J = 6.0, H5-NC), 7.36 (s+s, 3H, H2’’+H4’’), 6.91 (s, 1H, H4’-
NCN), 6.79 (td, 2H, 3J = 7.2, 4J = 1.2, H5-NCN), 6.17 (m, 1H, 3J = 13.2, 4J = 2.4, 
H4’-NC), 5.44 (dd, 1H, 3J = 8.4, 4J = 2.8, H6’-NC), 2.86 (s, 6H, HMe).  19F-NMR 
(CDCl3, 376 MHz): δ -63.5 (6F, ancillary), -110.3 and -110.5 (2F, NC).  Mass 
Spectrometry (MALDI+): m/z 879 [M]+, m/z 642 [M-(dtfmbA)]+. 
 
 
 
 261
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
phenylpyridine-N,C2')(3,5-bis-(trifluoromethyl)benzene-1-acetylide) 
[Ir(L3)(ppy)(A1)] (31) 
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The title compound was prepared from Ir(L3)(ppy)Cl (5) (20 mg, 0.027 mmol) in 
the same way as for the previous complex, leading to the target complex (12 mg, 
0.012, 47%).  1H NMR (CDCl3, 400 MHz) δ 10.16 (d, 3J = 5.5, 1H, H6-NC), 8.43 (d, 
3J = 8.4, 2H, H3-NC), 8.23 – 7.87 (d+t+d, 4H, H4-NC+H4’-NC+H3-NCN), 7.79 – 
7.45 (t+d+t, 4H, H4-NCN+H6’-NCN+H5-NC), 7.37 (s+s, 3J = 13.7, 3H, H2’’+H4’’), 
6.98 (t, 3J = 7.2, 2H, H5-NCN), 6.80 (t, 3J = 7.5, 1H, H5-NC), 6.63 (t, 3J = 7.3, 1H, 
H5’-NC), 5.72 (d, 3J = 7.4, 1H, H6’-NC).  19F-NMR(CDCl3, 400 MHz) δ –59.02 (6F, 
NCN), -63.50 (6F, ancillary).  Mass Spectrometry (MALDI+): m/z  951 [M]+, m/q 
714 [M-btfmbA]+.  HRMS (ASAP+): m/z 949.1100 [M]+. Calculated for 
C39H20N3F12191Ir: m/z 949.1072. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
phenylpyridine-N,C2')(4-methoxy-phenylacetylene)[Ir(L3)(ppy)(A3)] (32) 
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The title compound was prepared from Ir(L3)(ppy)Cl (5) (15 mg, 0.022 mmol) in 
the same way as for the previous complex, leading to the target complex (10 mg, 
52%).  1H-NMR (CDCl3, 400 MHz): δ 10.18 (d, 1H, 3J = 4.4, H6-NC), 8.45 (d, 1H, 
3J = 8.0, H3-NC) 8.05 (d, 2H, 3J = 8.4, H6-NCN), 7.98 (t, 2H, 3J = 8.0, H4-NCN), 
7.74 (d, 2H, 3J = 5.6, H3-NCN), 7.59 (t, 2H, 3J = 8.0, H5-NCN), 7.49 (t, 1H, 3J = 6.0, 
H5-NC), 7.36 (d+d, 4H, H2’’+H4’’), 6.91 (s, 1H, H4’-NCN), 6.81-6.72 (t+d, 2H , H3’-
NC+H4-NC), 6.17 (m, 1H, H5’-NC), 5.44 (dd, 1H, 3J = 8.4, 4J = 2.8, H6’-NC), 2.86 
(s, 6H, HOMe).  19F-NMR (CDCl3, 176 MHz): δ -57.0 (6F, NCN).  Mass 
Spectrometry (MALDI+): m/z 845 [M]+, m/z 714 [M-OMeA]+. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
phenylpyridine-N,C2')(phenylacetylene) [Ir(L3)(ppy)(A2)] (33) 
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The title compound was prepared from Ir(L3)(ppy)Cl (5) (15 mg, 0.022 mmol) in 
the same way as for the previous complex, leading to the target complex (8 mg, 
0.011 mmol, 50%).  1H-NMR (CDCl3, 400 MHz): δ 10.18 (d, 1H, 3J = 4.4, H6-NC), 
8.45 (d, 1H, 3J = 8.0, H3-NC) 8.05 (d, 2H, 3J = 8.4, H6-NCN), 7.98 (t, 2H, 3J = 8.0, 
H4-NCN), 7.74 (d, 2H, 3J = 5.6, H3-NCN), 7.59 (t, 2H, 3J = 8.0, H5-NCN), 7.49 (t, 
1H, 3J = 6.0, H5-NC), 7.30-7.40 (m, 3H, H2’’+H3’’+H4’’), 6.91 (s, 1H, H4’-NCN), 6.79 
(t+t, 2H, H3’-NC+H4’-NC), 6.17 (m, 1H, H5’-NC), 5.44 (dd, 1H, 3J = 8.4, 4J = 2.8, H6’-
NC), 2.86 (s, 6H, HMe).  Mass Spectrometry (MALDI+): m/z 815 [M]+, m/z 741 [M-
phenA]+. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
phenylpyridine-N,C2')(4-dimethylamino-phenylacetylene) [Ir(L3)(ppy)(A4)]  
(34) 
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The title compound was prepared from Ir(L3)(ppy)Cl (5) (20 mg, 0.027 mmol) in 
the same way as for the previous complex, leading to the target complex (10 mg, 
0.014 mmol, 52%).  1H-NMR (CDCl3, 400 MHz): δ 10.18 (d, 1H, 3J = 4.4, H6-NC), 
8.45 (d, 1H, 3J = 8.0, H3-NC) 8.05 (d, 2H, 3J = 8.4, H6-NCN), 7.98 (t, 3H, 3J = 8.0, 
H4-NCN), 7.74 (d, 2H, 3J = 5.6, H3-NCN), 7.59 (t, 2H, 3J = 8.0, H5-NC), 7.49 (t, 1H, 
3J = 6.0, H5-NC), 7.36 (d+d, 4H, H2’’+H4’’), 6.91 (s, 1H, H4’-NCN), 6.79 (t+t 2H, H3’-
NC+H4’-NC), 6.17 (m, 1H, H5’-NC), 5.44 (dd, 1H, 3J = 8.4, 4J = 2.8, H6’-NC), 2.86 
(s, 6H, HMe).  19F-NMR (CDCl3, 376 MHz) : δ -58.2 (6F, NCN).  Mass Spectrometry 
(MALDI): m/z 858 [M]+, m/z 714 [M-OMeA]+.  
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
phenylpyridine-N,C2')(4-cyano-phenylacetylene) [Ir(L3)(ppy)(A5)] (35) 
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The title compound was prepared from Ir(L3)(ppy)Cl (5) (15 mg, 0.022 mmol) in 
the same way as for the previous complex, leading to the target complex (12 mg, 
0.014 mmol, 64%).  1H-NMR (CDCl3, 400 MHz): δ 10.09 (dd, 1H, 3J = 4.0, 4J = 0.8, 
H6-NC), 8.35 (d, 2H, 3J = 8.0, H6-NCN), 8.05 (d+s, 2H, H3-NCN+H4’-NCN), 7.96 
(td, 1H, 3J = 7.2, 4J = 1.2, H4-NC), 7.88 (dd, 2H, 3J = 5.6, 4J = 1.2, H3-NCN), 7.64 
(td, 2H, 3J=8.0, 4J = 1.6, H4-NCN), 7.58 (d, 1H, 3J = 8.0, H3’-NC), 7.46 (td, 1H, 3J = 
6.0, 4J = 1.2, H5-NC), 7.22 (d, 2H, 3J = 8.4, H2’’ or 3’’), 7.94 (d, 2H, 3J = 8.4, H2’’ or 3’’), 
6.89 (td, 2H, 3J = 6.4, H5-NCN), 6.73 (td, 1H, 3J = 7.6, 4J = 1,.2, H4’-NC), 6.56 (td, 
1H, 3J = 8.0, 4J = 1.2, H5’-NC), 5.64 (dd, 1H, 3J = 8.0, 4J = 1.6, H6’-NC).  19F-NMR 
(CDCl3, 376 MHz): δ -58.7 (6F, NCN).  Mass Spectrometry (MALDI+): m/z 841 
[M]+, m/z 714 [M-OMeA]+.  HRMS (ASAP+): m/z 839.1383. Calculated for 
C38H21N4F6191Ir: m/z 839.1299. 
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Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
phenylpyridine-N,C2')(5-phenyl-tetrazole) [Ir(L3)(ppy)(phtr)] (36) 
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In a schlenk tube were Ir(L3)(ppy)Cl (5) (50 mg, 0.067 mmol) and AgBF4 (16 mg, 
0.073 mmol) in 5 ml of a solution acetone/water 2:1. the apparatus was proteted 
from light with aluminium foil and the mixture refluxed overnight under nitrogen.  
After cooling to room temperature, the precipitated AgCl was removed by 
centerfuge from the solution of the solvate-complex.  Meanwhile a solution of 5-
phenyl-tetrazole (12 mg, 0.085 mmol) in acetone (3 ml) was treated with few drops 
of Et3N and stirred for 30 minutes.  The solution containing the deprotonated 
tetrazole was then added dropwise to the solution containing the solvate-complex.  
The combined mixture was then refluxed overnight.  After cooling to room 
temperature, the mixture was diluited with 50 ml of dichloromethane and 
extractions were performed with 100*3 ml of water.  The organic layer was dried 
over MgSO4 and filtered.  Purificetion was achieved after silica gel 
chromatography (DCM/MeOH 95:5).  The product was an orange solid (15 mg, 
0.019 mmol, 28%).  1H-NMR (CD3Cl, 400 MHz): δ 8.79 (dd, 1H, 3J = 5.6, 4J = 1.2, 
H6-NC), 8.30 (d, 2H, 3J = 8.4, H6-NCN), 8.08 (d, 1H, 3J = 8.4, H3-NC), 8.0-7.92 
(s+t+d. 4H, H4’-NCN+H4-NC+H4’’), 7.73-7.68 (t+t, 3H, H4-NCN+H2’’ or 3’’), 7.60 (d, 
1H, 3J = 7.2, 4J = 0.8, H3’-NC), 7.36 (t, 1H, 3J = 6.4, 4J = 1.2, H5-NC), 7.25-7.15 
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(d+t, 3H, H3-NCN+H2’’ or 3’’), 7.0 (td, 2H, 3J = 6.4, 4J = 0.8, H5-NCN), 6.76 (td, 1H, 3J 
= 6.8, 4J = 1.2, H4’-NC), 6.59 (td, 1H, 3J = 7.2, 4J = 1.2, H5’-NC), 5.76 (dd, 1H, 3J = 
7.6, 4J = 0.8, H6’-NC).  13C-NMR (CDCl3, 700 MHz): δ 199.8, 183.5, 165.4 (C2-
NCN), 152.0 (CH4’-NCN), 150.0 (CH2’’-phtr), 149.7 (CH6-NC), 148.0, 144.2, 144.1, 
142.1, 142.0, 138.4 (CH4-NC), 137.1, 136.5 (CH3’-NC), 136.0, 130.3, 129.8 (CH4’-
NC), 128.6 (CH3-NCN or CH3’’-phtr), 127.9 (CH3-NCN or CH3’’-phtr), 126.2, 125.8, 
125.6 (CH4-phtr), 124.9 (CH6-NCN), 123.9 (CH6’-NC), 122.1 (CH5-NC), 119.1 
(CH3-NC), 119.0.  19F-NMR (CDCl3, 660 MHz): -58.8 (2F, NCN).  Mass 
Spectrometry (MALDI+): m/z 860 [M]+, 714 m/z [M-phtr]+.  HRMS (ASAP+): m/z 
858.1535 [M]+.  Calculated for C36H23N7F6191Ir: m/z 858.1525. 
 
 
 
Synthesis of Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-N,C2',N)(2-
phenylpyridine-N,C2')(5-(2-bromophenyl)-tetrazole) [Ir(L3)(ppy)(brphtr)] 
(37) 
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In a schlenk tube were Ir(L3)(ppy)Cl (5) (50 mg, 0.067 mmol) and AgBF4 (16 mg, 
0.073 mmol) in 5 ml of a solution acetone/water 2:1. the apparatus was proteted 
from light with aluminium foil and the mixture refluxed overnight under nitrogen.  
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Identical synthetic procedure was adopted as for the synthesis of 
Ir(L3)(ppy)(phtr) (36) adding 19 mg, (0.085 mmol) of 1-(4bromo-phenyl)-tetrazole 
in acetone (3 ml).  Purification of the product was achieved after silica gel 
chromatography (DCM/MeOH 95:5).  The product was an orange solid (61 mg, 
0.065 mmol, 97%).  1H-NMR (CD3Cl, 400 MHz): δ 8.79 (dd, 1H, 3J = 5.6, 4J = 1.2, 
H6-NC), 8.32 (d, 2H, 3J = 8.4, H6-NCN), 8.08 (d, 1H, 3J = 8.4, H3-NC), 7.97-7.92 
(s+t+d. 4H, H4’-NCN+H4-NC+H3-NCN), 7.72 (t, 2H, 3J = 7.6, 4J = 2.0, H4-NCN), 
7.62-7.58 (d+d, 3H, H3-NC+H2’’ or 3”), 7.36 (t, 1H, 3J = 7.2, 4J = 1.2, H5-NC), 7.31 (d, 
2H, 3J = 8.8, H2’’ or 3”), 6.99 (td, 2H, 3J = 6.8, 4J = 1.2, H5-NCN), 6.77 (td, 1H, 3J = 
7.2, 4J = 1.2, H4’-NC), 6.60 (td, 1H, 3J = 7.2, 4J = 1.2, H5’-NC), 5.77 (dd, 1H, 3J = 
8.4, 4J = 1.2, H6’-NC).  13C-NMR (CDCl3, 700 MHz): δ 199.8, 183.5, 165.4 (C2-
NCN), 152.0 (CH4’-NCN), 150.0 (CH2’’-phtr), 149.7 (CH6-NC), 148.0, 144.2, 144.1, 
142.1, 142.0, 138.4 (CH4-NC), 137.1, 136.5 (CH3’-NC), 136.0, 130.3, 129.8 (CH4’-
NC), 128.6 (CH3-NCN or CH3”-phtr), 127.9 (CH3-NCN or CH3”-phtr), 126.2, 125.8, 
125.6 (C4-phtr), 124.9 (CH6-NCN), 123.9 (CH6’-NC), 122.1 (CH5-NC), 119.1 (CH3-
NC), 119.0.  19F-NMR (CDCl3, 660 MHz): -58.8 (2F, NCN).  Mass Spectrometry 
(MALDI+): m/z 938 [M]+, 714 m/z [M-phtr]+.  HRMS (ASAP+): m/z 936.0656 [M]+. 
Calculated for 79BrF6N7C36H21191Ir : m/z 936.0575. 
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5.15. Synthesis of Rhodium complexes 
 
Synthesis of Rh(1,3-di-(2-pyridyl)-4,6-dimethylbenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2')chloride [Rh(L1)(dFppy)Cl] (38) 
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In Schlenk were added 50 mg of [Rh(L1)Cl(µ-Cl)]2 (0.058 mmol), 23 mg of dFppyH 
(0.131 mmol) in 3 ml of ethylene-glykol.  The mixture was refluxed for 4 hours and 
then cooled down to room tempetature.  A saturated aqueous solution of KPF6 
was then added and the precipitate collected by centrifuge and washed with 
acetonitrile.  The combined organic layer was dried under reduced pressure.  The 
product was a pale yellow solid (28 mg, 0.046 mmol, 41%).  1H-NMR (CDCl3, 500 
MHz): δ 10.18 (d, 1H, 3J = 4.5, H6-NC), 8.43 (d, 1H, 3J = 7.0, H3-NC), 8.07 (t, 1H, 
3J = 8.0, H4-NC), 7.98 (d, 2H, 3J = 7.0, H6-NCN), 7.62 (t, 2H, 3J = 7.5, H4-NCN), 
7.52 (d, 2H, 3J = 6.0, H3-NCN), 6.92 (s, 1H, H4’-NCN),6.86 (t, 1H, 3J = 6.5, H5-NC), 
6.81 (t, 2H, 3J = 6.8, H5-NCN), 6.25 (m, 1H, H4’-NC), 5.72 (dd, 1H, 3J = 6.5, 4J = 
0.5, H6’-NC), 2.81 (s, 6H, HMe).  19F-NMR (CDCl3, 176 MHz): δ -70.7 and -83.2 (2F, 
NC).  Mass Spectrometry (MALDI+): m/z 552 [M-Cl]+, m/z 586 [M]. 
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Synthesis of Rh(1,3-di-(2-pyridyl)-4,6-difluorobenzene-N,C2',N)(2,4-
(difluorophenyl)pyridine-N,C2')chloride [Rh(L2)(dFppy)Cl] (39) 
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Thiscomplex was prepared from [Rh(L2)Cl(µ-Cl)]2 (58 mg, 0.066 mmol), dFppyH 
(25 mg, 0.130 mmol) and Silver triflate (68 mg, 0.25 mmol) in 3ml of toluene.  The 
same synthetic method was adopted as for the synthesis of Rh(L1)(dFppy)Cl (38).  
The product was a pale yellow solid (12 mg, 0.018 mmol, 16%).  1H-NMR (CDCl3, 
400 MHz): δ 10.11 (d, 1H, 3J = 5.2, H6-NC), 8.38 (d, 1H, 3J = 9.2, H3-NC), 8.00 (d, 
2H, 3J = 8.0, H6-NCN), 7.62 (td, 2H, 3J = 8.0, 4J = 1.6, H4-NCN), 7.53 (t, 1H, 3J = 
6.4, H4-NC), 7.37 (d, 2H, 3J = 6.0, H3-NCN), 7.18 (s, 1H, H5-NC), 6.81 (td, 2H, 3J = 
7.6, 4J = 1.2, H5-NCN), 6.72 (t, 1H, 3J = 11.6, H4’-NCN), 6.23 (m, 1H, H4’-NC), 5.69 
(m, 1H, H6'-NC).  19F-NMR (CDCl3, 176 MHz): δ -78.80 (1F, NC), -79.0 (1F, NC), -
107.90 (2F, d, 3J = 7.2, NCN),  Mass Spectrometry (MALDI+): m/z 560 [M-Cl]+.  
HRMS (ASAP+): m/z 594.9959 [M–Cl]+. Calcd for C27H15N3F4Cl108Rh: m/z 
594.9945. 
(40) 
 
 
 
Synthesis of Rh(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-
N,C2',N)(2,4-difluorophenylpyridine-N,C2') chloride [Rh(L3)(dFppy)Cl] 
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This complex was prepared from [Rh(L3)Cl(µ-Cl)]2 (42 mg, 0.038 mmol) and 
dFppyH (15 mg, 0.079 mmol) in the presence of silver triflate (35 mg, 0.14 mmol) 
in toluene (4 mL), as described above for Ir(L1)(dFppy)Cl (1).  The crude product 
was purified by chromatography (silica gel, CH2Cl2/MeOH, gradient elution from 
100/0 to 99/1), giving an orange solid (15 mg, 56%).  1H NMR (CDCl3, 700 MHz): δ 
10.12 (1H, d, 3J = 5.2, H6-NC), 8.30 (1H, d, 3J = 8.4, H3-NC), 8.04 (3H, t+s, H4-
NC+H4-NCN), 7.74 (2H, td, 3J = 9.2, 4J = 1.6, H6-NCN), 7.58 (3H, d+t, H5-
NCN+H5-NC), 6.99 (2H, dd, 3J = 7.6, 4J = 1.2, H6-NCN), 6.23 (1H, td, 3J = 15.6, 4J 
= 2.8, H4’-NC), 5.32 (1H, dd, 3J = 9.0, 4J = 2.5, H6’-NC).  19F NMR (CDCl3, 376.4 
MHz): δ –58.7 (6F, s, CF3), –107.6 and –108.1 (2F, NC).  Mass Spectrometry 
(MALDI+): m/z 660 [M–Cl]+.  HRMS (ES+): m/z 660.8973 [M–Cl]+.  Calcd for 
C29H15N3F8Rh: m/z 660.01932. 
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5.16. Synthesis of multimetallic complexes 
 
Synthesis of bis[Ir(1,3-di-(2-pyridyl)-4,6-di-(trifluoromethyl)benzene-
N,C2',N)(2-phenylpyridine-N,C2',N)](4,4’-diethynylbiphenyl-acetylide) 
[b[Ir(L3)(ppy)]bpha] (41) 
 
 
 
Ir
F3C
F3C
N
N
Cl
N
Ir
F3C
F3C
N
N
N
KOH
2
Ir
CF3
CF3
N
N
N
CuI
6
54
3
4'
6'
5' 4'
3'
3
4
56
2"
3"
 
 
 
 273
 
In Schlenk 3mg (0.017mmol) of 4,4’-diethynylbiphenyl and 30 mg(0.5mmol) of 
KOH in 5 ml of methol were stirred for 1 hour.  A solution of Ir(L3)(ppy)Cl (5) 
(25mg, 0.033 mmol) and CuI (3 mg, 0.017) in methanol was added and stirred 
overnight.  The target complex precipitated from the solution and is isolated by 
cenerfuge and washed with methanol (7 mg, 0.005 mmol 53%).  1H-NMR (CDCl3, 
400 MHz): δ 10.31 (d, 2H, 3J = 6.0, H6-NC), 8.39 (d, 4H, 3J = 8.0, H6-NCN), 8.10-
8.06 (s+d, 4H, H4’-NCN+H3-NC), 8.00 (d, 2H, 3J = 5.6, H3’-NC), 7.96 (d, 4H, 3J = 
4.8, H3-NCN), 7.71-7.63 (t+t, 6H, H4-NCN+H4-NC), 7.50 (t, 2H, 3J = 6.4, H5-NC), 
7.16 (d, 4H, 3J = 8.0, H2” or 3”), 6.98 (d, 4H, 3J = 8.4, H2” or 3”), 9.93 (t, 4H, 3J = 6.0, 
H5-NCN), 6.78 (t, 2H, 3J = 8.0, H4’-NC), 6.61 (t, 2H, 3J = 7.2, H5’-NC), 5.69 (d, 2H, 
3J = 7.2, H6’-NC).  19F-NMR (CDCl3, 660 MHz): δ -58.8 (12F, NCN).  Mass 
Spectrometry (MALDI+): m/z 714 [M]+, =  m/z 1628 [M-bridge-M]+. 
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Synthesis of bis[Ir(1,3-di-(2-pyridyl)-4,6-di-trifluoromethylbenzene)(2-
phenylpyridine)] 4-4’ tetrazolyl-bisphenyl [b[Ir(L3)(ppy)]btrph] (42) 
 
 
 
Ir
F3C
F3C
N
N
Cl
N
Ir
F3C
F3C
N
N
N
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NN
HN N
Et3N
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2
N N
NHN
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CF3
N
N
N
N
N
N N
N
N
NN
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6
54
3
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4'5'
6'
3
4
56
2"
3"
 
 
 
 
In a schlenk tube were Ir(L3)(ppy)Cl (5) (50 mg, 0.067 mmol) and AgBF4 (16 mg, 
0.073 mmol) in 5 ml of a solution acetone/water 2:1. the apparatus was proteted 
from light with aluminium foil and the mixture refluxed overnight under nitrogen.  
After cooling to room temperature, the precipitated AgCl was removed by 
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centerfuge from the solution of the solvate-complex.  Meanwhile a solution of 4-4’ 
tetrazolyl-bis-phenyl (5 mg, 0.033 mmol) in acetone (3 ml) was treated with few 
drops of Et3N and stirred for 30 minutes.  The solution containing the deprotonated 
tetrazole was then added dropwise to the solution containing the solvate-complex.  
The combined mixture was then reflux overnight.  After cooling to room 
temperature, the mixture was diluited with 50 ml of dichloromethane and 
extractions were performed with 100x3 ml of water.  The organic layer was dried 
over MgSO4 and filtered. Purificetion was achieved after silica gel chromatography 
(DCM/MeOH 95:5).  The product was an orange solid (6 mg, 0.0035 mmol, 10%).  
1H-NMR (CD3Cl, 400 MHz): δ 8.87 (2H, dd, 3J = 8.8, 4J = 1.6, H6-NC), 8.39 (4H, d, 
3J = 8.4, H6-NCN), 8.14 (2H, d, 3J = 8.4, H3-NC), 8.04-7.96 (8H, s+d+t, H4’-
NCN+H3-NCN+H4-NC), 7.85-7.64 (8H, d+td, H2” or 3”+H4-NCN), 7.65 (2H, dd, 3J = 
8.4, 1.6, H3’-NC), 7.48 (4H, d, 3J = 8.8, H2” or 3”), 7.42 (2H, td, 3J = 8.4, 4J = 0.8, H5-
NC), 7.06 (4H, td, 3J = 7.2, 4J = 2.4, H5-NCN), 6.84 (2H, td, 3J = 7.6, 3J = 2.4, H4’-
NC), 6.68 (2H, td, 3J = 7.6, 4J = 2.4, H5’-NC), 5.85 (2H, dd, 3J = 7.6, 4J = 1.6, H6’-
NC).  19F-NMR: δ -77.6 (12F, NCN).  Mass Spectroscopy (MALDI+): m/z 714 [M]+, 
=  m/z 1717 [M-bridge-M]+.  HRMS (ES+): m/z 1713.2852 [M-bridge-M]+.  Calcd for 
C72H42N14F12191Ir: m/z 1713.2816. 
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